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ABSTRACT 
 
Proteins and peptides fold into dynamic structures that access a broad functional 
landscape, however, designing artificial polypeptide systems continues to be a great chal-
lenge. Conversely, deoxyribonucleic acid (DNA) engineering is now routinely used to 
build a wide variety of two dimensional and three dimensional (3D) nanostructures from 
simple hybridization based rules, and their functional diversity can be significantly ex-
panded through site specific incorporation of the appropriate guest molecules. This dis-
sertation describes a gentle methodology for using short (8 nucleotide) peptide nucleic 
acid (PNA) linkers to assemble polypeptides within a 3D DNA nanocage, as a proof of 
concept for constructing artificial catalytic centers. PNA-polypeptide conjugates were 
synthesized directly using microwave assisted solid phase synthesis or alternatively PNA 
linkers were conjugated to biologically expressed proteins using chemical crosslinking. 
The PNA-polypeptides hybridized to the preassembled DNA nanocage at room tempera-
ture or 11 ⁰C and could be assembled in a stepwise fashion. Time resolved fluorescence 
anisotropy and gel electrophoresis were used to determine that a negatively charged az-
urin protein was repelled outside of the negatively charged DNA nanocage, while a posi-
tively charged cytochrome c protein was retained inside. Spectroelectrochemistry and an 
in-gel luminol oxidation assay demonstrated the cytochrome c protein remained active 
within the DNA nanocage and its redox potential decreased modestly by 10 mV due to 
the presence of the DNA nanocage. These results demonstrate the benign PNA assembly 
conditions are ideal for preserving polypeptide structure and function, and will facilitate 
the polypeptide-based assembly of artificial catalytic centers inside a stable DNA 
nanocage. A prospective application of assembling multiple cyclic γ-PNA-peptides to 
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mimic the oxygen-evolving complex (OEC) catalytic active site from photosystem II 
(PSII) is described. In this way, the robust catalytic capacity of PSII could be utilized, 
without suffering the light-induced damage that occurs by the photoreactions within PSII 
via triplet state formation, which limits the efficiency of natural photosynthesis. There-
fore, this strategy has the potential to revolutionize the process of designing and building 
robust catalysts by leveraging nature’s recipes, and also providing a flexible and con-
trolled artificial environment that might even improve them further towards commercial 
viability. 
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PREFACE 
Significant portions of the text used in this dissertation were used directly from 
manuscripts published or submitted for publication with permission from the publishers 
shown in appendix A. 
Although the majority of the work described in this dissertation in Chapter 3, 4 
and 5 was done by Justin Flory, the PhD candidate, some of the work was carried out by 
others as a part of Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Re-
search Center funded by the U.S. Department of Energy, Office of Science, Office of 
Basic Energy Sciences under Award Number DE-SC0001016. A breakdown of the col-
laborative work done by other members of the center, in close collaboration with the PhD 
candidate, is described as follows, and their contributions are greatly appreciated and so 
by acknowledged here. The figures containing the major results provided by the collabo-
rator is listed for convenience. The PhD candidate used the results provided by the col-
laborators to produce the figures in this dissertation.  
Trey Johnson (undergraduate student, working under the supervision of Justin Flory): γ-
PNA + Cy5 conjugation and PAGE purification and elution from gel blocks (Figure 5-3, 
Figure 5-4); assembly and purification of labeled and unlabeled DNA nanocages for γ-
PNA (Figure 5-7) and some DNA nanocages for PNA-protein assembly (Figure 2-14); 
purity assessment by native PAGE and MALDI of γ-PNA-Cy5 (Figure 5-5, Figure 5-6); 
hybridization of unlabeled and Cy5 labeled γ-PNA with DNA nanocages (Figure 5-7); 
some purification of ssDNA for DNA nanocages. Figure 5-3 was prepared by Trey John-
son. 
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Chad Simmons: PNA + Azurin conjugation and purification (Figure 2-9); DNA 
nanocage molecular model shown in Figure 6-5; DNA-PNA nanocage molecular model 
shown in Figure 2-18, Figure 4-10 and Figure 4-12; molecular models of azurin and cy-
tochrome c shown in Figure 4-1, Figure 4-4, Figure 4-5, Figure 4-10 and Figure 4-12. 
Ingo Grotjohann: Prepared Figure 6-4 and the molecular model of photosystem II used 
in Figure 1-1 and Figure 6-2. 
Alessio Adreoni: Expression and purification of azurin. 
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CHAPTER 1 – Introduction 
Due to the interdisciplinary nature of the work presented in this dissertation, I 
would like to first explore the broader context that links together the various disciplines 
and fields, and how this relates to the my background, interests and ambitions. The first 
section of the introduction provides insight into how nanotechnology is used in biological 
systems (i.e., bionanotechnology) and the potential impact of making improvements at 
the nanoscale. The next section introduces DNA nanotechnology, emphasizing some of 
the work that has been done for organizing peptides and proteins, but underscoring the 
need to develop methodologies for trying to assemble highly interconnected DNA-
polypeptide complexes within appropriately sized (<4 nm radius) nanostructures in order 
to mimic protein catalytic active sites. The next section introduces Peptide Nucleic Acid 
(PNA) as a compelling hybrid molecule that is ideal for developing a completely new 
type of methodology for connecting a number of peptides within small DNA nanoscaf-
folds. The introduction proceeds to describe the specific aims of the work described in 
this dissertation, and concludes by describing the outline and organization of the work 
contained herein. 
 
Bionanotechnology: Understanding and reengineering nature’s molecular machines 
Engineering is a powerful methodology, unique to humankind, which uses 
knowledge of basic scientific principles to design and build new and transformative tech-
nologies that have not existed previously except in the mind of the designer. As an ap-
plied physics undergraduate student taking a cellular and molecular biology course at 
Sonoma State University (CA), I gazed in amazement at some of nature’s remarkable 
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‘molecular machines’ and wondered how we might be able to use them and improve 
them to benefit society. Biological systems carry out a huge diversity of sophisticated 
tasks on the molecular level, such as self-assembling and repairing materials, self-
reproducing, transporting cargo, transmitting and receiving signals, capturing and con-
verting different forms of energy among many others, all which are carefully controlled 
through complex feedback mechanisms. At the core of each of these extraordinary capa-
bilities are proteins and other biomolecules that operate on the nanoscale (i.e., bionano-
technology), and through a remarkable set of organizational structures, seamlessly drive 
macroscopic functions. Figure 1-1 demonstrates the hierarchical level of organization in a 
plant, showing the careful ordering from the nanoscale world of molecules and proteins 
(0.1–100 nm), to the mesoscale world of chloroplasts and cells (0.1–1000 µm), and final-
ly to the macroscale world of leafs and plants (0.001–100 m).  
The fact that the molecules and proteins within a plant have a profound impact on 
the functionality of a leaf underscores how research and engineering at the level of bi-
onanotechnology can impact our world in a wide variety of ways to meet the current and 
future needs of humankind. Furthermore, these incredible molecular machines function 
and survive using widely available resources, such as sunlight, water and oxygen, and are 
constructed using the earth’s abundant elements (e.g., C, H, N, O, P, S). Thus biology 
provides an ideal recipe for sustainable processes to manufacture goods, such as fuels, 
food and plastics, and to perform services, such as waste water remediation and CO2 se-
questration. These processes could help to mitigate the current conflicts between human 
development and the environment, such as accumulation of non-biodegradable waste, air 
and water contamination, greenhouse gas emission and climate change. 
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Figure 1-1. Hierarchy of organization in a plant. [Left, Nanoscale] Hierarchy of pro-
tein structures, which serve as nature’s molecular machines on the nanoscale: 1) amino 
acids are joined to make polypeptides; 2) polypeptides self-assemble into stable structural 
motifs, such as an alpha helix or beta sheet; 3) these motifs foldup to form functional pro-
teins; 4) some proteins interact to form complexes with other proteins and biomolecules 
with more sophisticated capabilities.
1
 [Right, Mesoscale] In plants, photosynthetic pro-
teins operate within the membranes of stacked thylakoids in the chloroplast, which reside 
in the mesophyll cells in plant leaves.
2
 [Center, Macroscale] Trees arrange the leaves in a 
canopy to capture a large area of sunlight and convert light energy into the chemical en-
ergy for growth and proliferation. Photosystem II image: crystal structure solved by 
Umena et al (PDB accession code 3ARC).
3
 The image was created from 3ARC by Ingo 
Grotjohann. 
 
 With the intention of trying to find ways to mimic nature (i.e., biomimicry) or 
even improve on nature (i.e., biological engineering) to address critical needs for sustain-
able manufacturing, I joined the interdisciplinary Biological Design Graduate Program at 
Arizona State University (ASU). Bionanotechnolgy spans a range of scientific disci-
plines, including physics, chemistry, biology and engineering, so a training program that 
emphasizes interdisciplinary research would be critical to navigating the complex inter-
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faces between these disciplines. ASU is also one of the world’s leading institutions for 
photosynthesis research and DNA nanotechnology, making it a perfect fit for cutting 
edge research in bionanotechnology. I was immediately drawn to a challenging project 
that looked to leverage significant advancements in engineering DNA nanostructures to 
reengineer some of nature’s molecular machines (i.e., peptides and proteins) that were 
important for solar energy conversion in photosynthesis. With funding from the Depart-
ment of Energy for an Engineering Frontier Research Center, the Center for Bio-Inspired 
Solar Fuel production was facilitating the research necessary to build bio-inspired cata-
lysts for sustainable fuel production. However, in order to use DNA nanoscaffolds for 
assembling bio-inspired catalysts, a number of new tools needed to be developed and 
characterized to pave the way for this promising line of research, and as such, is the pri-
mary focus of the work in this dissertation. 
 
DNA nanostructures for engineering polypeptides 
The field of structural DNA nanotechnology has transformed our thinking about 
the purpose and possibilities of canonical base pairing biopolymers, which can have a 
much broader structural landscape than what has evolved in natural organisms. Deoxyri-
bonucleic acid (DNA) is a ubiquitous biological polymer evolved as a stable means for 
storing the information required to synthesize ribonucleic acid (RNA) and protein mole-
cules, which are used by the organism to do useful work. Two DNA strands are normally 
intertwined in a helical conformation and held together through bonding between com-
plementary bases, as originally discovered by Watson and Crick:
4
 adenosine (A) forms 
two hydrogen bonds with thymine (T), (or uracil (U) in the case of RNA) and cytosine 
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(C) forms three hydrogen bonds with guanine (G). When chromosomal DNA is copied, 
strand breaks can occur at the same point in the original and copied strands, which allows 
the strands to crossover, creating what is called a Holliday junction,
5
 as show in Figure 
1-2A. Because the sequences in the original and copied strands are identical, the Holliday 
junction can migrate up and down both strands.  
 
Figure 1-2. DNA Holliday junction and examples of 2D and 3D DNA nanostructures 
made of synthetic oligonucleotides. [A] Natural crossover junction formed between two 
DNA strands during recombination. Image from PDB accession code 3CRX.
6
 [B] Model 
showing a crossover tile with sticky ends a and b and complementary sticky ends a’ and 
b’7 that assemble to form a periodic lattice as shown in [C].8 [D] Non-self-
complementary tiles A and B are preassembled and then mixed to form periodic lattices.
9
 
Scale bar 300 nm. [E] (left) Schematic showing how short oligonucleotides are preas-
sembled into crossover motifs and subsequently mixed to form large 3D nanostructures, 
such as a tetrahedron, dodecahedron and Buckyball. (right) Cryo transmission electron 
micrograph of each 3D shape.
10
 Figures reproduced with permission from: [B] ref. 
7
, © 
Wiley 2006, [C] ref. 
8
, © AAAS 2003, [D] ref. 9, © AAAS 1998, [E] ref. 9, © NPG 2008. 
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In a pioneering effort, Nadrian Seeman theorized
11
 and later showed
12
 that similar 
junctions could be assembled using shorter strands of DNA (oligonucleotides), but by 
restricting the complementary regions to only part of the sequence, stable 2D and 3D 
nanostructures could be engineered. This work launched a new field now called ‘structur-
al DNA nanotechnology’; the reader is referred to several excellent reviews of the pro-
gress made in this dynamic field and the challenges that remain.
13–15
 Over the ensuing 
three decades, the rules for constructing DNA nanostructures have been refined,
16
 but is 
still are largely governed by simple Watson-Crick base pairing between complementary 
DNA sequences, making them significantly more straightforward to engineer than pro-
teins or peptides.
17,18
  
Seeman’s stable crossover structure set the stage for building a wide assortment of 
nanostructures assembled using mostly short [<100 nucleotides (nt)] oligonucleotides that 
could be readily synthesized. One common motif developed early on was a crossover tile, 
which structurally mimicked a small Holliday junction (Figure 1-2B),
7
 but included short 
single stranded domains called ‘sticky ends’ (a and b in Figure 1-2B) that were comple-
mentary to sticky ends somewhere else on the same tile (a’ and b’ in Figure 1-2B).7 In 
this way the tiles would spontaneously assemble together into large lattices, which could 
be further decorated with proteins, nanoparticles or other guest molecules with highly 
controlled nanometer spacing, as shown in Figure 1-2C.
8
 More complex tiles, in which 
strands crossover two
9
 or three times
19
 (i.e., double or triple crossover) were soon devel-
oped, along with non-self-complementary tiles (A and B in Figure 1-2D) that allowed 
each tile to be preassembled in high yield and subsequently mixed to build more complex 
periodic patterns, as shown in Figure 1-2D.
9
 This technique was later extended to build 
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3D structures, such as the tetrahedron, dodecahedron and Buckyball shown in Figure 
1-2E,
10
 by using other variations on the preassembled tile. One of the capstone accom-
plishments of this era of the field, was the rational design and assembly of a 3D DNA 
crystal by the group of Seeman.
20
 
 
Figure 1-3. 2D and 3D DNA nanostructures made using DNA origami. [A] Schematic 
[A] and AFM image [B] of a 2D DNA smiley face made from a >7000nt M13 bacterio-
phage DNA strand folded together like ‘origami’ and held together by over 200 short oli-
gonucleotide ‘staple’ strands.21 Schematic [C] and reconstructed cyro transmission elec-
tron micrograph (TEM) [D] of a hollow 3D DNA box made using DNA origami.
22
 DNA 
cylinder model [E] and TEM [F] of a DNA nanoflask made using DNA origami.
23
 Scale 
bar for [F] is 75 nm. [G] Basic crossover motif used in DNA origami (right) and a four 
arm junction (left) for increasing the angle of helical junctions [H] for designing more 
complex gridiron structures. [A] A hexagonal gridiron schematic (left) and TEM image 
(right).
24
 Figures reproduced with permission from: [A] and [B] ref. 
21
, © NPG 2006, [C] 
and [D] ref. 
22
, © NPG 2009, [E] and [F] ref. 23, © AAAS 2011, [G], [H] and [I] ref. 24, © 
AAAS 2013. 
 
One of the most transformative advancements in the field, that significantly ex-
panded the size and complexity of controlled DNA nanostructure assembly was Paul 
Rothemund’s seminal paper describing what he called ‘single-stranded DNA origami’.21 
DNA origami uses a long (>7000nt) strand of DNA from the M13 bacteriophage, which 
can be carefully folded together into a massive number of different shapes and structures, 
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which are held together by over 200 short oligonucleotides called ‘staple strands’.21 Fig-
ure 1-3
21
 shows the outline of the M13 strand as it is woven together into a smiley face 
[A] and the corresponding atomic force microscopy (AFM) image [B] of the assembled 
structure. Due to the large number of unique staple strands, each one could be uniquely 
functionalized to systematically arrange a large number of guest molecules almost any-
where on this molecular pegboard. This technique was later extended to build remarkable 
3D shapes, including a hollow box shown in Figure 1-3C, D.
22
 The group of Hao Yan 
made significant advancements to DNA origami based structural design by establishing 
design principles for producing complex curved 3D shapes, such as the DNA nanoflask 
shown in Figure 1-3E, F.
25
 Furthermore, the Yan group showed that the basic DNA ori-
gami crossover pattern, shown in Figure 1-3G (right), could be replaced by a four arm 
junction Figure 1-3G (left), resembling the Holliday junction, which allowed for a much 
broader junction angle between the joined helices (Figure 1-3H) and thus more complex 
gridiron-like structures (Figure 1-3I).
24
  
Because the functional diversity of unmodified DNA is limited, much effort has 
been focused on introducing functional groups. DNA scaffolds have been used to intro-
duce polymers to form foldamers
26
 or block copolymers,
27
 and metals to arrange nano-
particles,
28–30
 form nanowires,
8,31
 and nanomagnets.
32
 DNA nanostructures have also 
been developed for hybridization based biosensing, such as for unlabeled detection of 
RNA.
33
 Novel developments have been shown to introduce conformational dynamics into 
normally static DNA nanostructures by introducing ‘fuel’ DNA strands that competitive-
ly replace strands in an existing structure such that it can switch to a new 
conformation,
34,35
 and even ‘walk’ across a DNA surface.36 DNA strands can also be cop-
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ied in huge quantities and with high fidelity using enzymes in vitro by means of polymer-
ase chain reaction, helping to reduce the potential cost of using DNA nanostructures in 
commercial applications. The group of Hao Yan made significant progress in this direc-
tion, by designing DNA nanostructures that form spontaneously after in vitro enzymatic 
amplification,
37
 and later showed that genes encoding DNA nanostructures could be 
transformed and assembled within living cells.
38
  
 
Figure 1-4. Arranging polypeptides with DNA nanostructures . [A] (Left) Schematics 
showing a peptide epitope conjugated to a DNA linker attached to a 2D DNA array (top) 
and then with the complementary antibody bound (bottom). (Right) AFM images of the 
same constructs showing rows of peptides (top) and the bound antibodies (bottom) on the 
DNA surface.
39
 [B] Schematic showing the crystal structure of a peptide binding protein 
Syk kinase, the peptide binding sites, and an oligonucleotide helix presenting two pep-
tides with various nucleotide (nt) separations.
40
 [C] (top) Assembly of an enzyme cascade 
on a DNA origami tile where glucose oxidase (GOx) produces H2O2 using glucose, 
which is used by the adjacent enzyme horseradish peroxidase (HRP) to produce a detect-
able substrate ATBS
–
. The rate of catalysis in the multi-enzyme system was enhanced at 
shorter separation distances and using the water shell from a non-catalytic protein.
41
 Fig-
ures reproduced with permission from: [A] ref. 
39
, © Wiley 2007, [B] ref. 40, © Wiley 
2011, [C] ref. 
41
, © ACS 2012.  
 
DNA scaffolds offer a flexible, biocompatible workbench to explore the wide va-
riety of functions performed by proteins in nature, such as catalysis, scaffolding, molecu-
lar transport and molecular recognition among others. Methods for manipulating proteins 
10 
 
and peptides on 1D and 2D DNA nanostructures have been utilized to organize proteins 
on 2D arrays,
8
 to study antibody recognition of peptide epitopes,
39
 for selectively arrang-
ing multiple enzymes,
42
 investigating DNA binding proteins that recognize single strand-
ed aptamer sequences
43,44
 or specific DNA sequences in the major groove of the DNA 
helix,
45
 assembling complementary protein subunits
46
 or protein ligands,
40,47
 and for in-
vestigating the spatial dependence of enzyme cascades.
48,49
 Some of these applications 
using DNA to arrange polypeptides are shown in Figure 1-4.
39–41
 3D DNA nanostructures 
have also been used to encapsulate
50
 and arrange proteins
51–53
 as well as to organize 
membrane proteins for NMR structure determination.
54
 The relative ease with which 
DNA nanostructures are now constructed, compared to the challenges associated with 
protein and peptide engineering,
17,18
 raises the possibility of using DNA to investigate 
and modulate polypeptide function.  
Small 3D DNA nanostructures (radius <4 nm, <100 kDa) are particularly interest-
ing because they allow each spatial dimension to be controlled on the scale of typical 
peptide and protein intra and intermolecular interactions. While a number of techniques 
are available for identifying protein-protein interactions ,
55,56
 many of these interactions 
are dependent on the method used to discover them or are non-functional,
57
 so new meth-
ods are needed to validate and further characterize the specific properties of each interac-
tion.
58
 Detailed characterization of proteins and protein complexes may require relatively 
high molar concentration, such as for spectroelectrochemistry
59
 or circular dichroism,
60
 
which are not practical with large DNA origami nanostructures (> 4 MDa).
21
 Although, 
DNA provides a spatially precise scaffold for arranging polypeptides, its biological origin 
makes it more prone to naturally interact with the target molecules. For example, some 
11 
 
proteins contain specific DNA binding domains,
61
 which may strongly interact with the 
DNA scaffold, while other proteins may be influenced by non-specific interactions with 
the negatively charged backbone or hydrophobic nucleobase core. For these reasons, a 
better understanding of the interactions between several proteins and the DNA scaffold is 
needed to establish guidelines for using DNA scaffolds to study proteins.  
Small DNA nanostructures are also better suited to investigate intramolecular pro-
tein interactions (i.e., interactions occurring within a protein), which could further eluci-
date relationships between a proteins structure and function. Some proteins carry out 
multiple functions, such as photosystem II, which performs solar-driven water oxidation 
in photosynthetic organisms, and involves light capture, photochemical conversion of 
light into electrical energy, and catalysis. Small DNA nanostructures are an intriguing 
platform to decouple and investigate these processes independently, and even optimize 
and reengineer them. However, this type of extensive polypeptide manipulation may re-
quire assembling a number of polypeptides within a small DNA cavity, which is not prac-
tical using current conjugation methods. Furthermore, high resolution structural infor-
mation, which elucidates the orientation of the DNA helices, is essential to properly ori-
ent the polypeptides within the DNA nanostructure. However, due to the challenges asso-
ciated with obtaining high resolution DNA structures, few are available.
62–64
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Figure 1-5. DNA tetrahedron assembly, protein encapsulation and cryo Electron 
Microscopy density. [A] Schematic showing the assembly of a 3D DNA tetrahedron 
made from four 63nt DNA strands (top) each containing a 20nt domain complementary 
to a domain of matching color on each of the other strands. After annealing, the 5’ and 3’ 
ends of each strand can be enzymatically ligated to improve stability.
65
 [B] A strand 
schematic (left) and molecular model (right) of the DNA tetrahedron encapsulating the 
protein cytochrome c. The protein was attached at each of the indicated base positions 
(5–15) and position 8 was found to orient the protein inside the tetrahedron.50 [C] Elec-
tron density (top) and molecular model (bottom) of the DNA tetrahedron. The green ar-
row points to the major groove in the center of the helix facing outwards.
64
 Figures re-
produced with permission from: [A] ref. 
65
, © AAAS 2005, [B] ref. 50, © Wiley 2006, [C] 
ref. 
64
, © ACS 2009. 
 
One particularly well characterized small DNA nanostructure is an 78 kDa DNA 
tetrahedron with 7 nm edges, as originally designed by Goodman, Turberfield and 
coworkers.
65
 The tetrahedron is assembled by mixing each of the four 63nt oligonucleo-
tides at low concentration (< 1 µM) followed by high temperature annealing (i.e., from 
>90 ⁰C to < 25 ⁰C). The assembly process is shown in Figure 1-5,65 along with an option-
al ligation step to connect the ends of each strand post-assembly to provide additional 
stability. The authors were able to identify the location of the major and minor grooves 
and approximate base orientations through a series of DNA linking
65
 and protein encap-
sulation experiments,
50
 along with electron density from cryo-electron microscopy.
64
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Figure 1-5B
50
 shows a sequence schematic of the DNA tetrahedron along with the vari-
ous base positions where the protein cytochrome c was attached. Base position 8 was 
found to orient the protein inward such that it was fully encapsulated, as shown in the 
molecular model in Figure 1-5B.
50
 Cryo electron micrograph electron density (Figure 
1-5C top)
64
 was subsequently used to identify the location of the major and minor 
grooves and further refine the base orientations from their previous studies. A molecular 
model of the DNA tetrahedron is shown in Figure 1-5C (bottom).
64
 Together, this struc-
tural information provides an excellent guide for determining the base positions to intro-
duce other guest molecules with well-defined spatial orientations. 
Biological molecules can be challenging to work with because their structure and 
function can be disturbed through solution additives, such as organic solvents or metal 
salts, or when exposed to elevated temperatures. The temperature sensitivity is particular-
ly challenging because of the typical high temperature annealing step required during 
DNA nanostructure assembly. Smaller DNA nanostructures can be assembled quite rap-
idly (e.g., 0.5–5 min), and sometimes from lower initial starting temperatures (e.g., 54 
⁰C),50 which may limit thermal damage to the guest molecule. However, large DNA 
nanostructures can take up to a week to assemble properly.
25
 In order to decouple the 
complex and lengthy assembly process of large DNA nanostructures, the staple strands 
can be lengthened at defined positions in order to provide an unhybridized domain for 
capturing a secondary ‘helper strand’ post-assembly under mild conditions (e.g., <40 ⁰C), 
which is conjugated to a guest molecule.
29
 In this approach, the sequence of the helper 
strand provides a unique molecular recognition domain for placing the guest molecule on 
the DNA nanoscaffold, and allows a single robust bio-orthogonal chemical coupling 
14 
 
method to be used for conjugating a number of guest molecules each to a unique helper 
strand. 
The two step process, of first preassembling the DNA nanostructure followed by 
assembling guest molecule(s) using helper strands, works well with large DNA 
nanostructures when the molecules are more widely spaced (>5–10 nm). To allow for 
sufficient thermal stability at room temperature, typical DNA helper strands sequences 
are at least 15–20nt long, which form 4.9–6.5 nm long double-stranded DNA (dsDNA) 
helices upon hybridization. However, such long linker sequences put significant con-
straints on how the linker can be used in small DNA nanostructures (radius <4 nm). The 
linker length could be shortened by increasing the GC content of the sequence, however 
this would limit the sequence variability needed to attach more than a few guest mole-
cules. While conjugation strategies using nucleic acid linkers provide a large sequence 
space for directing their assembly, there is a need to increase the thermal stability of these 
linkers for assembling guest molecules within small DNA nanostructures. 
 
PNA for linking polypeptides to DNA 
Peptide nucleic acid (PNA)
66
 is a DNA analog, which contains a peptide-like 
backbone and nucleobase side chains, allowing it to hybridize with a complementary 
DNA, RNA or PNA stand. The chemical structure of a peptide, PNA and DNA backbone 
is shown in Figure 1-6A. Because PNA lacks the negative charges contained on the DNA 
backbone, it can bind with higher stability to a complementary DNA strand because the 
backbone repulsion is absent; this is especially true at low salt concentrations where the 
negative DNA phosphates are poorly shielded. Purine rich PNA sequences also tend to 
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have significantly higher thermal stability because the PNA backbone is more flexible 
than the DNA backbone and allows for greater pi-pi stacking between adjacent nucleo-
bases (P.E. Nielsen, personal communication, January 9
th
, 2013). This remarkable stabil-
ity allows it to bind to double stranded DNA and displace the DNA strand with the same 
sequence, by so called strand invasion.
66
 Like peptides, PNAs are linked by amide bonds 
and can be synthesized using similar solid phase protocols,
67
 thus allowing for seamless 
synthesis of PNA-peptide conjugates.
68
 A microwave assisted solid phase peptide synthe-
sizer, which can also be used to synthesize PNA strands and PNA-peptide conjugates, is 
shown in Figure 1-6B.
69
  
 
Figure 1-6. Chemical structures of PNA, DNA and peptide backbones, and a micro-
wave assisted solid phase peptide (and PNA) synthesizer. [A] Chemical structure of a 
peptide, PNA and DNA strand. The α, β and γ substitution positions are shown on the 
PNA backbone. [B] Microwave assisted solid phase synthesizer for peptides and PNA.
69
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Figure 1-7. Applications with PNA. [A] (left) Chemical structure of a PNA-DNA du-
plex with a tripeptide ligand attached to a lysine residue at the gamma position of the 
PNA backbone. Ribbon (center) and cartoon (right) diagrams showing the same PNA-
DNA duplex with multiple ligands attached to the PNA strand.
47
 [B] Molecular model 
showing three ligands from the PNA-DNA duplex from [A] binding to the receptors on 
the integrin protein.
47
 [C] Fluorescein (white) labeled PNA strands hybridized in situ to 
chromosome telomeres counterstained with propidium iodide (orange).
70
 Figures adapted 
with permission from: [A] and [B] ref. 
47
, © NPG 2012, [C] ref. 70, © Oxford 1996. 
 
PNA has been used for a number of other applications, which have recently been 
reviewed,
71
 including a review focused on chemical modifications to PNA.
72
 Its synthetic 
backbone makes it highly resistant to nucleases and proteases
73
 and useful for targeting 
DNA
70
 and RNA,
74
 as well as using it as a molecular probe
75
 and biosensor.
76,77
 Figure 
1-7C
70
 shows fluorescently labeled PNA strands hybridized in situ to terminal repeating 
nucleotide sequences (telomeres) on each chromosome. PNA has also been assembled 
within DNA scaffolds to investigate applications in bionanotechnology.
47,78,79
 Substitu-
tions to the gamma position on the PNA backbone (see Figure 1-6) have been shown to 
increase the solubility and thermal stability of the PNA strand,
80
 as well as provide a han-
dle to introduce functional groups without affecting its binding to a complementary 
strand.
81
 Figure 1-7A
47
 shows the chemical structure, ribbon and cartoon representation 
of a PNA strand functionalized at the gamma position with a lysine side chain, which 
serves as the attachment point for a tripeptide ligand. A complementary DNA strand, 
with repeating complementary sequences for the ligand containing PNA strand, increases 
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the valency of the tripeptide ligand to enhance binding to the receptors on the integrin 
protein. Figure 1-7B
47
 shows a molecular model of the ligand containing DNA-PNA du-
plex bound to the integrin protein.
47
 
PNA is an intriguing synthetic polymer for bridging the diverse functional land-
scape of polypeptides with the straight-forward construction of nucleic acid nanostruc-
tures. PNA-peptide conjugates could be synthesized directly, which would facilitate hy-
bridization based strategies for organizing peptides within DNA nanostructures. Because 
of PNAs increased thermal stability compared to DNA, only short sequences of PNA 
(8nt) are necessary, making them ideally suited for introducing a number of different pep-
tides within small DNA nanostructures. When the PNA strands are functionalized at the 
gamma position, it would allow the peptide to be attached at any position along the back-
bone or even at multiple locations,
47,82
 providing flexibility for arranging the peptides 
within the DNA nanostructure. Furthermore, conjugating the peptides at both ends to the 
PNA strand, to form cyclic PNA-peptides, would transfer additional structural support 
from the underlying DNA framework. 
 
Specific Aims 
Although a significant amount of work has been done manipulating proteins and 
peptides with DNA nanoscaffolds, relatively little is known about how the DNA 
nanostructures affect the function of the proteins and how the polypeptides interact with 
the DNA nanostructures. Furthermore, the work to date has not tried to spatially confine 
the polypeptides to the scale where intramolecular interactions within a protein dominate 
(i.e., <5 nm), or to precisely control the 3D orientation of the attached polypeptides. 
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 The specific aims for the work in this dissertation are described as follows:  
1. Design a DNA nanocage that can bind and assemble multiple PNA-polypeptides.  
2. Synthesize PNA-peptide conjugates using microwave-assisted solid phase peptide (or 
PNA) synthesis (SPPS). 
3. Label PNA-polypeptides with fluorescent dyes to study their assembly, thermal sta-
bility and arrangement in the DNA nanocage. 
4. Conjugate PNA to biologically expressed proteins. 
5. Purify PNA-protein conjugates from unreacted PNA and protein. 
6. Assemble PNA-polypeptides within a DNA nanocage using a gentle and flexible 
method that preserves function and provides temporal control over the assembly. 
7. Validate the proper placement of the PNA-polypeptides within the DNA nanocage. 
8. Characterize the stability of the PNA-polypeptides within the DNA nanocage. 
9. Characterize the interactions of the polypeptides with the DNA nanocage. 
10. Characterize the redox activity of the polypeptides in the DNA nanocage. 
11. Characterize the structure of the polypeptides in the DNA nanocage. 
12. Design a protein active site mimic using a DNA-PNA-peptide complex. 
 
Outline and organization 
This dissertation will describe a series of methods developed for constructing 
multiple PNA-polypeptide conjugates, which utilize short sequences (8nt) of PNA, in or-
der to assemble polypeptides at specific locations within a 3D DNA nananocage based on 
the sequence of each PNA strand. This is the first time PNA strands have been used to 
assemble polypeptides within 3D DNA nanostructures, which has significant advantages 
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over traditional methods that directly conjugate polypeptides to DNA. Chapter 3 de-
scribes a DNA nanocage design that facilitates binding multiple PNA strands, and devel-
ops a synthesis protocol to directly synthesize PNA-peptide conjugates using SPPS. The 
peptides were designed to be short, so that the arrangement of the PNA-peptides within 
the DNA nanocage could be assessed using energy transfer between fluorescent dyes at-
tached to the peptides. Chapter 4 builds on this work, by investigating the effect of PNA 
assembly with much longer polypeptides. Because SPPS can be challenging for long 
PNA-peptide sequences, a protocol was developed to conjugate PNA to biologically ex-
pressed proteins. Two different proteins were chosen to investigate the effect the DNA 
nanocage would have on protein function, as well as the protein orientation within the 
DNA nanocage based on its surface charge. Chapter 5 describes modifications to the ini-
tial DNA nanocage design to accommodate a PNA strand binding to an alternate binding 
site, which would facilitate peptide arrangements that better mimic the scaffold provided 
by the protein photosystem II (PSII), for assembling an artificial catalytic center.  
Chapter 6 provides a prospective of using DNA nanocages to build an artificial 
catalytic center from photosystem II, which is called the oxygen-evolving complex 
(OEC). A cyclic PNA-peptide design using gamma modified PNA strands is also dis-
cussed, which would further stabilize the attached peptides when assembled in the DNA 
nanocage. The detailed design principles contained in this chapter provide a logical direc-
tion for the scientific community to continue and build on this work, which could have a 
meaningful impact on engineering practical and economical water oxidation catalysts. 
Chapter 7 summarizes the findings from Chapters 3, 4 and 5 and gives an outlook for us-
ing DNA nanoscaffolds to assemble polypeptides using PNA linkers, which mimic pro-
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tein active sites for investigating protein structure and function, and concludes with an 
outlook for creating DNA-PNA-peptide complexes with novel functions. The methods 
developed in this dissertation lay the foundation for building functional DNA-PNA-
protein complexes and assembling peptide-based artificial catalytic centers. 
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CHAPTER 2 – Materials and Methods 
A major goal throughout the work described in this dissertation was to develop a 
toolkit that would facilitate gentle and controlled peptide and protein assembly within 3D 
DNA nanostructures using PNA linkers. Methods developed early on were used repeated-
ly and expanded upon in subsequent work. Due to the significant overlap of the methods 
used in different parts of this work, all the methods used in this dissertation were com-
piled into a single all-encompassing section described here. In this way, the methods can 
be placed in a logical arrangement that should facilitate others that wish to begin working 
in this exciting field.  
Some typical results are included for many of the methods to illustrate the type of 
performance that was achieved. Some of these figures also contain supporting discussion 
to clarify complex interpretation of the results. The results included in this section are 
mostly figures that support some of the main results discussed in more detail in Chapters 
3–5, thus those chapters will refer back to this section for these supporting figures. The 
following is an outline of the general method sections included here, organized by topic:  
1. PNA preparative methods: PNA-peptide synthesis, purification and functionali-
zation; γ-PNA functionalization and purification. 
2. Protein preparative methods: Cytochrome c preparation; Azurin expression and 
purification. 
3. PNA-protein conjugation and purification: PNA-protein conjugation, purifica-
tion and characterization; ssDNA toehold mediated PNA and PNA-protein purifi-
cation. 
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4. DNA-PNA-polypeptide complex preparation: DNA nanocage preparation; 
PNA-polypeptide assembly with the DNA nanocage. 
5. DNA-PNA-polypeptide characterization: DNA-PNA-polypeptide thermal sta-
bility and fluorescence characterization; Cytochrome c activity and redox poten-
tial; Circular dichroism of cytochrome c. 
6. Modeling: Molecular structures, models and chemical structures. 
 
PNA-peptide synthesis, purification and functionalization 
PNA coupling 
Fluorenylmethyloxycarbonyl (Fmoc) protected PNA monomers were purchased 
from PolyOrg (Leominister, MA, USA) and Fmoc protected amino acids from Merck 
(DE). The PNA domains were synthesized using a CEM Liberty Automated Microwave 
Peptide Synthesizer (Figure 1-6B) following methods similar to those reported by Fabani 
and coworkers.
83
 Deprotection of and coupling to PNA monomers and the first glycine 
amino acid were performed as follows. Deprotection was performed at room temperature 
in 20% piperidine in dimethylformamide (DMF) initially for 60 seconds and a second 
time for 12 minutes after washing with DMF at 25 °C. The UV absorbance of the cleaved 
Fmoc at 301 nm was monitored in the waste stream using the CEM UV monitoring ac-
cessory, as shown in Figure 2-1. Coupling was performed once for 30 minutes at 75 °C 
using microwave heating in the ratio of monomer/activator/base of 1.0/1.0/4.0 in 4 fold 
excess to resin, where the monomer was dissolved in DMF, the activator was 0.2 M 2-
(1H-7-Azabenzotriazol-1-yl)--1,1,3,3-tetramethyl uronium hexafluorophosphate meth-
anaminium (HATU) in DMF, and the base was a mixture of 0.4 M diisopropyletheyla-
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mine (DIEA) and 0.4 M lutidine in N-methylpyrrolidone (NMP). Initially we tried using 
benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) as re-
ported by Fabani and coworkers,
83
 but we observed some PyBOP related impurities as 
reported by Pritz and coworkers
84
 that were not observed with HATU. Following the rec-
ommendation of several PNA protocols
67,83
 all DMF used in PNA synthesis was anhy-
drous (Sigma). 
 
Figure 2-1. UV absorbance of Fmoc deprotection during PNA synthesis. In order to 
quantify the amount of Fmoc protecting group removed from the N terminal PNA base 
during each deprotection step, the UV absorbance at 301 nm of the waste line was meas-
ured using the CEM UV monitoring accessory. About 4–7% of the total absorbance for 
each PNA base was detected after the second step, underscoring the necessity for the sec-
ond deprotection step. 
 
Amino acid coupling 
After verifying the PNA-Gly synthesis by RP-HPLC and MALDI, the remaining 
amino acids (Pro-Gly) were added using the synthesizer similar to the method reported 
by Fabani and coworkers
83
 and summarized as follows. Deprotection was performed in 
20% piperidine in DMF at 75 °C using microwave heating initially for 30 seconds and a 
second time for 3 minutes after washing with DMF. Coupling was performed once for 10 
minutes at 75 °C using microwave heating in the ratio of monomer/activator/base of 
1.0/1.0/4.0 in 4 fold excess to resin, where the activator was 0.2 M O-Benzotriazole-
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N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) in DMF and the base 
was 0.8 M DIEA in NMP. Because of the problems we found with PyBOP during PNA 
synthesis, we opted to use the more conventional peptide synthesis activator HBTU. 
 
Fluorescent dye coupling 
5(6)carboxyfluorescein (FAM) was coupled to PNA1-GPG construct with the 
synthesizer using a method similar to that reported by Kowalczyk and coworkers
85
 sum-
marized as follows. Deprotection was performed in 20% piperidine in DMF at 75 °C us-
ing microwave heating initially for 30 seconds and a second time for 3 minutes after 
washing with DMF. Coupling was performed once for 30 minutes at 75 °C using micro-
wave heating in the ratio of monomer/activator/base of 1.0/1.0/4.0 in 4 fold excess to res-
in. The resin was washed with 20% piperidine twice with microwave heating to 75 °C for 
3 minutes to remove polymerized dye as originally reported by Fischer and coworkers
86
 
using a method similar to that reported by Kowalczyk and coworkers.
85
 
5(6)carboxytetramethylrhodamine (TMR) was coupled to PNA2-GPG similar to 
the method described by Kaihatsu and coworkers
68
 as follows. Fmoc was deprotected by 
shaking with 20% piperidine in DMF 3 times for 5 minutes at room temperature. TMR 
was coupled in the ratio of monomer/activator/base of 1.0/1.0/4.0 in 4 fold excess to res-
in, where the activator was 0.2 M HBTU in DMF and the base was 0.8 M DIEA, by shak-
ing at room temperature for 6–8 hours. The resin was washed with DMF followed by di-
chloromethane (DCM) and dried by lyophilization. 
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Figure 2-2. Chemical structures of FAM and TMR. Chemical structures of the dianion 
5-carboxyfluorescein (left) and neutral zwitterion 5-tetramethylrhodamine (right) conju-
gated to the PNA-peptide via an amide linkage. The less expensive 5(6) dye isomer mix-
ture was used in this study, although in some cases the dye isomers could be separated 
after conjugation to the PNA-peptide. 
 
PNA-peptide acetylation 
N terminally acetylated PNA-peptides were prepared as fluorescence controls by 
first deprotecting 3 times for 5 minutes at room temperature. First PNA1-GPG-NH2 was 
acetylated in 0.5 M Acetic Anhydride, 0.125 M DIEA and 0.015 M Hydroxybenzotria-
zole (HOBt) by shaking for 3 hours at room temperature. After cleavage the RP-HPLC 
chromatogram showed several species which were identified by MALDI to be the prod-
uct with from one up to four acetylations, and demonstrates the sensitivity of PNA to 
over-acetylation. Fortunately, the desired mono-acetylated product could be separated 
from the multi-acetylated impurities and collected by RP-HPLC. PNA2-GPG-NH2 was 
acetylated using more mild conditions as published in a previous PNA capping 
protocol,
83
 where the PNA-GPG-NH2 was acetylated for 5 minutes at room temperature 
in DMF with 5% acetic anhydride and 5% lutidine. The resin was washed with DMF fol-
lowed by DCM and dried by lyophilization. Only the mono-acetylated form of PNA2-
GPG-Ac was observed. 
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Cleavage 
All PNA-peptide products were cleaved from the resin by shaking for 2–3 hours 
in trifluoroacetic acid (TFA)/anisole/triisopropylsilane (TIS)/water in the ratios of 
90.0/5.0/2.5/2.5%, precipitated in cold ether and lyophilized. 
 
PNA-peptide purification and mass identification by MALDI 
All PNA-peptide products were purified by RP-HPLC on a Waters system using 
an Agilent C18 Prep column (Polaris 5, C18-A 150 x 21.2mm). The purity was con-
firmed by RP-HPLC using an Agilent C18 Analytical column (Varian Polaris 5 C18-A 
250 x 4.6mm) to be greater than 95% for all products except PNA2-GPG-TMR, which 
showed a purity of 90%. MALDI and RP-HPLC chromatograms are shown for all prod-
ucts in Figure 2-3 and Figure 2-4, respectively. The solvents used during RP-HPLC were: 
A) 99.9% water + 0.1% TFA, and B) 95% acetonitrile + 4.9% water + 0.1% TFA. The 
product masses were identified by MALDI mass spectrometry on a Voyager DE-STR 
MALDI-TOF (Applied Biosystems) in reflector mode using Sinapinic Acid as the ma-
trix.
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The purified PNA-peptides were lyophilized and suspended in TAE.Mg buffer 
(40 mM Tris, 20 mM Acetate, 2 mM Ethylenediaminetetraacetic acid (EDTA), 12.5 mM 
Magnesium Acetate, pH 8.3). If the sample was not well dissolved it was heated and 
sonicated for 10–20 minutes, and if necessary, mixed with 5–30% acetonitrile (by vol-
ume). The extinction coefficients at the peak absorption for each PNA sequence were 
calculated online at http://biophysics.idtdna.com/UVSpectrum.html using Integrated 
DNA Technologies (IDT, Coralville, IA) published algorithm.
88
 The calculated extinction 
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coefficients of PNA1 ɛ258 = 69,932 M
-1
cm
-1
 and PNA2 ɛ260 = 73,000 M
-1
cm
-1
 were used 
to measure the concentration of each dissolved PNA sequence. The extinction coeffi-
cients at 260 nm of FAM (ɛ260 = 13,700 M
-1
cm
-1
) and TMR (ɛ260 = 29,100 M
-1
cm
-1
) were 
used to calculate the PNA extinction coefficients for dye labeled samples and were as-
sumed to be the same as those provided by the manufacturer (IDT) for ssDNA labeled 
with the same dyes. 
 
Figure 2-3. MALDI mass spectrum of the synthesized PNA-peptides. MALDI mass 
spectrum of PNA1-GPG-5-FAM [A], PNA2-GPG-5-TMR [B], PNA1-GPG-Ac (Acety-
lated) [C] and PNA2-GPG-Ac [D] after initial purification taken in reflector mode using 
Sinapinic Acid as the matrix. [A] The measured masses of 2761.2, 2784.3, 2445.2, 
2414.6 Daltons (Da) agree within +0.2, +0.2, -1.8 and 0.6 Da of the expected mass of 
2761.0, 2784.1, 2447.0, 2414.0 Da for PNA-peptides A, B, C and D, respectively. The 
spectra also show the corresponding sodium (M+Na) and potassium (M+K) adducts, as 
well as a minor impurity with a single glycine insertion (M+Gly) as well as a glycine in-
sertion with an extra acetylation (M+Gly+Ac). PNA2-GPG-Ac and 5-TMR also show a 
minor impurity with a cytosine insertion (M+Cyt) and deletion (M-Cyt) as well as a dou-
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ble glycine insertion (M+2Gly) for PNA2-GPG-5-TMR. The broad PSA peak is an arti-
fact from post source fragmentation. 
 
 
Figure 2-4. RP-HPLC chromatograms of the synthesized PNA-peptides. RP-HPLC 
chromatograms demonstrating the purity after initial purification of [A] PNA1-GPG-5-
FAM (>95%), [B] PNA2-GPG-5-TMR (~90%), [C] PNA1-GPG-Ac (>95%) and [D] 
PNA2-GPG-Ac (>95%). The following stepwise gradients were used to mix solvent α 
(99.9% water, 0.1% TFA) and solvent β (95% acetonitrile, 4.9% water, 0.1% TFA) at a 
flow rate of 1ml/min: [A, B] 1%/min (0-10% β), 0.5%/min (10-20% β), 0.25%/min (20-
35% β); [C, D] 1%/min (0-5% β), 0.5%/min (5-10% β), 0.25%/min (10-25% β). The nu-
cleobase absorption at 260nm was monitored to detect the elution of the product. FAM 
and TMR absorption at 440nm and 560nm were monitored to confirm the presence of the 
dye label for [A] and [B], respectively. The absorption of FAM in [A] is substantially re-
duced at low pH
89
 in its anionic (ɛ453 = 29,000 M
-1
cm
-1
) and neutral forms (ɛ434 = 11,000 
M
-1
cm
-1
). 
 
PNA maleimide functionalization 
Sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-
SMCC, Bioworld), an amine reactive cross-linker, was dissolved to 10 mM in 50 mM 
phosphate buffer at pH 7.2. PNA-Gly-NH2 was dissolved in 0.1 M phosphate buffer at 
pH 7.2 containing 0.15 M NaCl and diluted with acetonitrile to 10–20% total by volume. 
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15x molar excess Sulfo-SMCC was mixed with the PNA for 1 hour at room temperature 
(final PNA concentration ~500 µM). The excess SMCC and unreacted PNA were re-
moved using RP-HPLC, as shown in Figure 2-4, and then lyophilized. The matrix  
 
 
Figure 2-5. MALDI-MS spectrum and RP-HPLC of PNA-Gly-SMCC. MALDI-MS 
spectrum of PNA-Gly-SMCC after initial purification. The measurement was performed 
in reflector mode using sinapinic acid as the matrix. The measured mass of 2468.2 Dal-
tons (Da) agrees within +0.2 Da of the expected mass of 2468.0. The spectra also show 
the corresponding sodium (M+Na) and potassium (M+K) adducts, as well as a minor im-
purity with a single glycine insertion (M+Gly) as well as a second SMCC attached 
(M+SMCC). The broad peak is an artifact from post source decay (PSD). The inset 
shows the RP-HPLC chromatogram: one main peak elutes from the column showing neg-
ligible impurities after the first purification step (purity ~100%). The following stepwise 
gradients were used to mix solvent α (99.9% water, 0.1% TFA) and solvent β (95% ace-
tonitrile, 4.9% water, 0.1% TFA) at a flow rate of 1 ml/min: 1%/min (0–30% β). The nu-
cleobase absorption at 260 nm was monitored to detect the elution of the product. 
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assisted laser desorption ionization mass spectrometry (MALDI-MS) spectrum is also 
shown in Figure 2-4. 
 
γ-PNA functionalization and purification 
γ-PNA Cy5 labeling 
A scheme describing the Cy5 labeling of PNA using copper-free click chemistry 
is shown in Figure 5-3. γ-PNA1 and γ-PNA3 were purchased from PNA Bio (Panagene 
distributor) as a lyophilized powder and resuspended in nanopure water. The sequences 
of γ-PNA1 and γ-PNA3 are provided in Table 5-1. γ-PNA1 was heated to 60 ⁰C for 15 
minutes to completely dissolve at ~500 µM. Cyanine 5 (Cy5) functionalized with the 
strained alkyne dibenzocyclooctyl (DBCO), referred to hereafter as Cy5-DBCO, was 
purchased from ClickChemistryTools (Scottsdale, AZ, USA) and dissolved in methanol 
to ~10 µM. 0.1 M sodium acetate buffer was prepared and the pH was adjusted to 4.0 us-
ing 0.1 M acetic acid. The buffer was mixed 1:3 (v/v) with methanol and the pH was ad-
justed once again to 4.0 by mixing acetic acid 1:10 (v/v) with buffer. The final buffer 
contained about 30 mM sodium acetate in 60% methanol with a pH of 4.0. In separate 
centrifuge tubes, 2x molar excess of Cy5-DBCO was added to γ-PNA1 and γ-PNA3 and 
mixed 1:8 (v/v) with the sodium acetate / methanol buffer (~50% methanol). The cocktail 
was reacted overnight at room temperature. In the morning, the pH was adjusted to 7.0 
using sodium hydroxide and mixed 1:16 (v/v) with 0.5 M TCEP to reduce any γ-PNA 
disulfide dimers formed at the gamma position and incubated for 30 minutes.  
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γ-PNA Cy5 purification 
The cocktail was mixed 2:1 with 80% glycerol and loaded on a 10% denaturing 
polyacrylamide gel electrophoresis (PAGE) gel (~10 µL / lane). The gel was run at 300 V 
for 973 Vhrs and visualized without removing it from the glass plates using a UVP Bio-
Spectrum (Upland, CA, USA) with a 630 nm excitation filter (UVP, 38-0359-03) and a 
695 nm emission filter (UVP, 38-0339-01) as shown in Figure 5-4. The gel was run for 
an additional 237 Vhrs (1210 total Vhrs) to allow the unreacted Cy5 to run off the gel so 
the product bands could be more easily visualized for excision. The desired product 
bands were cut and eluted with water in Costar® Spin-X® centrifuge tubes (Corning). 
The gel blocks were soaked from 1.25 hours to several days (115hrs), as described in Ta-
ble 5-3, and spun down at 14k x g for 7-15 minutes to remove the eluted product from the 
gel blocks. The elution was performed 3–4 times, until the fluorescence of the gel blocks 
approached background levels. The progress of the elution was monitored by imaging the 
Cy5 fluorescence of the tubes for 5 seconds. The fluorescence intensity of a 2400 square 
pixel area of the gel block section of the brightest tube (i.e., containing the most product) 
was integrated and plotted as a function of the number of elutions. The data was fit using 
Origin version 9.1 with the following exponential function:  ( )        
     , 
where y0 is the lower decay limit, A is the pre-exponential factor, R0 is the rate of decay 
and n is the number of elutions. The fitting parameter values for γ-PNA1-Cy5 and γ-
PNA3-Cy5 are shown in Table 5-4. The fraction of the product remaining in the gel 
blocks after each elution is plotted in Figure 5-4, listed in Table 5-3 and was calculated as 
follows:                 ( )  
      
 
, where In is the integrated intensity of the gel 
blocks after the n
th
 elution. The fraction of product eluted from the gel blocks after each 
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elution is listed in Table 5-3 and was calculated as one minus the fraction remaining in 
the gel blocks. The eluted fractions were pooled together and desalted by RP-HPLC on a 
Waters system using an Agilent C18 Prep column (Polaris 5, C18-A 150 x 21.2mm), ly-
ophilized and reconstituted in water with 10-20% acetonitrile. The other bands with much 
lower fluorescence in the gel shown in Figure 5-4, were desalted using C18 spin columns 
(Pierce) per the manufacturer’s instructions and found to be impurities by MALDI. 
 
Cytochrome c preparation 
A scheme outlining the preparation of unlabeled and labeled PNA-cytochrome c 
conjugates is shown in Figure 4-4. 
 
Fluorescent labeling of cytochrome c with TMR 
Fluorescent labeling of cytochrome c on amine residues was performed before the 
introduction of thiols on the surface. Equine heart cytochrome c (Sigma) was dissolved to 
about 400 µM in 0.1 M phosphate buffer at pH 7.2 containing 0.15 M NaCl and 1 mM 
Ethylenediaminetetraacetic acid (EDTA). Carboxytetramethylrhodamine (TMR) N-
Hydroxysuccinimide ester (Pierce) was dissolved in DMF to 24 mM and then incubated 
in 3x molar excess with cytochrome c for 1 hour (~5% DMF (v/v)). Excess dye was re-
moved using a NAP-5 column (GE Healthcare) equilibrated in the same buffer, and the 
sample was concentrated using 3 kDa MWCO centrifugal filters (EMD Millipore) to 
about 1 mM. The fluorescence spectrum is shown in Figure 2-19. 
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Thiolation of cytochrome c using SPDP 
Our initial attempts to conjugate PNA to a naturally occurring surface cysteine on 
yeast cytochrome c were unsuccessful, and may reflect the poor accessibility of this resi-
due.
90
 We then resorted to using non-specific crosslinking techniques as previously re-
ported
50
 by first introducing thiols to surface amines of equine heart cytochrome c using 
the SPDP cross-linker. N-Succinimidyl 3-(2-pyridyldithio)-propionate (SPDP, Pierce), a 
heterobifunctional cross-linker, was dissolved to 80 mM in dimethyl sulfoxide (DMSO). 
For labeled constructs TMR labeled cytochrome c was concentrated to 1 mM and used 
directly. For unlabeled constructs, equine heart cytochrome c (Sigma) was dissolved to 
5–10 mg/mL (400–800 µM) in 0.1 M phosphate buffer at pH 7.2 containing 0.15 M NaCl 
and 1 mM EDTA. 1.6x molar excess SPDP was mixed with either the TMR labeled or 
unlabeled cytochrome c at room temperature for 1 hour. Excess SPDP was removed us-
ing a NAP-5 column equilibrated in 0.1 M HEPES buffer at pH 7.2 containing 5 mM 
EDTA and which was previously degassed by vacuum. The number of thiols introduced 
per protein was quantified by the increase in absorbance at 343 nm from the release of 
pyridine-2-thione after reduction of SPDP by tris(2-carboxyethyl)phosphine (TCEP) 
(Figure 2-6). On average 1.1–1.4 and 2.6 thiols per protein were introduced when 1.6x 
and 2.3x molar excess of SPDP were used, respectively. This agrees with molecular 
weight distribution observed in the MALDI-MS spectrum (Figure 2-6). 
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Figure 2-6. Quantification of SPDP thiolation of cytochrome c by MALDI-MS and 
UV-Vis. MALDI-MS spectrum of cytochrome c labeled with 2.3x molar excess of SPDP. 
The measurement was performed in linear mode using sinapinic acid as the matrix. The 
measured masses of 12358, 12558, 12751, 12946, 13134 Daltons (Da) agrees within 0, 0, 
-4, -9, and 20 Da of the expected masses for cytochrome c conjugated with zero (12358), 
one (12557), two (12756), three (12955) and four (13154) SPDP molecules (MW 199.3 
Da). The inset shows the increase in absorbance at 343 nm when pyridine 2-thione is re-
leased after introducing TCEP to expose ~2.6 free surface thiols per cytochrome c. 
 
Azurin expression and purification 
The mutant version N42C of azurin (Pseudomonas aeruginosa) was expressed in 
E. coli and purified by using a slightly modified version of a previously published meth-
od.
91
 Cells from E. coli strain JM109 were transformed using a pUC-derived plasmid 
(pGKN42C) containing the azurin gene preceded by a signal peptide for periplasmic 
translocation. After culturing, cells were harvested and resuspended in a solution of 20% 
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(w/v) sucrose in 30 mM Tris/HCl pH 8.0 containing 10 mM EDTA and 5 mM dithio-
threitol (DTT) for 20 minutes at room temperature. Subsequently, the solution was centri-
fuged at 8000 rpm for 15 minutes and the supernatant was collected (sucrose fraction). 
The cells were resuspended in milliQ water containing 10 mM EDTA and 5 mM DTT at 
4 °C, stirred for 20 minutes and centrifuged at 8000 rpm for 15 minutes. The supernatant 
was collected and added to the sucrose fraction, while the pellet was discarded. In E. coli, 
azurin is normally expressed in its apo-form, and the Zn containing form is isolated as a 
by-product of the expression.
92
 A stepwise precipitation step was performed by lowering 
the pH of the solution to pH 4 by adding acetic acid. The precipitated proteins were re-
moved by centrifugation (8000 rpm, 20 minutes). The resulting clarified solution was 
loaded on a home-packed CM sepharose Fast Flow (Amersham Biosciences) column 
(Vtot ~ 120 ml) equilibrated with 50 mM ammonium acetate buffer, in presence of 5 mM 
DTT. Elution was performed at 5 ml/min by using a pH gradient from pH 4 to pH 6.9 in 
10 column volumes (CV). Fractions containing azurin were collected and, after buffer 
exchange, loaded onto a home-packed DEAE sepharose Fast Flow (Amersham Biosci-
ences) column (Vtot ~ 80 ml) equilibrated with 5 mM Tris/HCl buffer, pH 8.5, containing 
5 mM DTT. The protein was eluted using a salt gradient from 0 to 50 mM of NaCl in 10 
CV. Two main peaks eluted from the column, one being the apo, and the other the Zn 
form of the protein, respectively. The Zn N42C azurin fractions were pooled together, 
concentrated and the buffer was exchanged to HEPES 20 mM, pH 7, by Amicon ultrafil-
tration. The protein was subsequently flash frozen in liquid nitrogen and stored at –80 °C. 
  All the chromatographic steps were performed on an Äkta Purifier system (GE 
Healthcare). The purification process was monitored by checking the purity of the protein 
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after each chromatographic step on sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) and by means of UV/Vis spectroscopy (Cary 50 spectrophotome-
ter, Varian Inc., Agilent Technologies, USA). Isoelectric focusing gel electrophoresis was 
used to discriminate between apo and Zn containing azurin fractions after the DEAE col-
umn separation. The final product appeared on an SDS-PAGE gel as a single band with 
apparent mass of ~14 kDa. 
 
PNA-protein conjugation, purification and characterization 
A scheme outlining the preparation of unlabeled and labeled PNA-protein conjugates is 
shown in Figure 4-4. 
 
PNA-cytochrome c conjugation 
PNA-SMCC was dissolved to ~750 µM in 0.1 M HEPES buffer at pH 7.2, de-
gassed by vacuum, containing 5 mM EDTA and diluted with acetonitrile to 20% (v/v) to 
help dissolve the PNA. Tris(2-carboxyethyl)phosphine (TCEP) was dissolved to 0.5 M 
and titrated to pH 7. Thiolated cytochrome c (CytC-SPDP) was reduced with a 20x molar 
excess TCEP for 30–60 minutes to release pyridine-2-thione and expose the introduced 
surface thiols. 1.0x to 1.8x molar excess of reduced CytC-SPDP was mixed with roughly 
equal volume PNA-SMCC to maintain 10% acetonitrile (v/v) in the cocktail to keep the 
PNA soluble, and was incubated at room temperature or 37 ⁰C overnight. Figure 2-7 
shows the MALDI-MS spectrum, which indicates the presence of the PNA-CytC conju-
gate. Alternate conjugation protocols used 10% methanol in place of the acetonitrile or 
just buffer (i.e., no organic solvents), which did not have any noticeable impact on the 
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conjugation efficiency at low concentration (<100 µM) , as shown in Figure 2-8. Howev-
er, 10% acetonitrile did allow the PNA to remain soluble at much higher concentrations 
(>500 µM), which, in combination with high CytC concentrations (>500 µM), did help to 
improve the conjugation yield to around ~25% in subsequent conjugation preparations. 
 
 
Figure 2-7. MALDI-MS spectrum of SPDP thiolated cytochrome c conjugated to 
PNA-SMCC. MALDI-MS spectrum of SPDP thiolated cytochrome c conjugated to 
PNA-SMCC. The measurement was performed in linear mode using sinapinic acid as the 
matrix. Unreacted SPDP thiolated cytochrome c is detected as a series of peaks centered 
at 12578 Da and the corresponding double ionization peaks centered at 6307 Da. The 
peaks centered at 15135 Da correspond to the thiolated cytochrome c (12578 Da) conju-
gated to a single PNA-SMCC (2468 Da) with an unreacted surface thiol (89 Da). A weak 
peak is also detected for a thiolated cytochrome c conjugated to two PNAs (17621 Da). 
The inset shows the increase in absorbance at 260 nm from native cytochrome c (CytC) 
and the cocktail mixture of CytC and PNA-CytC after removing unconjugated PNA, re-
sulting in ~6% conjugation yield. For comparison, the spectrum of PNA-CytC is shown 
after purification by toehold mediated strand exchange. 
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Figure 2-8. Native PAGE (7%) at 4 °C of the DNA nanocage incubated with PNA-
CytC. PNA-SMCC was conjugated with thiolated cytochrome c in a buffer containing 
10% methanol (lanes 3, 5, 6), 10% (lane 8) acetonitrile (ACN) or just aqueous buffer 
(lane 9). After removing unreacted PNA-SMCC by SE-FPLC, was incubated in 10x mo-
lar excess with the DNA nanocage (lanes 3, 8, 9) or the DNA nanocage with a binding 
sequence non-complementary (NC) to the PNA sequence (lane 5). The DNA nanocage 
was also incubated with 10x excess of free cytochrome c (lane 6). Only DNA nanocages 
with the correct PNA binding sequence and incubated with the PNA-CytC conjugate 
show the slower moving band containing cytochrome c. There was no noticeable differ-
ence in conjugation yield when the aqueous buffer contained 10% methanol or 10% ace-
tonitrile by volume. 
 
Aminoethylmaleimide (AEM) was dissolved to 50 mM in 0.1 M HEPES buffer at 
pH 7.2 containing 5 mM EDTA. 25x molar excess TCEP was added to the PNA-CytC 
cocktail (~250 µM) for 30 minutes to ensure all unreacted thiols were in the reduced 
form. 100x molar excess AEM was mixed with the PNA-CytC cocktail for 30 minutes to 
quench any free surface thiols and to restore the positive charge of the native surface ly-
sines originally displaced by SPDP. Unreacted AEM and PNA were removed by Size 
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Exclusion Fast Protein Liquid Chromatography (SE-FPLC) with a Superdex 75 column 
(column volume 24 mL) using an Amersham Pharmacia (GE Healthcare) ÄKTA Purifier 
with a flow rate of 0.2 mL/min in 1x TAE.Mg buffer or, 0.1 M HEPES buffer pH 7.0 
buffer containing 0.15 M NaCl, both or 10 mM sodium phosphate buffer pH 7.0 buffer 
containing 12 mM magnesium acetate and 0.15 M NaCl; each was degassed to remove 
oxygen. The low flow rate (0.2 mL/min) and moderate amount of salt (0.15 M NaCl) sig-
nificantly improved separation of the unreacted PNA from the combined peak of the pro-
tein and PNA-protein. After subsequent toehold mediated ssDNA strand purification as 
described in the PNA-protein purification by toehold-mediated DNA strand displacement 
section, the purity of the PNA-CytC conjugates were analyzed by 15% SDS-PAGE with 
a 4% stacking layer with anode buffer (0.1 M Tris pH 8.8) and cathode buffer (0.1 M 
Tris, 0.1 M Tricine, 0.1% SDS, pH ~8.2). The gel was run at constant 70 mA for about 1 
hour. The gel was subsequently silver stained as described in the PNA-protein assembly 
section. The concentration of PNA-cytochrome c conjugate was determined by deconvo-
luting the heme absorbance from the PNA absorbance at 260 nm using the calculated ex-
tinction coefficient for the PNA described in the PNA synthesis methods and the pub-
lished ε410 of 106,000 M
-1
cm
-1
 for cytochrome c from the literature
93
 along with the 
measured absorbance scan of the free cytochrome c.  
A NAP-5 column was unable to adequately remove the unreacted PNA from the 
PNA-CytC, therefore a SE-FPLC chromatographic step was used to remove the unreact-
ed AEM and PNA. Although SE-FPLC was not able to separate the PNA-CytC conjugate 
from the free protein, hybridization of the PNA-CytC conjugate to the DNA nanocage 
(MW ~95 kDa) can be easily separated from the free protein (MW 12.5 kDa) using SE-
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FPLC. When the final product, which contained a mixture of free cytochrome c and 
PNA-CytC conjugate, was incubated with the DNA nanocage, PAGE in Figure 4-8 did 
not show any bands with the characteristic gel shift observed upon binding PNA alone, 
indicating that all unconjugated PNA was successfully removed from the sample. 
 
PNA-azurin conjugation, purification and characterization 
The N42C azurin mutant protein, prepared as described above, was exchanged in-
to 0.1 M phosphate buffer pH 7.2 containing 0.15 M NaCl, concentrated to about 1.2 mM 
using 3 kDa MWCO centrifugal filters and reduced with a 10x molar excess of TCEP for 
2–3 hours to reduce any intermolecular disulfide dimers. PNA-SMCC was dissolved in 
0.1 M phosphate buffer at pH 7.2 containing 0.15 M NaCl. A 2.7x molar ratio of PNA-
SMCC was added to the azurin and diluted with additional buffer to a final PNA concen-
tration of about 100 µM and incubated at 37 ⁰C overnight and analyzed by MALDI-MS, 
as shown in Figure 2-9. Unreacted PNA was removed using SE-FPLC with a HiLoad 
Prep grade Superdex 200 16/60 size exclusion column (GE Healthcare, 120 mL column 
volume) on an Amersham Pharmacia (GE Healthcare) ÄKTA Purifier controlled by Uni-
corn 5.11 software with a flow rate of 1 mL/min. To assess the purity of the PNA-azurin 
conjugate, NuPAGE 4–12% gradient SDS–PAGE gels (Invitrogen) were run at 180 V for 
50 minutes and stained with Coomassie blue for 1 hour and subsequently destained over-
night in water. The resulting gel image is shown in Figure 2-9. The ratio of PNA-azurin 
conjugate to unreacted azurin was determined to be 38% by deconvoluting the PNA and 
azurin absorbance at 260, 280 and 292 nm, which is in agreement with the SDS-PAGE 
band intensities. The PNA extinction coefficients were determined using the absorption 
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spectra of PNA alone and the extinction coefficient at 260 nm of 69,932 M
-1
cm
-1
 calcu-
lated in the PNA synthesis methods section. The azurin extinction coefficients were de-
termined using the absorption spectra of azurin alone and the published extinction coeffi-
cient of 9,800 M
-1
cm
-1
 at 280 nm.
94
 The extinction coefficient of PNA-azurin was ε260 = 
76,792 M
-1
cm
-1
, and the mixture of PNA-azurin with unreacted azurin was ε260 = 87,974 
M
-1
cm
-1
 which was used to determine the concentration of the PNA-azurin. 
 
 
Figure 2-9. MALDI-MS spectrum and SDS-PAGE of azurin conjugated to PNA-
SMCC. MALDI-MS spectrum of azurin conjugated to PNA-SMCC. The measurement 
was performed in linear mode using sinapinic acid as the matrix. The measured masses of 
16385, 8197, 13920 and 27835 Dalton (Da) agree with the expected masses of PNA-
azurin (M+H = 16388, M+2H = 8197), unreacted azurin (13.9 kDa) and an azurin dimer 
(27.8 kDa). The inset shows a 4–12% gradient SDS-PAGE of the mixture of free azurin 
and PNA-azurin conjugate. 
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During SE-FPLC, the PNA-azurin conjugate was not well separated from the un-
reacted azurin, but was separated from the unreacted PNA. When the PNA-azurin sample 
was incubated with the DNA nanocage, a faint band was visible on the gel with the char-
acteristic shift of free PNA as shown in Figure 4-8, indicating a small amount of free 
PNA was not removed during the SE-FPLC run. 
 
TMR labeling of PNA-azurin 
After removal of unreacted PNA, some surface amines on the PNA-azurin conju-
gate were dye labeled. Carboxytetramethylrhodamine (TMR) N-Hydroxysuccinimide es-
ter (Pierce) was dissolved in DMF to 10 mM and then incubated in 5x molar excess with 
PNA-Az in 0.1 M phosphate buffer pH 7.2 containing 0.15 M NaCl and 1 mM EDTA for 
1 hour (~1.5% DMF (v/v)). Unreacted dye was removed using a NAP-5 column equili-
brated in the same buffer and the labeled protein was subsequently concentrated to about 
1 mM. The fluorescence spectrum is shown in Figure 2-19. 
 
ssDNA toehold mediated PNA and PNA-protein purification 
A scheme describing toehold mediated PNA and PNA-protein purification is 
shown in Figure 4-5. 
 
Toehold DNA design 
Typically PNA sequences have a greater binding affinity and thermal stability 
than their corresponding DNA sequences.
95
 This property of PNA has been used to in-
vade dsDNA in nanomechanical DNA devices.
96
 To ensure the complementary toehold 
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DNA sequence had a significant thermodynamic driving force to displace the PNA se-
quence, an 8nt toehold domain was chosen that provided an increase in dissociation tem-
perature of 27 ⁰C of the cDNA-toehold duplex over the PNA-toehold duplex. The 8nt 
length also should provide the most rapid strand displacement kinetics.
97
  
 
PNA-FAM purification 
Increasing molar excess (0.5x to 5x) of FAM labeled 16nt toehold DNA was in-
cubated with TMR labeled PNA at 37 ⁰C for 5 min and then cooled to 4 ⁰C for 5 min. 
Additional aliquots of PNA-TMR were incubated at 37 ⁰C with 2x excess of FAM la-
beled 16nt toehold DNA and then subsequently incubated with increasing amounts of ful-
ly complementary DNA (1x to 20x cDNA) based on the original amount of PNA-TMR. 
All aliquots were analyzed by native PAGE (7%) as shown in Figure 2-10. 
PNA purification by toehold mediated DNA strand displacement was analyzed by 
native PAGE (7%) as shown in Figure 2-10. The ethidium bromide stain on the left 
shows the slowest moving DNA-FAM + PNA-TMR duplex band (~32 base pair), which 
has maximum intensity after just stoichiometric amounts of DNA-FAM is added and dis-
appears after just after 2x molar excess cDNA is added. Free DNA-FAM begins to accu-
mulate after 1x molar excess is added with respect to PNA-TMR. The middle band (16 
base pair) shows the DNA-FAM + cDNA duplex form as the PNA-TMR is displaced. 
The TMR fluorescence image on the top right, shows the unbound and displaced PNA-
TMR band migrates quite slowly due to the partial negative charge on the TMR dye. 
Some PNA-TMR does not bind to the DNA-FAM strand, possibly because it has an in-
compatible isomeric form, while a small amount dissociates during the gel run. The FAM 
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fluorescence image on the bottom right shows the presence of excess DNA-FAM after 
the PNA-TMR is saturated, as well as the duplex formed with DNA-FAM + cDNA. The 
two right most lanes show that PNA-TMR can also be liberated from DNA-FAM by in-
cubating with cDNA at room temperature. 
 
 
Figure 2-10. Native PAGE (7%) at 4 ⁰C of toehold mediated ssDNA purification of 
PNA. Ethidium bromide stain [Left], FAM fluorescence [Center] and TMR fluorescence 
[Right]. Lanes 2–5: 2x PNA-TMR incubated with increasing amounts (0.5x to 5x) of 
FAM labeled 16nt toehold DNA (DNA-FAM) at 37 ⁰C. Lane 6: 2x DNA-FAM incubated 
with 2x fully complementary DNA (cDNA) at 37 ⁰C. Lanes 7–13: 2x PNA-TMR was 
incubated with 2x DNA-FAM at 37 ⁰C cooled to 4 ⁰C and then incubated with increasing 
amounts (1x to 20x) of cDNA at 37 ⁰C (Lanes 7–11) or 25 ⁰C (Lanes 12–13) to displace 
the PNA-TMR. Note: While the ethidium bromide image shows the ethidium bromide 
fluorescence of the DNA ladder in lane 1, the signal from the PNA-TMR and DNA-FAM 
bands are due to the native fluorescence emission of TMR and FAM at 605 nm due to 
direct excitation at 302 nm. The unlabeled cDNA band is not visualized by ethidium 
bromide, likely due to its short length. 
 
2x molar excess 16nt toehold DNA was incubated at 37 ⁰C for 15 min with TMR 
labeled PNA (PNA-TMR), cooled to 4 ⁰C for several hours, and then purified using IEX-
FPLC with the column cooled on ice, as shown in Figure 2-11. All products were re-
tained on the column. The DNA-PNA-TMR duplex elutes prior to the excess ssDNA 
peak with good separation, as shown by the TMR absorption in the collected fraction 
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(Figure 2-11, inset). Some PNA-TMR also elutes with the ssDNA peak. Both PNA-TMR 
peaks can be recovered by incubating with the fully complementary cDNA strand and 
subsequent IEX-FPLC purification. 
 
 
Figure 2-11. IEX-FPLC of toehold mediated ssDNA purification of PNA-TMR. IEX-
FPLC chromatogram of PNA-TMR incubated with 2x excess 16nt toehold DNA with the 
column on ice. The following stepwise gradient was used to mix solvent α (TAE.Mg pH 
9.0) and solvent β (TAE.Mg pH 9.0 + 2 M NaCl): 5%/min (0–20% β), 1%/min (20–24% 
β), 0.25%/min (24–28% β). The nucleobase absorption at 260 nm and the TMR absorp-
tion at 560 nm were monitored. The inset shows the TMR absorption of the first collected 
DNA-PNA-TMR fraction at 15.6 mL. 
 
PNA-CytC purification 
A 16nt or 66nt ‘toehold’ ssDNA strand was denatured by heating to 60 ⁰C for 5 
minutes. 2x molar excess of either toehold ssDNA was added to the crude mixture of 
PNA-CytC conjugate and free cytochrome c and incubated at room temperature or 37 ⁰C 
for at least 20 minutes and then cooled on ice for at least 20 minutes. The DNA-PNA-
protein complexes were purified from the free protein using SE-FPLC with a Superdex 
75 column (GE Healthcare), with the column and buffers chilled on ice, as shown in Fig-
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ure 4. The fractions containing the DNA-PNA-protein complexes were incubated with 2x 
molar excess of a ssDNA fully complementary to the toehold (cDNA) at room tempera-
ture for at least 15 minutes and then cooled on ice for at least 5 minutes. The cDNA and 
toehold DNA were removed from the PNA-protein using ion exchange FPLC (IEX-
FPLC) using the gradient described in Figure 4-7. The sequences of the strands used in 
this method are described in the Figure 4-6. 
 
 
Figure 2-12. IEX-FPLC of toehold mediated ssDNA purification of PNA-CytC. IEX-
FPLC chromatogram of PNA-CytC incubated with 2x excess 66nt toehold DNA. The 1x 
peak indicates the elution of CytC labeled with a single PNA and hybridized to a single 
toehold DNA strand. 2x, 3x and 4x indicate 2, 3 or 4 DNA-PNAs per protein, which are 
more visible on the right chromatogram with a zoomed in scale. The following stepwise 
gradient was used to mix solvent α (TAE.Mg pH 9.0) and solvent β (TAE.Mg pH 9.0 + 2 
M NaCl): 2.5%/min (15–40% β), 15%/min (40–100% β. The nucleobase absorption at 
260 nm and the CytC Soret absorption at 414 nm were monitored. 
 
 Although we initially found that PNA-CytC when hybridized to the 16nt toehold 
strand would not bind to the IEX-FPLC anion exchange column, we later found that 
PNA-CytC when hybridized to the larger and more stable 66nt toehold strand did stick to 
the anion exchange column, as shown in Figure 2-12. The column was also kept at room 
temperature, indicating the DNA-PNA-CytC complex is stable on the anion exchange 
column. The chromatogram shows several peaks with both significant A414 and A260, in-
dicating the presence of PNA-CytC hybridized to the 66nt toehold DNA strand in each 
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peak. The first peak with significant A414 has the shortest retention time and the highest 
A414/A260 ratio, indicating the elution of cytochrome c labeled with a single PNA strand 
and hybridized to a single 66nt toehold strand. The second peak, which elutes just after 
the unhybridized toehold DNA strands (i.e., free DNA), has a longer retention time and a 
lower A414/A260 ratio, indicating the elution of cytochrome c labeled with two PNA 
strands and hybridized to two toehold DNA strands. Similarly two other peaks are ob-
served with longer retention times and lower A414/A260 ratios, indicating a small amount 
of cytochrome c has three or four PNAs attached with their corresponding toehold DNA 
strands. IEX-FPLC provides much better separation of each PNA-CytC species compared 
to SE-FPLC, as shown in Figure 4-7, and does not require cooling the column. Thus IEX-
FPLC is a superior separation technique and is more convenient than purification by 
means of SE-FPLC. 
 
DNA nanocage preparation 
ssDNA purification 
Single stranded DNA of the sequences defined in Figure 3-2 were purchased from 
IDT (Integrated DNA Technologies) as a lyophilized powder, except for dye labeled 
strands which were purchased HPLC purified. IDT introduced FAM to strand S2 during 
the synthesis using a FAM modified thymine base and introduced TMR after synthesis by 
coupling a N-Hydroxysuccinimide ester functionalized TMR to an amine modified thy-
mine base. Each strand was suspended in nanopure water to a concentration of 0.5 
OD/μL and purified by denaturing PAGE using an SE 600 Ruby dual cooled standard 
vertical unit powered by a Fisher FB1000 supply in a buffer of 1xTBE (89 mM Tris, 89 
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mM Boric Acid, 2 mM EDTA, pH 8.5). The gels were heated to 35 °C using a Fisher 
Scientific Isotemp 3006S temperature controlled water bath circulating through the SE 
600 Ruby lower buffer chamber. A 9% gel (8.3 M urea, 9% 19:1 Acryla-
mide:Bisacrylamide polymerized with ammonium persulfate (APS) and catalyzed by Tet-
ramethylethylenediamine (TEMED) in 1xTBE) was used for 63nt and 66nt strands and 
an 8% gel was used for 55nt strands. The bands of the desired sequence were identified 
by staining with a 1x Ethidium Bromide (EtBr) solution (0.5 μg/mL) for 5–10 minutes, 
destaining in distilled water for 5–10 minutes and visualized briefly on a UV Transillu-
minator with 302 nm light. The bands were cut and shaken overnight in elution buffer 
(500 mM ammonium acetate, 10 mM magnesium acetate, and 2 mM EDTA) at room 
temperature. The tracking dyes and EtBr stain were removed by washing with butanol 
followed by cold ethanol precipitation and centrifugation. The DNA pellet was dried with 
a vacuum centrifuge and suspended in nanopure water. The concentration was deter-
mined using the measured absorbance at 260 nm and the extinction coefficients provided 
by the manufacturer.  
 
DNA nanocage assembly 
Four 63nt DNA strands were designed with mutually complementary sequences 
such that a DNA tetrahedron forms through hydrogen bonding between all base pairs, as 
previously reported.
65
 A temperature gradient was used to allow the most energetically 
favorable state to form before lower temperatures are reached that can stabilize less fa-
vorable conformations. Using stoichiometric strand ratios and low concentrations, we ob-
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served high assembly yields (~90%) with only minor aggregation as detected by Size Ex-
clusion Fast Protein Liquid Chromatography (SE-FPLC).  
 
Figure 2-13. SE-FPLC chromatograms of the DNA nanocage with and without 
PNA-peptides. SE-FPLC chromatotrograms of [A] the DNA nanocage alone at room 
temperature and [B] the DNA nanocage with both dye labeled PNA-peptides (DNA + 
PNA1-FAM + PNA2-TMR) added in 5x molar excess at 4 °C. The absorbance of DNA 
and PNA at 260 nm were recorded for both chromatograms and for the [B] chromato-
gram the absorbance of FAM (500 nm) and TMR (560 nm) were also recorded. A500 and 
A560 are shown 10x larger than the actual recorded values. Both chromatograms were 
recorded at a flow rate of 1 mL/min. [A] Shows small amounts of dimers and higher or-
der oligomer aggregates, followed by the main peak (yield ~90%) containing the mono-
meric DNA nanocage. [B] The first peak in the chromatogram represents the DNA-PNA-
peptide complex and shows strong dye absorption from the bound labeled PNA-peptides. 
The second peak consists of the excess dye labeled PNA-peptides removed during purifi-
cation. 
 
Unless otherwise noted, 2.25 nmol of each DNA strand was added to 45 mL (50 
nM) of TAE.Mg buffer, in 50 mL centrifuge tubes. The tubes were heated to 90 °C and 
then cooled on ice. The DNA nanocage samples were concentrated with 15 mL Amicon 
Ultra 30 kDa MWCO centrifugal filters (EMD Millipore) and purified by SE-FPLC with 
an Amersham Biosciences (GE Healthcare) HiLoad Prep grade Superdex 200 column 
using an Amersham Pharmacia (GE Healthcare) ÄKTA Purifier controlled by Unicorn 
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5.11 software with a flow rate of 1 mL/min. A representative SE-FPLC chromatogram is 
shown in Figure 2-9. The chromatogram shows a small peak of dimers and higher order 
oligomer aggregates, followed by the main peak (yield ~90%) containing the monomeric 
DNA nanocage. Alternatively, the annealed DNA nanocages were concentrated to 0.25–
10 mL and purified by IEX-FPLC using a Mono-Q 5/50 GL (1 mL column volume) ani-
on exchange column (GE Healthcare) on an Amersham Pharmacia (GE Healthcare) 
ÄKTA Purifier controlled by Unicorn 5.11 software with a flow rate of 1 mL/min. The 
following stepwise gradient was used to mix solvent α (TAE.Mg pH 9.0) and solvent β 
(TAE.Mg pH 9.0 + 2 M NaCl): 3.75%/min (20–35% β), 0.25%/min (35–40% β), 1%/min 
(40–50% β). The DNA nanocages were concentrated again to 5–15 µM. A representative 
chromatogram is shown in Figure 2-14A. 
 The IEX-FPLC chromatogram of the annealed DNA nanocage is shown in Figure 
2-14. The monomeric DNA nanocage elutes as the first main peak, which is composed of 
3–4 overlaid peaks, and is followed by a series of small peaks containing aggregated 
DNA nanocages. While heterogeneity is observed for the main DNA nanocage peak(s), 
all of these peaks pooled together run as a single band during native PAGE, as shown in 
lane 2 in Figure 2-14C. This heterogeneity in elution could be due to weak associations 
between different oligomeric complexes of DNA nanocages that have a small effect on 
the IEX retention time, which are observed during shallow gradients (0.25% or 5 mM 
NaCl / min), but that easily dissociate back to a monomeric form during gel migration. 
Although, agarose gel and electroelution is the current standard for purifying large DNA 
nanostructures,
98
 given the excellent separation of the DNA tetrahedron from higher oli-
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gomeric aggregates using IEX-FPLC with a shallow salt gradient, it may also be possible 
to purify moderate to large DNA nanostructures in the same fashion. 
 
Figure 2-14. DNA nanocage assembly and PNA incubation. [A] Ion Exchange FPLC 
chromatogram of the annealed DNA nanocage. The following gradient was used to mix 
solvent α (TAE.Mg pH 9.0) and solvent β (TAE.Mg pH 9.0 + 2 M NaCl): 3.75%/min 
(20–35% β), 0.25%/min (35–40% β), 1%/min (40–50% β). [B] Size Exclusion FPLC 
chromatogram of the DNA nanocage incubated with 3x excess PNA-CytC (mixture with 
free CytC). The column and buffers were chilled on ice during the run. [C] Native PAGE 
(7%) at 4 ⁰C showing the fraction of PNA-protein hybridized to the DNA nanocage after 
SE-FPLC purification, as indicated in parenthesis for each lane as follows: Lane 6 = 
DNA + PNA-CytC (~75%), Lane 7 = DNA-FAM + PNA-CytC-TMR (~30%), Lane 8 = 
DNA + PNA-Az-TMR (~60%), Lane 9 = DNA-FAM + PNA-Az-TMR (~50%). This gel 
also compares the mobility shift induced from PNA-azurin binding (without purification): 
Lane 2 and 3 have the standard DNA nanocage without and with PNA-azurin, respective-
ly, Lane 4 and 5 have the inverted DNA nanocage without and with PNA-azurin, respec-
tively, where the PNA binding domain is moved across the helix, rotating the orientation 
of protein attachment by about 180 degrees. 
 
The DNA absorbance at 258 nm was measured on a Beckman Coulter DU640 
spectrophotometer using a Hellman TrayCell fiber optic ultra-micro cell with 0.2mm and 
1mm path length caps. The molar extinction coefficient of the DNA nanocage was calcu-
lated by adding up the extinction coefficients of each of the 6 edges of double stranded 
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DNA in the nanocage (A = 321,775, B = 322,314, C = 323,636, D = 319,211, E = 
316,521, F = 320,058 M
-1
cm
-1
, where A–F are the edge labels given by the original pub-
lisher of this structure
65
 and used in Figure 3-2, along with the extinction coefficient of 12 
single stranded adenosine bases (151,128 M
-1
cm
-1
) at the vertices. These extinction coef-
ficients were calculated online at http://biophysics.idtdna.com/UVSpectrum.html using 
IDT’s published algorithm,88 which is based on a nearest-neighbor model. This algorithm 
also accounts for the sequence dependent hypochromic absorbance reduction observed in 
dsDNA from the absorbance of its constituent ssDNA. The following extinction coeffi-
cients (M
-1
cm
-1
) were calculated:  
A) Fully assembled DNA nanocage with all bases on the edges hybridized, ɛ258= 
2,074,643,  
B) DNA nanocage from A, with 8nt removed for binding PNA1, ɛ258= 2,074,181,  
C) DNA nanocage from A, with 8nt removed for binding PNA2, ɛ258= 2,074,894,  
D) DNA nanocage from A, with 16nt removed for binding both PNA1 and PNA2, 
ɛ258= 1,977,651. 
 
PNA-polypeptide assembly with the DNA nanocage 
PNA-peptide incubation with the DNA nanocage 
The desired amount of preassembled and purified DNA nanocage, typically 20–
1000 pmol, was diluted in 1x TAE.Mg buffer to 2 μM concentration, mixed with varying 
molar ratios of PNA-peptide, incubated at room temperature for 5–10 minutes and then 
chilled to 4 °C using a thermocycler. For analytical studies, the samples were analyzed 
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directly using native PAGE at 4 ⁰C, as shown in Figure 2-15. For large scale preparations 
the sample was purified at 4 °C by SE-FPLC as described in the DNA Nanocage Assem-
bly section. A representative chromatogram is shown in Figure 2-13. The main peak has a 
large absorbance at 260 nm (A260) from the DNA and PNA nucleobases as well as ab-
sorbance from the PNA1-peptide FAM label at 500 nm (A500) and PNA2-peptide TMR 
label at 560 nm (A560). The A500 and A560 trace intensities are about 20 times less than 
A260, which is expected for quantitative PNA-peptide binding to the DNA nanocage 
based on the extinction coefficients ɛ258= 2,117,443, ɛ500 = 96,840 (ɛ258/ɛ500 = 21.9), ɛ560 
= 91,000 M
-1
cm
-1
 (ɛ258/ɛ560 = 23.3), as detailed in the PNA-peptide hybridization effi-
ciency section. The chromatogram in Figure 2-13 also shows a second well separated 
peak at a longer elution time from the unhybridized PNA-peptides. Alternatively, because 
of the near quantitative yield of the PNA-peptide incubation, for small scale preparations 
the excess PNA-peptide was removed using a 0.5 mL Amicon Ultra 30 kDa MWCO cen-
trifugal filters (EMD Millipore) by spinning 3–4 times, where after the first 2–3 spins the 
sample were mixed with 0.5 mL of cold (4 °C) TAE.Mg buffer to ensure all free PNA-
peptide was removed. Both PNA-peptides could also be assembled in a stepwise fashion. 
After each PNA-peptide was added to the DNA nanocage the excess PNA-peptide was 
also removed using centrifugal filters. The process was repeated for adding the second 
PNA-peptide. The same end product was achieved regardless of whether the PNA-
peptides were assembled simultaneously or in a stepwise fashion. 
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Figure 2-15. Native PAGE of the DNA nanocage incubated with PNA1-GPG at 4 °C. 
7% Native PAGE at 4 °C of the DNA nanocage incubated with the indicated molar ratio 
of PNA1-GPG labeled with FAM and with TMR. [Left] Gel image (EtBr) showing the 
EtBr fluorescence (Ex. 302 nm, Em. 605 nm) after staining. [Middle] Gel image (FAM) 
taken of the native FAM fluorescence (Ex. 475 nm, Em. 535 nm) prior to EtBr staining. 
[Right] Gel image (TMR) taken of the native TMR fluorescence (Ex. 560 nm, Em. 645 
nm) prior to EtBr staining. For more information refer to Figure 3-4. 
 
PNA-protein incubation with the DNA nanocage 
The complexes listed in Figure 4-3 were formed as follows. For gel hybridization 
experiments, 0.5x to 5x (PNA-CytC) or 0x to 8x (PNA-Az) PNA-protein conjugate was 
incubated for 20–30 minutes at room temperature with the preassembled DNA nanocage 
diluted to 2 µM in TAE.Mg buffer with 1 M NaCl to prevent non-specific binding of the 
protein to the DNA nanocage, then cooled to 4 ⁰C for another 15–20 minutes, then loaded 
directly and analyzed by native PAGE at 4 ⁰C. For larger scale preparations, 2x to 5x of 
each PNA-protein conjugate was used instead with 0.5 to 1 M NaCl, and excess PNA-
protein was removed by gel filtration using an Amersham Biosciences (GE Healthcare) 
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Superdex 75 column cooled with ice, using an Amersham Pharmacia (GE Healthcare) 
ÄKTA Purifier with a flow rate of 1 mL/min of degassed 1x TAE.Mg buffer also cooled 
on ice. The collected fractions were concentrated to the desired amount using Amicon 
Ultra 30 kDa MWCO centrifuge filters (EMD Millipore). A representative chromatogram 
is shown in Figure 2-14B. 
Dye labeled and unlabeled DNA-PNA-protein and DNA-PNA complexes were 
analyzed by native PAGE (7%) with the gels cooled to 4 ⁰C and imaged on a UVP Bio-
Spectrum, as described previously.
79
 Native dye fluorescence was imaged first by excit-
ing at either 475 nm (FAM) or 560 nm (TMR) and imaging at 535 nm (FAM) or 645 nm 
(TMR). Next, the gels were stained with ethidium bromide for 5–10 minutes and des-
tained in nanopure water for 5–10 minutes, then excited at 302 nm and imaged at 605 nm. 
The gels were washed in nanopure water for an additional 10 minutes then fixed in the 
gel by rocking for 1 hour in 40 mL of 12.5% (v/v) glutaraldehyde in water. Excess glu-
taraldehyde was removed by rinsing the gel several times with deionized water followed 
by soaking twice for 15 minutes in deionized water. The gels were stained in the dark for 
1 hour by rocking in 40–80 mL of 1% (w/v) silver nitrate in water. Excess silver nitrate 
was removed by rinsing the gel 3–4 times followed by soaking the gel in water for 5 
minutes and then subsequently for 15–20 minutes. The gel was transferred to 10–20 mL 
of developer solution (0.25% (v/v) formaldehyde, 6.25% (w/v) sodium bicarbonate in 
water) where it was gently agitated until the bands of interest were nicely visible and then 
immediately transferred to 20–30 mL of fixing solution (10% (v/v) glycerol, 10% (v/v) 
acetic acid in water). The gel was then imaged on the UVP BioSpectrum via white light 
transillumination from the Manual BioLite. Optimal contrast was achieved using a 535 
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nm emission filter and converting the image to black and white. Color was added to the 
image using CorelDRAW version 16.0 (Corel corporation) to produce a yellow back-
ground with brown bands as typically shown with silver stain. Silver staining has proven 
to be an excellent method for identifying protein containing gel bands of small DNA 
nanostructures,
99
 but it may not be practical with large DNA origami nanostructures due 
to the background DNA staining from such large (>4 MDa) scaffolds. 
 
PNA-peptide hybridization efficiency 
In order to determine the degree of PNA-peptide hybridization to the DNA 
nanocage, the ratio of the PNA and DNA nucleobase absorption at 258 nm to that of the 
PNA dye label (FAM = A500/A258, TMR = A560/A258) were normalized to the calculated 
ratio of their respective extinction coefficients (FAM = ɛ500 / ɛ258, TMR = ɛ560 / ɛ258. The 
spectra were measured at room temperature (DNA + PNA1-TMR) or with the sample 
kept on ice for measuring the absorption spectrum (DNA + PNA1-FAM) to ensure stable 
hybridization in the presence of electrostatic repulsion of FAM
2-
 away from the DNA 
nanocage. The extinction coefficients of the dyes were provided by the manufacturer, In-
tegrated DNA Technologies (FAM: ɛ495 = 75,000 and ɛ260 = 13,700 M
-1
cm
-1
, TMR: ɛ559 
= 91,000 and ɛ260 = 29,100 M
-1
cm
-1
), where the observed absorption peaks were slightly 
red shifted to 500 nm and 560 nm, respectively, after conjugation to PNA or DNA. The 
extinction coefficient for the DNA and PNA at 258 nm in the complex was ɛ258= 
2,074,643 M
-1
cm
-1
, and was calculated as described in the DNA Nanocage Assembly sec-
tion. For the fully assembled complex with both dye labeled PNA-peptides, the extinction 
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coefficient of TMR at 500nm was determined experimentally to be 21,840 M
-1
cm
-1
 from 
the ratio of the absorption maxima at 560 nm (A560), where the extinction coefficient is 
known, to the absorption at 500 nm (A500), where A500 = 0.24 x A560. Adding up all the 
constituent extinction coefficients for the fully assembled complex with both labeled 
PNA-peptides yields: ɛ258= 2,117,443, ɛ500 = 96,840 (ɛ258/ɛ500 = 21.9), ɛ560 = 91,000 M
-
1
cm
-1
 (ɛ258/ɛ560 = 23.3).  
The absorption spectra were measured as described in the DNA Nanocage As-
sembly section. The purified samples were analyzed by native PAGE. A 7% gel was typ-
ically used (7% 19:1 Acrylamide:Bisacrylamide polymerized with APS and catalyzed by 
TEMED in 1xTAE.Mg). Samples were mixed with 10x native tracking dye (0.2% Bro-
mophenol Blue, 0.2% Xylene cyanol, 50% glycerol in 1x TAE.Mg) to a final ratio of 1:1. 
The gels were typically run at a constant 12.5 V/cm (200 V/16 cm) with the gels cooled 
to the specified temperature using a Fisher Scientific Isotemp 3006S temperature con-
trolled water bath circulating through the SE 600 Ruby lower buffer chamber. Gels were 
visualized on a UVP BioSpectrum (Upland, CA, USA) equipped with a BioLite Manual 
transilluminator with a 150 W Halogen light source and Ascent 4000C 4.2 M pixel color 
CCD camera. FAM was visualized using a 475 nm excitation filter (UVP, 38-0340-03) 
and a 535 nm emission filter (UVP, 38-0340-01). TMR was visualized using a 560 nm 
excitation filter (UVP, 38-0341-03) and a 645 nm emission filter (UVP, 38-0341-01). 
DNA was visualized by EtBr staining and imaged at 302 nm using a Benchtop 2UV 
Transilluminator (UVP, 95-0495-01) and a 605 nm emission filter (UVP, 38-0220-01). 
The PNA-peptide hybridization efficiency to the DNA nanocage, shown in Figure 3-4, 
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was determined by integrating the FAM and TMR fluorescence intensity of each band of 
the unstained complex scaled by the amount of the complex in that lane, as determined by 
the Ethidium Bromide (EtBr) fluorescence intensity of the stained complex, and then 
normalized to the maximum FAM or TMR fluorescence. 
 
PNA-polypeptide hybridization kinetics 
The peak fluorescence (521 nm) of the FAM labeled DNA nanocage was meas-
ured using a Nanolog Fluorometer (Horiba Jobin Yvon, 450 W Xenon continuous wave 
lamp, R928 photomultiplier tube, 1200 grooves/mm excitation and emission gratings) 
with a 3 mm quartz cuvette (Starna Cells, 16.45F-Q-3/Z15), by exciting the donor (FAM) 
at 450 nm in order to minimize the amount of direct acceptor (TMR) excitation. The fluo-
rescence intensity was integrated for 0.5 seconds and measured once per second with ex-
citation and emission slit widths of 1.25 nm. A computer controlled NESLAB RTE 7 cir-
culating, refrigerated water bath (Thermo Scientific) was used to maintain a 25 °C or 11 
°C sample temperature through the FluorEssence v3.5 software interface. 15 pmol of 
DNA-FAM nanocage was diluted into 75 μL of TAE.Mg buffer and the fluorescence 
peak was collected for one minute. Data collection was paused for about 15 seconds 
while 5x molar excess (75 pmol) of PNA1-GPG-TMR (1 μL of 76 μM), 4x TMR labeled 
PNA-azurin or 5x TMR labeled PNA-CytC was added and mixed. Data collection was 
resumed until 15 total minutes of data was collected. The FAM fluorescence was 
quenched by the TMR label as well as the native heme absorbance in the case of cyto-
chrome c. Similarly, DNA-FAM was monitored at 11 ⁰C as 2x PNA-CytC (unlabeled) 
was added. The data was processed by normalizing the minimum and maximum fluores-
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cence values to zero and one, respectively, and then inverted (   (    )) to show the 
fraction of PNA bound as a function of time, as shown in Figure 2-16 and Figure 3-6. 
The binding kinetics was fit with an exponential function using OriginPro version 9.1.0 
with the following equation:         
     , where y0 is the upper limit once bind-
ing terminates, A is the exponential prefactor and R0 is the rate of PNA-protein hybridiza-
tion. The fitting parameters are shown in Table 3-1 for PNA1-GPG-TMR and Table 2-1 
for the PNA-proteins. 
 TMR labeled PNA-proteins were added to separate FAM labeled DNA nanocages 
(DNA-FAM) to investigate the hybri                                                 o-
nance energy transfer (FRET), as the fluorescence from the excited donor FAM becomes 
quenched by the acceptor TMR during PNA-protein hybridization. The peak FAM fluo-
rescence of DNA-FAM was monitored as either 5x molar excess PNA-CytC-TMR or 4x 
molar excess of PNA-Az-TMR were separately added and mixed at 25 ⁰C in the presence 
of 1 M NaCl to prevent non-specific binding. DNA-FAM fluorescence was rapidly 
quenched upon TMR labeled PNA-protein binding as shown in Figure 2-16A and Figure 
2-16C. The raw fluorescence data was normalized and inverted to show the fraction of 
PNA-protein bound to the DNA nanocage as a function of time, as shown in Figure 
2-16B and Figure 2-16D. PNA-Az-TMR and PNA-CytC-TMR were found to reach 99% 
hybridization within 2 minutes and within 4 minutes, respectively, as shown in Figure 
2-16. These rates are slightly faster than the 5–10 minutes previously observed for PNA-
peptides.
79
 The positively charged PNA-CytC may take longer to bind because of strong-
er electrostatic interaction with the DNA nanocage in conformations that slow the PNA 
from locating its binding site. 2x molar excess of unlabeled PNA-CytC was also incubat-
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ed with DNA-FAM as a control for another fluorescence experiment, but it was found 
that the heme absorption also quenched the FAM fluorescence such that the binding ki-
netics could be monitored. PNA-CytC was found to bind to the DNA nanocage at 11 ⁰C 
within 16 minutes, as shown in Figure 2-16E and Figure 2-16F. 
 
 
Figure 2-16. Time course PNA-protein hybridization with the DNA nanocage. Mo-
lecular models of the FAM labeled DNA nanocage with TMR labeled CytC [K] and Az-
urin [L]. 2x to 4x excess PNA-protein was mixed for ~15 seconds (no data collected) and 
then the FAM fluorescence at 520 nm was monitored over time for PNA-CytC-TMR at 
25°C [A, E] and PNA-CytC-TMR at 11°C [B, F], PNA-CytC (unlabeled) at 25°C [C, G] 
and PNA-CytC (unlabeled) at 11°C [D, H] and PNA-Az-TMR at 25°C [I, J]. Plot of the 
peak FAM fluorescence at 521 nm as a function of time after the PNA-protein was added 
[E, F, G, H, J]. The peak FAM fluorescence was normalized and inverted to show the 
fraction of PNA-protein bound and plotted as a function of time [A, B, C, D, I]. The ex-
ponential fit was produced as described in the methods section and the fitting parameters 
are shown in Table 2-1. 
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Table 2-1. Fitting parameters and time to reach 99% hybridization for PNA-protein 
binding kinetics with DNA nanocage. Table of parameters obtained by fitting the hy-
bridization kinetics data shown in Figure 2-16 to an exponential function. The equation is 
described in the PNA-protein assembly with the DNA nanocage methods section, and 
was used to determine the time for each PNA-protein to reach 99% hybridization. 
Fitting 
Parameter 
[25 ⁰C] DNA-FAM + 
PNA-CytC-TMR 
[25 ⁰C] DNA-FAM + 
PNA-Az-TMR 
[11 ⁰C] DNA-FAM 
+ PNA-CytC 
y0 100.7 ± 0.05% 100.4 ± 0.2% 100.1 ± 0.05% 
A (counts) (209.4 ± 1.2) x 10
-3
 (211.6 ± 6.2) x 10
-3
 (280.5 ± 0.4) x 10
-3
 
R0 
(counts/sec)
 
(9.9 ± 0.1) x 10
-3
 (26.8 ± 1.2) x 10
-3
 (3.29 ± 0.02) x 10
-3
 
R
2
 0.9941 0.9685 0.9982 
Time to 99% 
Hybridization 
252 sec (4.2 min) 101 sec (1.7 min) 977 sec (16.3 min) 
 
DNA-PNA-polypeptide thermal stability and fluorescence characterization 
Sample preparation 
For thermal stability measurements, the following constructs were assembled by 
incubating 2–5x molar excess of PNA-polypeptide with the DNA nanocage and purified 
by SE-FPLC at 4 °C, as described in the DNA Nanocage Assembly section: 1) DNA-
FAM + PNA1-TMR, 2) DNA-TMR + PNA1-FAM, 3) DNA-FAM + PNA-CytC-TMR, 
4) DNA-FAM + PNA-Az-TMR, and controls 5) DNA-FAM, and 6) DNA + PNA1-FAM. 
For TCSPC measurements the following complexes were assembled by incubation and 
kept at 4 °C during purification and thereafter: 1) DNA + PNA1-FAM + PNA2-TMR, a 
donor only control 2) DNA + PNA1-FAM + PNA2-Ac (acetylated), and acceptor only 
controls 3) DNA + PNA1-Ac + PNA2-TMR, 4) DNA + PNA-CytC-TMR, 5) DNA + 
PNA-Az-TMR. The named constructs are all defined in Figure 3-3. 
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Steady state fluorescence spectra 
The same setup was used as described in the PNA hybridization kinetics section. 
We excited FAM at 440 nm for thermal dissociation experiments for PNA-peptides and 
450 nm for PNA-proteins. However, the laser intensity for TCSPC experiments was 
much stronger at 450 nm so we chose to excite FAM at 450 nm for both TCSPC experi-
ments and steady state FRET experiments, which allowed for direct comparison of ener-
gy transfer efficiency. Furthermore, after more careful analysis of the TMR and FAM 
absorption spectra, we noticed that TMR had a slightly lower absorption at 450 nm than 
440 nm and FAM had higher absorption, so the 450 nm excitation wavelength is pre-
ferred. Donor and acceptor emission spectra were collected in 1 nm increments, integrat-
ing the fluorescence intensity for 0.5 seconds per data point, with excitation and emission 
slit widths as specified: 1.25 nm for steady state FRET measurements and 2.5 nm for 
thermal dissociation experiments. Fluorescence measurements were preceded by measur-
ing the absorption on a JASCO V-670 spectrophotometer in order to normalize the fluo-
rescence. The peak emission was normalized to the concentration of DNA nanocage from 
the absorbance at 260 nm for each construct. For thermal dissociation experiments, a wa-
ter bath was used to control the sample temperature as described in the PNA hybridiza-
tion kinetics section. The temperature was increased from 11 °C to 85 °C and back to 
11°C in 0.5°C steps. Each temperature was equilibrated ±0.25 °C for 30 seconds before 
the fluorescence spectrum was acquired. All spectra were corrected for systematic re-
sponses of the gratings, monochromator components and detector using the correction 
file (Mcorr_R928P.spc) provided by the manufacturer (Horiba Jobin Yvon). Although 
both complexes shown in Figure 3-7 were measured at 210 nM concentration, the higher 
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fluorescence signal observed for DNA-TMR + PNA1-FAM is likely because of the high-
er FAM quantum yield when attached to the PNA over when attached directly to the 
DNA nanocage. 
 
Dissociation temperature (TD) curves 
Two donor only controls were prepared to quantify the change in donor (FAM) 
fluorescence with temperature. A control was prepared with the donor coupled directly to 
the DNA nanocage (DNA-FAM) as well as a control with the donor coupled to the 
PNA1-peptide and hybridized to the DNA nanocage (DNA + PNA1-FAM). The steady 
state fluorescence emission spectra were monitored as a function of temperature as de-
scribed in the Steady State Fluorescence Spectra section. The fractional change from the 
maximum donor fluorescence at each temperature was converted into a correction factor 
using the following formula: CF(λ) = 1 + 
      –   
     
 , where CF(λ) is the wavelength de-
pendent correction factor, I11°C is the maximum donor fluorescence of the control which 
occurs at the coldest temperature of the experiment (11 °C) and Iλ is the donor fluores-
cence of the control at each wavelength, as shown in Figure 2-17.  
The maximum donor fluorescence of the scan at each temperature was corrected 
by the corresponding control (i.e., DNA-FAM + PNA1-TMR, DNA-FAM + PNA-CytC-
TMR and DNA-FAM + PNA-Az-TMR were corrected by DNA-FAM; DNA-TMR + 
PNA1-FAM was corrected by DNA + PNA1-FAM). The corrected data were normalized 
to the maximum peak donor fluorescence and fit to a sigmoidal dose response curve us-
ing Origin version 8.6 (PNA-peptide complexes) or 9.1 (PNA-protein complexes), with 
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the following equation:        (
     
    (   (  )  ) 
), where A1 and A2 are the lower and 
upper asymptotes, respectively, x is the normalized, corrected fluorescence at a given 
temperature, LOG(x0) is the base 10 logarithm at the inflection point of the curve, x0 , 
which is also the dissociation temperature (TD), and p is the variable Hill slope at x0. The 
fit assumes a two state model where the associated complex [DNA + PNA1] dissociates 
directly to its constituent components [PNA1] and [DNA] without any intermediate 
states. 
 
Figure 2-17. Temperature dependence of FAM Fluorescence. [A] Temperature de-
pendent peak fluorescence of FAM labeled on the DNA nanocage (DNA-FAM) and la-
beled on the PNA-peptide and hybridized in the unlabeled DNA nanocage (DNA + 
PNA1-FAM). [B] Correction factor calculated from the fractional change in FAM fluo-
rescence for each construct from [A] with respect to the maximum fluorescence of each 
scan. 
 
The predicted dissociation temperatures were calculated using the method de-
scribed by Giesen, Nielsen and coworkers
95
 with the following equation:            
                     , where           and   are constants with the values of 
20.79, 0.83, -26.13 and 0.44, respectively,       is the predicted dissociation tempera-
ture of a DNA duplex of the same sequence calculated online at 
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http://biophysics.idtdna.com using the methods described by Owczarzy and coworkers
100
 
based on the nearest neighbor model,      is the fraction of the sequence with pyrimidine 
(C or T) bases, and L is the length of the sequence. 
 
 
Figure 2-18. Fluorescence spectra of the TMR labeled PNA-proteins bound to the 
FAM labeled DNA nanocage as a function of temperature. The FAM labeled DNA 
nanocage (DNA-FAM) containing either TMR labeled PNA-CytC (A) or PNA-azurin (C) 
was excited at 450 nm and the emission was monitored as a function of wavelength as the 
temperature was increased from 11 ⁰C to 85 ⁰C. The molecular models of the constructs 
used to measure the spectra in from A and C are shown in B and D. The peak donor fluo-
rescence of each construct is plotted versus temperature and fitted with a sigmoidal dose 
response curve (E), where the inflection point corresponds to the dissociation temperature 
(TD) indicated on the plot. The difference (Δ) from a theoretical value (36.6 °C) is also 
shown, which is greater than the value predicted for a similar DNA sequence (34.5 °C). 
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Donor quantum yield 
The quantum yield (QY, ) of the donor (FAM) was calculated by measuring its 
peak fluorescence intensity when conjugated to the PNA-peptide and hybridized to the 
DNA nanocage (DNA + PNA1-FAM and DNA + PNA1-FAM + PNA2-Ac) and when 
conjugated directly to the DNA nanocage (DNA-FAM), and comparing these values to 
the fluorescence intensity of the dye standard Sodium Fluorescein in 0.1 M NaOH, which 
has   = 0.925 at 22 °C reported by Magde and coworkers.
101
 The QY was calculated 
using the following equation:     
 
 
  
  
  
   
 , where the fluorescence intensity of the 
sample (I) and reference (IR) are normalized by their absorbances (A and AR, respective-
ly) at the excitation wavelength and scaled by the ratio of the square of the two index of 
refraction (        , respectively). For quantum yields measured at low concentration, 
the excitation and emission slit widths were opened up to 2.5nm to increase the fluores-
cent signal. However, at these low concentrations the dye absorbance could not be deter-
mined reliably. In this case the fluorescence intensities of the donor complex and the ref-
erence were normalized by the estimated sample concentration based on the dilution fac-
tor from a known initial sample concentration. 
 
Calculating the absorption spectra and extinction coefficients for the overlap integral of 
TMR labeled PNA-proteins 
The overlap between the donor (FAM) fluorescence emission and acceptor 
(TMR) absorption is used to determine the Förster radius. We determined the spectra for 
the conjugate when hybridized to the DNA nanocage because of the dependence of the 
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TMR absorption spectrum its environment. The absorption of the FAM labeled DNA 
nanocage (DNA-FAM) was subtracted from that of the DNA-FAM nanocage hybridized 
to either TMR labeled protein, as shown in Figure 2-19. The determined absorption spec-
tra for DNA + PNA-CytC-TMR and DNA + PNA-Az-TMR were used along with the 
fluorescence emission of the DNA-FAM nanocage to determine the overlap integral in 
subsequent Förster distance calculations. The extinction coefficient of PNA-Az-TMR and 
PNA-CytC-TMR at 555 nm in separate DNA-FAM nanocages was calculated to be 
32,000 M
-1
cm
-1
 and 71,638 M
-1
cm
-1
 as follows:            
    
    
 where ε258 is the ex-
tinction of the nucleobases in the DNA nanocage and PNA sequence of 2,074,643 M
-1
cm
-
1
 as calculated previously
79
 and A258 and A555 are the observed absorbance values for the 
complex. Absorption spectra were measured on a Beckman Coulter DU640 spectropho-
tometer using a Hellman TrayCell fiber optic ultra-micro cell with 0.2 mm or 1 mm path 
length caps. 
The TMR absorbance spectra when attached to either protein showed an increase 
in the absorption peak at 518 nm, compared to the free dye, as shown in Figure 2-19. This 
phenomenon is commonly observed when TMR self-associates, such as when conjugated 
to proteins
102
 or in solution at high concentration.
103
 The higher energy peak at 518 nm 
for PNA-CytC-TMR indicates that it may have a higher degree of labeling than for PNA-
Az-TMR. However, because of the convolution between the TMR absorption spectral 
shift and amplitude due to multiple dye labels per protein, we were unable to quantify the 
extent of TMR labeling on each protein. Figure 2-19C and Figure 2-19D show the spectra 
of PNA-CytC-TMR and PNA-Az-TMR within a mixture with CytC-TMR and Az-TMR, 
respectively, prior to and after hybridization with the DNA nanocage. The 518 nm peak is 
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significantly reduced upon binding to the DNA nanocage. This may be partially ex-
plained by the lower effective concentration of the dye labeled PNA-protein bound to the 
DNA nanocage, making it much less likely for the dye labeled proteins to self-associate.  
 
Figure 2-19. Calculated dye labeled PNA-protein absorption spectra and spectral 
changes upon hybridization to the DNA nanocage. Absorption spectra of the FAM la-
beled DNA nanocage with TMR labeled PNA-protein (blue), the FAM labeled DNA 
nanocage alone (green) and the absorption spectra of the TMR labeled protein (red) cal-
culated by subtracting the green curve from the blue curve for PNA-CytC-TMR [A] or 
PNA-Az-TMR [B]. Changes to the TMR absorption spectra upon biding to the DNA 
nanocage for PNA-CytC-TMR [C] or PNA-Az-TMR [D]. Prior to binding to the DNA 
nanocage, the samples of PNA-CytC-TMR and PNA-Az-TMR also contain TMR labeled 
protein without PNA; the effect this has on the observed changes in spectra is discussed 
below. 
 
The reduction in the 518 nm peak is more significant for PNA-CytC-TMR than for PNA-
Az-TMR. Because cytochrome c was labeled with TMR prior to conjugation with PNA, 
    PNA  m y    j      p  f       lly     y      m   ’  w    f w   TMR l   l , w     
would lead to a larger reduction in the 518 nm peak compared to the PNA-Az-TMR, 
which was labeled with TMR after PNA conjugation. The slight difference in the Soret 
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peak of 411 nm and 413 nm between PNA-CytC-TMR and DNA-PNA-CytC-TMR is 
within the expected range for fully oxidized (410 nm) and fully reduced (414 nm) sta468. 
 
Fluorescence lifetime 
Time Correlated Single Photon Counting (TCSPC) spectra were measured using a 
20 MHz Fianium FemtoPower1060, Supercontinuum Laser Source with the output set to 
450 nm or 500 nm to excite the donor or acceptor, respectively, at a 10 nm spectral 
bandwidth using a combination of Acousto-Optic Tunable Filter (Fianium Ltd., Eugene, 
OR) and an interference filter centered at the excitation wavelength. The fluorescent sig-
nal was collected at a right angle to the excitation beam and detected using a double-
grating monochromator (Jobin-Yvon, Gemini-180) and a microchannel plate photomulti-
plier tube (Hamamatsu R3809U-50). Data was acquired with a single photon counting 
card (Becker-Hickl, SPC-830). Lifetime data were collected through a polarizer set at the 
magic angle (54.7°). The instrument response function (IRF) was measured by sample 
scattering at the excitation wavelength and had a full width at half-maximum (FWHM) of 
105–115 ps for data collected for the DAS and 60–118 ps for data collected for anisotro-
py. The sample was cooled to 11 °C using a refrigerated water bath to maintain quantita-
tive PNA-peptide binding to the DNA nanocage during the measurement without water 
condensing on the fluorescence cuvette. All decay kinetics used to construct the DAS 
were collected for the same amount of time at each wavelength. The home-built software 
ASUFIT version 3.1 (PNA-peptide complexes) or 3.2 (PNA-protein complexes) running 
on MATLAB version 7.0.4 was used to fit the decay kinetics using a multi-exponential 
model for lifetime data or for DAS, all recorded wavelengths were fit simultaneously and 
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deconvoluted by global analysis. The lifetimes shown in Figure 2-21 are an average of 
the components identified in Table 2-2. The fluorescence kinetics data as a function of 
decay time and wavelength were fit simultaneously using the following multi-exponential 
decay model,  (   )  ∑   ( )     ( 
 
  ( )
) , where F is the fluorescence intensity de-
cay kinetics at the measured wavelength,   ( ) is the calculated lifetime of the identified 
decay component and   ( ) is the calculated amplitude of decay at the measured wave-
length. 
 
Figure 2-20. Donor (FAM) fluorescence decay kinetics attached to DNA nanocage 
with and without the acceptor (TMR) labeled PNA-proteins hybridized to the DNA 
nanocage. Fluorescence decay kinetics measured by TCSPC at 11°C of [A] the donor 
(FAM) when excited at 450 nm attached to the DNA nanocage alone (blue) and when 
hybridized to the acceptor (TMR) labeled PNA-azurin (red) or PNA-cytochrome c 
(green) as well as [B] the acceptor (TMR) when excited at 500 nm attached to the either 
PNA-CytC or PNA-azurin and hybridized to the unlabeled DNA nanocage. 
 
The lifetimes shown in Figure 3-8 (A) are an average of the components identi-
fied in Table 3-2 as calculated using the equation  ( )  
∑   ( )   ( )) 
∑   ( ) 
, where the ampli-
tude   ( ) is the percentage of each component of a given lifetime   ( ). The energy 
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transfer efficiency was calculated from the percent change in donor lifetime in the pres-
ence of the acceptor using the following equation:     
   
  
, where   is the energy 
transfer efficiency,    is the lifetime of the donor alone and     is the lifetime of the do-
nor in the presence of the acceptor. 
 
Table 2-2. Lifetime components and calculated average lifetimes of the donor and 
acceptor fluorophores. Each “%” column shows the relative amount of each lifetime 
component. The lifetime of the donor (FAM) in the presence of the acceptor (TMR) was 
measured in the donor emission region (500 nm) when the donor was excited at 450 nm. 
The lifetime of the acceptor (TMR) was measured at 600 nm by exciting the acceptor at 
500 nm. DNA + PNA-CytC-TMR complex required four fitting parameters due to the 
higher degree of TMR labeling on cytochrome c and correspondingly more complex de-
cay pathways compared to azurin. 
FAM Construct  1 % of  1  2 % of  2 Average   
Lifetime 
DNA-FAM 
alone 
4.49 ± 0.06 ns 81.5% 1.08 ± 0.24 ns 18.5% 3.86 ±     
0.09 ns 
DNA-FAM + 
PNA-Az-TMR 
4.10 ± 0.14 ns 71.5% 0.9 ± 0.3 ns 28.5% 3.19 ±     
0.19 ns 
DNA-FAM + 
PNA-CytC-TMR 
3.75 ± 0.12 ns 55.4% 0.80 ± 0.14 ns 44.6% 2.43 ±     
0.13 ns 
 
TMR   
Construct 
 1 % of 
 1 
 2 % of 
 2 
 3 % of 
 3 
 4 % of 
 4 
Average 
Lifetime 
DNA + PNA-
Az-TMR 
3.82 ± 
0.07 ns 
74.8 1.57 ± 
0.21 ns 
25.2 - - - - 3.25 ±   
0.11 ns 
DNA + PNA-
CytC-TMR 
32 ±   
7 ps 
63.1 192 ± 
16 ps 
23.5 624 ± 
29 ps 
12.3 2.05 ± 
0.2 ns 
1.1 164 ± 14 ps 
 
Fluorescence decay kinetics were measured by exciting the DNA-FAM at 450 nm 
and measuring the fluorescence decay at 500 nm where it should be dominated by the 
FAM kinetics. The decay was fit by two exponentials globally over the wavelength re-
gion from 500 to 700 nm. A 1 ps decay component was necessary in some of the fits due 
to a slight time offset between the measured decay kinetics and the measured instrument 
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response function (IRF). This is well below the resolution limit of the instrument and 
therefore was not included for calculating the lifetimes. The lifetimes of each construct 
were calculated by weighting the lifetime from each exponential by the amplitude per-
centage required to produce the fit, as shown in Table 2-2. The DNA-FAM lifetime of 
3.86 ± 0.09 ns is decreased to 3.19 ± 0.19 ns in the presence of PNA-Az-TMR and de-
creased to 2.43 ± 0.13 ns in the presence of the PNA-CytC-TMR due to energy transfer. 
The change in donor lifetime was used to calculate the energy transfer efficiency of 17 ± 
5% for PNA-Az-TMR and 37 ± 3% for PNA-CytC-TMR, as described previously,
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which are both in agreement with the results obtained using steady state fluorescence. 
TCSPC was also used to measure the fluorescence decay kinetics of the TMR labeled 
proteins attached to the unlabeled DNA nanocage, which are plotted in Figure 2-20B. 
The average lifetime of PNA-Az-TMR in the DNA nanocage was 3.25 ± 0.11 ns, which 
is in agreement with the lifetime of monomeric TMR.
104
 The average lifetime of PNA-
CytC-TMR in the DNA nanocage was significantly reduced to 164 ± 14 ps, which is like-
ly because of the increased absorbance of the non-fluorescent energy band at 518 nm.
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Decay kinetics were also measured at various wavelengths between 500–640 nm 
that span the FAM emission spectrum and fit using global analysis with two exponentials. 
The amplitudes are plotted as a function of wavelength as the decay associated spectra 
(DAS) shown in Figure 2-21. Just as with the lifetime fitting, a 1 ps exponential term was 
used to compensate for the IRF time delay offset artifact, but was not included during 
subsequent analysis. DNA-FAM + PNA-Az-TMR had a 4.3 ± 0.1 ns component, which 
is from both the native FAM decay and TMR decay after energy transfer. The DAS fit 
also contains a 1.1 ± 0.4 ns component that shows reduced amplitude (increased fluores-
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cence) in the TMR absorption region at 590 nm compared to the 4.3 ns component, indi-
cating energy transfer from DNA-FAM to PNA-Az-TMR. DNA-FAM + PNA-CytC-
TMR also has a 4.0 ± 0.1 ns component for the native FAM decay as well as 1.0 ± 0.15  
 
Figure 2-21. Decay associated spectra (DAS) of the FAM labeled DNA nanocage hy-
bridized to either the TMR labeled PNA-azurin or PNA-cytochrome c. Fluorescence 
decay spectra were collected at several wavelengths and fit simultaneously to two com-
ponents using global analysis. The relative amplitudes of each component from the anal-
ysis are plotted as a function of wavelength in the Decay Associated Spectra (DAS) for 
the FAM labeled DNA nanocage hybridized to either the TMR labeled PNA-azurin (A) 
or PNA-cytochrome c (B). Each component of the DAS from A and B were normalized 
and plotted in C and D, respectively, to highlight the reduced amplitude from energy 
transfer at 590 nm for PNA-Az-TMR (C) and at 540 nm for PNA-CytC-TMR (D). 
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ns component with reduced amplitude at 540 nm indicating energy transfer from DNA-
FAM to PNA-CytC-TMR. The shift of the reduced amplitude domain from 590 to 540 
nm indicates energy transfer to PNA-CytC-TMR is almost exclusively due to the 518 nm 
absorption band, which is expected because of the more significant overlap with the 
DNA-FAM emission. However, because the 518 nm TMR band is non-fluorescent,
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there is much less amplitude decrease (increased fluorescence) due to energy transfer 
from FAM to TMR between 580–600 nm as compared to the same band in the 4.3 ns 
component for PNA-Az-TMR. 
 
Fluorescence anisotropy 
Fluorescence decay measurements were performed as described in the Fluores-
cence Lifetime section with the laser tuned to excite either the donor (FAM) at 450 nm or 
the acceptor (TMR) at 500 nm. We measured DNA nanocage complexes containing PNA 
at 11 °C to stabilize the PNA-DNA hybridization and measured at 22 °C for DNA 
nanocage complexes without PNA. DNA dye labeling was performed by the manufactur-
er (IDT) through a thymine base internally modified with amino hexane linker, which is 
located at the vertex adjacent to the PNA1 binding gap in the fully assembled DNA 
nanocage. The anisotropy (r) of each dye was calculated as a function of decay time (t) 
by comparing the emission with polarization both parallel (VV, vertical excitation and 
emission) and perpendicular (VH, vertical excitation and horizontal emission) relative to 
the polarization of the excitation using the following equation:  ( )   
   ( )  ( )    ( )
   ( )   ( )    ( )
, 
where IVV(t) and IVH(t) are the emission spectra collected as a function of time parallel 
and perpendicular to the excitation polarization, respectively, and G(t) is the “G factor” 
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as a function of time as defined by:  ( )   
   ( )
   ( )
 , where IHV and IHH are the emission 
spectra collected as a function of time perpendicular and parallel to the excitation polari-
zation, respectively, when the excitation polarization is rotated 90 degrees from what was 
used to measure IVV(t) and IVH(t). The “G factor” for our measurement setup was 1.5 at 
520 nm emission and 1.3 at 600 nm emission. The anisotropy is plotted in Figure 8 along 
with the central moving average at each data point ± 0.02 ns (9 data points) for data be-
fore 0.3 ns and ± 0.12 ns (49 data points) for data after 0.3 ns. 
 
Förster radius, energy transfer efficiency and distance calculations 
The Förster radii of each complex were calculated using the following equation 
  
 (   )               (        ( )), where   is the orientation factor and is as-
sumed to be ⅔ for a randomly oriented dye,   is the index of refraction of the aqueous 1x 
TAE.Mg buffer, which is assumed to be the same as water (  =1.333),   is the quantum 
yield of the donor, as calculated for each complex in the Donor Quantum Yield section, 
and  ( ) is the overlap integral (M-1cm3), which is defined as follows:  ( )  
∫   ( )
 
 
  ( ) 
   , where    is the donor fluorescence at each wavelength, with the 
total donor fluorescence overlap region normalized to unity,    is the extinction coeffi-
cient (M
-1
cm
-1
) of the acceptor at each wavelength, which was calculated based on the 
extinction coefficient for the peak absorbance of TMR at 560 nm (91,000 M
-1
cm
-1
) as 
provided by the manufacturer IDT, and   is the wavelength in centimeters. The overlap 
integral was calculated using numerical approximation by summing the product of the 
integrand from the start of the fluorescence scan at 470 nm to 650 nm, where the acceptor 
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absorption is negligible. The Förster distance for each complex was calculated using the 
following equation:      √
 
 
  
 
 , where    is the calculated Förster radius, and   is 
the energy transfer efficiency, which is calculated for each complex as follows:     
   
  
, where     and    are the peak donor fluorescence intensities with and without the 
acceptor, respectively, normalized by the absorption of each complex at the excitation 
wavelength, or normalized by the sample concentration for very dilute samples. 
 
Förster distance uncertainty calculations 
The anisotropy data was used to put limits on the orientation factor   based on a 
method developed by Lakowicz and coworkers
13
 using the following equation:     
  
 
 
 
    
(     )
 
   and     
   
 
 
                  and    √
  
  
 , where    is the 
fraction of depolarization from the local fluorophore motion and    is fraction of depolar-
ization from the rotational diffusion of the DNA nanocage. Because the DNA nanocage is 
so large (radius ~3 nm) we assume that the depolarization from rotational diffusion dur-
ing the lifetime of our fluorophores (~4 ns) is negligible. Thus we can use our measured 
anisotropies for    (FAM = 0.12, TMR = 0.24) and the maximum possible aniosotropy of 
0.4 for    to calculate the depolarization factors (FAM = 0.55, TMR = 0.78) and limits on 
the orientation factor (     = 0.2,      = 1.7). The anisotropy of the TMR labeled PNA-
proteins could not be reliably determined due to the effects of multiple dye labels on 
some proteins. Instead, the anisotropy of the TMR labeled DNA nanocage was used for 
the acceptor in the DNA-PNA-protein complexes, because the rotation of the DNA 
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nanocage is the slowest moving component of the system and therefore estimates the 
highest possible anisotropy and largest possible uncertainty in the measured distances. 
For each of the distances calculated using the Förster equation and shown in Figure 3-10, 
the orientation factor limits were used to calculate the upper (    ) and lower (    ) dis-
tance limits from the following equations:            √ 
    
 
 
   and            
√ 
    
 
 
  , where       are the measured distances from the Förster equation. The uncer-
tainties reported in Figure 3-10 were the average difference between each measured dis-
tance and its corresponding upper and lower limits.  
 
Molecular structures, models and chemical structures 
Molecular structures of DNA nanocage, PNA, cytochrome c and azurin 
The molecular structures of the 8mer PNA,
105
 cytochrome c,
106
 azurin
107
 and the 
photosystem II active site
108
 shown in Figure 2-18, Figure 4-1, Figure 4-4, Figure 4-5, 
Figure 4-10, Figure 4-12 and Figure 6-5 were taken from the protein data bank and ren-
dered using PyMOL
109
 version 0.99 or 1.1. The molecular model of the DNA tetrahedron 
shown in Figure 2-18, Figure 4-10, Figure 4-12 and Figure 6-5 was assembled in Coot
110
 
version 0.7.1 and then exported as a PDB file that was then used as a model to generate 
the structural figures shown in Figure 9. PDB accession codes for the PNA, cytochrome 
c, azurin and photosystem II active site protein models are 3MBS, 1HRC, 1JVO and 
2AXT, respectively. 
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PNA-protein chemical linker structures 
The structures of the chemical linkers used to connect the PNA to both proteins 
shown in Figure 9 as well as the chemical structure of luminol in Figure 1 were drawn 
using Marvin Sketch version 6.0.0.
111
 The minimum and maximum length of the PNA-
protein linker indicated in Figure 9 was calculated as twice the minimum and maximum 
projected radii, respectively, as predicted using the geometry calculator in Marvin Sketch. 
 
Cytochrome c activity and redox potential 
Luminol oxidation activity 
Preassembled DNA nanocages were incubated with either 3x excess PNA-CytC, 
5x molar excess of free cytochrome c or 5x molar excess of PNA-FAM for 30 minutes at 
room temperature and cooled to 4 ⁰C for 30 additional minutes. Excess PNA-CytC was 
removed from the DNA-PNA-CytC sample by SE-FPLC as described in the PNA-protein 
assembly methods section. A 15% native PAGE (resolving gel) was cast leaving 1–2 mm 
below the bottom edge of the comb. After polymerization a 4% native PAGE (stacking 
gel) was poured on top of the resolving gel. 100 pmol of each sample was loaded on the 
gel (cooled to 4 ⁰C) and run for 2–3 hours at 200 V until the DNA nanocage complexes 
had entered the resolving gel; the progress of the gel was monitored using the FAM fluo-
rescence from the DNA-PNA-FAM construct in lane 4. The gel was trimmed to fit in a 
small plastic container, soaked for 5 minutes in 7–10 mL of SuperSignal West Femto en-
hanced luminol chemluminescence solution (Thermo Pierce), washed briefly for 10 sec 
and then imaged using a UVP BioSpectrum (Upland, CA) equipped with an Ascent 
4000C 4.2 million pixel color CCD camera. The image was captured every 20 minutes 
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for 2 hours using Dynamic Integration mode. A 32 square pixel area in the band of inter-
est, free of any detector noise spots, was integrated to determine the mean area density 
for the DNA + PNA-CytC sample and the DNA + free cytochrome c control band. The 
mean area density of the same size, nearby spot without any stain on ethidium bromide 
image was subtracted to remove the background. The background corrected average 
mean density for each band was plotted as a function of integration time, as shown in 
Figure 6C. The DNA + PNA-CytC data was fit using OriginPro version 9.1.0 with the 
following exponential function:  ( )        
     where y0 is the upper limit of 
56,160 counts, A is the pre-exponential factor of 56,034 counts, R0 is the rate of decay of 
0.011 counts per second and t is the time in seconds. The gel was subsequently washed 
for 10 minutes, stained with ethidium bromide for 5 minutes, destained for 5 minutes in 
nanopure water and visualized on a UVP Biospectrum as described previously.
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Redox potential titration with ferri/ferrocyanide 
The method described by Craig and Nichols 
112
 was modified to work with small-
er volumes and lower concentrations. The DNA-PNA-CytC complex was prepared as 
described in the DNA nanocage assembly section, by incubating the DNA nanocage with 
3x molar excess of PNA-CytC. Free cytochrome c and excess PNA-CytC and were re-
moved by SE-FPLC at 4 °C into 10 mM phosphate buffer at pH 7.0 containing 15 mM 
magnesium acetate. Equine heart cytochrome c (Sigma) was dissolved in the same buffer 
and used as a control in a separate experiment. Stock concentrations of 1.875 mM ferri-
cyanide, 100 mM ferrocyanide and 100 mM dithionite were prepared just prior to use in 
10 mM phosphate buffer at pH 7.0 containing 15 mM magnesium acetate and degassed 
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by vacuum to remove oxygen. DNA-PNA-CytC was diluted until the cytochrome c con-
centration was about 10 µM and degassed by vacuum to remove oxygen. Then three sep-
arate 13.5 µL aliquots were diluted with 1.5 µL of the ferricyanide, ferrocyanide or dithi-
onite (1:10 dilution) stocks solutions to maintain the same DNA-PNA-CytC concentra-
tion for each aliquot. The same process was used for the equine heart cytochrome c as a 
control. Absorbance scans of each sample were measured at room temperature (free cyto-
chrome c) or 6 ⁰C (DNA-PNA-CytC and free cytochrome c) using an ultra-micro 
B0631081 10 µL, 10 mm cuvette (Perkin Elmer) on a Lamda XLS+ spectrophotometer 
(Perkin Elmer) to determine the heme absorbance at 550 nm of the fully reduced cyto-
chrome c in dithionite and fully oxidized cytochrome c in ferricyanide, as shown in Fig-
ure 2-22. The cuvette reservoir volume was increased to accommodate the ~30 µL of to-
tal volume added during the experiment by cutting off about 1 cm of the ends of two 
1000 µL pipet tips and inserting them into the entry and exit holes in the cuvette. Next, a 
stepwise oxidation of the sample was performed by adding six separate 375 pmol (1 µL) 
aliquots of the sample in ferricyanide directly into the cuvette containing the sample in 
ferrocyanide and mixed with a pipet, followed by 3 separate 750 pmol (2 µL) aliquots, 
where the heme absorbance was measured after each step. For the DNA-PNA-CytC 
complex, which showed a lower redox potential, the concentration of ferricyanide added 
was reduced by 4x, by using half of the stock ferricyanide concentration (1.875 mM) and 
adding aliquots of half the volume of sample in ferricyanide (95.75 pmol or 0.5 µL and 
187.5 pmol or 1 µL). A UV-Vis scan of the 10 mM solution of ferrocyanide used during 
the experiment was found to contain a small fraction (0.163%) already oxidized to the 
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ferricyanide form. This resulted in a baseline ferricyanide concentration of 16.3 µM be-
fore aliquots of sample in ferricyanide were added.  
The collected data was analyzed as follows. The absorbance at 550 nm for each 
step was normalized to the change in absorbance from the fully reduced state (sample in 
dithionite normalized to 1.0) to the fully oxidized state (sample in ferricyanide normal-
ized to 0.0) to determine the fraction of reduced (ferroCytC) and oxidized (ferriCytC) cy-
tochrome c using the following equation:                 
                           
                             
 
and                                  , where                is the cytochrome c ab-
sorbance at 550 nm in the fully oxidized state (i.e., in ferricyanide), and                is 
the cytochrome c absorbance at 550 nm in the fully reduced state (i.e., in dithionite) and 
            is the cytochrome c absorbance in ferrocyanide after each aliquot of sample 
containing ferricyanide was added. Due to small variations in concentration between 
samples, the                value in the fully reduced state was determined from the 
measured                value as follows:                 
              
     
, where 22.5% 
was the average measured fraction of absorbance in the fully oxidized state with respect 
to the fully reduced state. For the DNA-PNA-CytC complex, which showed a lower re-
dox potential, the sample became fully oxidized during the titration, so the value of 
               at the end of the redox titration was used for               . Data points 
with an                             less than 1 mAU were not included because they 
were within the noise of the spectrophotometer (±0.3 mAU), which were generally data 
collected with a               . < 1%.  
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For each step,     
              
              
 was plotted against     
            
            
 along with a linear fit 
of the data, as shown in Figure 7. The following equation was used to fit each dataset us-
ing Microsoft excel 2010:       ,where m is slope, and b is the y intercept. Only 
datasets with linear fits with R
2
 > 0.8 were included. The x intercept of the fit was used 
with the Nernst equation to calculate the redox potential of cytochrome c as follows: 
     
          
   
  
  
    , where         
  is the redox potential of ferricyanide of 430 
mV,
113
 R is the ideal gas constant of 8.314 
 
     
, T is the temperature of the experiment 
in kelvin, z is one for the number of electrons involved in the oxidation-reduction reac-
tion, F is Faraday’s constant of 96485 
 
   
, and      is the x intercept obtained from the 
fit. Error bars were calculated as the standard error obtained 2 measurements. 
 
 
Figure 2-22. Visible spectra of cytochrome c, PNA-CytC and DNA-PNA-CytC. Visi-
ble spectra of cytochrome c (red), PNA-CytC (green) and DNA-PNA-CytC (blue) when 
oxidized with ferricyanide (A) or reduced with dithionite (B). 
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Circular dichroism of cytochrome c 
Circular dichoism spectra were acquired using a JASCO J-710 spectropolarimeter in the 
UV region (190–250 nm) and Soret band (400–430 nm). All data were collected at 11 ⁰C 
using the Peltier cooling accessory to ensure complete binding of the DNA-PNA-CytC 
complex, and the remaining samples for consistency. UV measurements were made in a 
Far-UV quartz cuvette with a 1 mm path length (Starna Cells 21-Q-1). Due to low sample 
concentration (~10 µM), Soret measurements were made in a Far-UV quartz cuvette with 
a 1 mm path length (Starna Cells 16.100-Q-10/Z8.5). The following scan parameters 
were used for the UV and Soret, respectively: Rate (50 nm/min, 20 nm/min), pitch (0.5 
nm, 0.2 nm), bandwidth (1 nm, 2 nm), response time (4 sec). Each sample was mixed 
with 5% (v/v) 375 µM ferricyanide to oxidize the heme active site prior to data collec-
tion. The following samples were exchanged into 10 mM potassium phosphate buffer pH 
7.0 and measured at the Soret and UV: CytC, PNA-CytC, buffer with ferricyanide. DNA-
PNA-CytC was exchanged into sodium phosphate buffer pH 7.0 containing 10 mM mag-
nesium acetate to stabilize the DNA nanocage and measured at the Soret band only, be-
cause the high absorbance from the DNA nanocage in the UV masked the features of the 
protein. A scan of the buffer alone containing ferricyanide was collected and used as a 
baseline to subtract from the data. All data for samples and controls were collected as an 
average of 10 scans. After baseline subtraction, the molar ellipticity [θ] of the UV and 
Soret data was calculated
114
 as follows:      
      
   
, where θ is the ellipticity in degrees 
recorded by the instrument, C is the molar sample concentration and l is the path length 
in centimeters. The results are shown in Figure 2-23. 
84 
 
 
Figure 2-23. Circular dichroism of cytochrome c, PNA-CytC and DNA-PNA-CytC. 
UV [A] and Soret band [B] CD spectra of cytochrome c (CytC), when conjugated to PNA 
(PNA-CytC) and when hybridized into the DNA nanocage (DNA-PNA-CytC). Each 
spectrum is an average of 10 scans. Note: The large absorbance from the DNA nanocage 
in the UV prevented CD spectra for DNA-PNA-CytC in the UV region. 
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CHAPTER 3 – PNA-Peptide Assembly in a 3D DNA nanocage at Room Temperature 
Adapted with permission from Flory, J. D.; Shinde, S.; Lin, S.; Liu, Y.; Yan, H.; 
Ghirlanda, G.; Fromme, P. J. Am. Chem. Soc. 2013, 135, 6985–6993.79 Copyright 2013 
American Chemical Society. 
Abstract 
Proteins and peptides fold into dynamic structures that access a broad functional 
landscape, however, designing artificial polypeptide systems is still a great challenge. 
Conversely, DNA engineering is now routinely used to build a wide variety of 2D and 3D 
nanostructures from hybridization based rules, and their functional diversity can be sig-
nificantly expanded through site specific incorporation of the appropriate guest mole-
cules. Here we demonstrate a new approach to rationally design 3D nucleic acid–amino 
acid complexes using Peptide Nucleic Acid (PNA) to assemble peptides inside a 3D 
DNA nanocage. The PNA-peptides were found to bind to the preassembled DNA 
nanocage in 5–10 minutes at room temperature and assembly could be performed in a 
stepwise fashion. Biophysical characterization of the DNA-PNA-peptide complex was 
performed using gel electrophoresis as well as steady state and time resolved fluores-
cence spectroscopy. Based on these results we have developed a model for the arrange-
ment of the PNA-peptides inside the DNA nanocage. This work demonstrates a flexible 
new approach to leverage rationally designed nucleic acid (DNA-PNA) nanoscaffolds to 
guide polypeptide engineering. 
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Introduction 
The field of structural DNA nanotechnology has transformed our thinking about 
the purpose and possibilities of canonical base pairing biopolymers, which can have a 
much broader structural landscape than what has evolved in natural organisms. The se-
quences of multiple DNA strands have been designed and assembled into a wide variety 
of interesting nanostructures, such as a 2D crystal lattice,
9
 3D tetrahedron,
65
 3D crystal,
20
 
octahedron,
115
 various fully addressable 2D nanoscaffolds
21
 and complex 3D shapes.
25
 
We refer the reader to several excellent reviews of the progress made in this dynamic 
field and challenges that remain.
13–15
 
Because the functional diversity of unmodified DNA is limited, much effort has 
been focused on introducing functional groups. DNA scaffolds offer a flexible, biocom-
patible workbench to explore the wide variety of functions performed by proteins in na-
ture, such as catalysis, scaffolding, molecular transport and molecular recognition among 
others. For example, DNA scaffolds have been used to organize proteins on 2D arrays,
8
 
to study antibody recognition of peptide epitopes
39
 and to investigate the spatial depend-
ence of enzyme cascades.
48
 Remarkably nearly all of the biomolecules found in the bio-
sphere are synthesized through unique metabolic pathways of reactions catalyzed by pro-
teins. Some large proteins, such as the 350 kDa protein photosystem II (PSII), perform 
multiple functions including light absorption, photochemical conversion, electron transfer 
and catalytic water oxidation.
3
 While light absorption and most of the electron transfer 
reaction take place in the membrane intrinsic part of PSII, the catalytic site for water oxi-
dation is located in the membrane extrinsic part of PSII suggesting that a water soluble 
version of the water splitting complex is possible. The crystal structure of PSII
3
 shows 
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that coordinating sphere around the metal cluster in the active site is only a small part of 
the protein, but that the amino acid ligands come from multiple protein subunits. We hy-
pothesize that the scaffolding function of a protein could be replaced by strategically at-
taching peptides inside the well-defined cavity of a 3D nucleic acid nanoscaffold, which 
matches the size of the first and second coordination sphere of the catalytic center (<10 
nm). 
Different bio-orthogonal linking chemistries are required to control peptide as-
sembly within a highly interconnected nucleic acid-polypeptide complex. Erben, Good-
man and Turberfield coupled the protein cytochrome c to one of the strands of the same 
DNA tetrahedron used in our design and annealed the DNA-protein complex in one 
step.
50
 While this strategy allows the same bio-orthogonal linking chemistry to be used on 
multiple DNA strands, it requires that all components be assembled at once and under 
conditions that favor proper DNA nanocage assembly, namely low concentration (sub 
micromolar) and high temperature annealing (optimally 90 °C ramped to room tempera-
ture). An alternative linking strategy that allows more control over the assembly process 
is to use nucleobase hybridization, where the nucleobase sequence is used to provide or-
thogonal attachment. This approach is routinely used to functionalize large DNA 
nanostructures, such as DNA origami,
29
 because functionalization can be done after the 
DNA nanostructure is formed. To allow for sufficient thermal stability at room tempera-
ture, typical DNA hybridization linker sequences are at least 15–20 nucleotides (nt) long, 
which form 4.9–6.5nm long dsDNA helices upon hybridization. However, such long 
linker sequences put significant constraints on how the linker can be used in small DNA 
nanostructures (radius <4 nm). The linker length could be shortened by increasing the GC 
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content of the sequence, however this would limit the sequence variability needed to at-
tach multiple peptides to the DNA nanostructure. 
 
Figure 3-1. Schematic of the designed dye labeled DNA-PNA-peptide complex. [Left 
Figure] Cartoon of the proposed design for assembling two fluorescently labeled peptides 
into a DNA nanocage each using a PNA linker with the indicated sequences. The arrow 
indicates the direction of energy transfer between the fluorescein (FAM) donor and the 
tetramethylrhodamine (TMR) acceptor dyes. [Right Figure] Close up showing the chemi-
cal structures of the N terminal (5’) end of the dye labeled PNA1-peptide, the 3’ end of 
the adjacent DNA strand and the complementary DNA strand that drives the assembly of 
this peptide into the DNA nanocage. Chemical structures were drawn using Marvin 
Sketch.
111
 
 
Our approach, as shown in the schematic in Figure 3-1 is to connect peptides to 
the DNA scaffold using short (8nt) linker sequences of the more thermostable Peptide 
Nucleic Acid (PNA) originally developed by Nielsen and coworkers.
66
 PNA synthesis is 
compatible with peptide synthesis, so the polypeptides can be synthesized directly with 
the linking PNA sequences using established protocols.
83
 There is a great interest in using 
PNA for gene targeting
116
 and sensing
117,118
 applications because of PNAs hypersensitivi-
ty to sequence mismatches,
119
 its ability to invade double stranded DNA sequences
66
 and 
its resistance to enzymatic degradation.
73
 PNA has also been investigated as a nanoscaf-
89 
 
fold. First it was incorporated into a two dimensional DNA array, resulting in only a 
slight unwinding of the helix,
78
 and more recently used to arrange peptide ligands along a 
linear strand of DNA to assemble several protein subunits.
47
  
Here we report results for a design strategy using PNA to assemble peptides in-
side a 3D DNA nanostructure. Two fluorescently labeled PNA-peptides were synthesized 
using microwave assisted solid phase synthesis. The PNA-peptides were assembled into 
the DNA nanostructure in 5–10 minutes at room temperature. The peptides can be either 
assembled together or in a specified order. Steady state fluorescence was used to monitor 
Förster Resonance Energy Transfer (FRET) between a single dye labeled PNA-peptide 
bound to the DNA nanocage with a complementary dye label, in order to determine the 
temperature of PNA dissociation out of the DNA nanocage. Time resolved fluorescence 
spectroscopy was used to identify different interactions and decay pathways experienced 
by each fluorescent dye in the DNA-PNA-peptide complex. Finally, FRET theory was 
used to calculate the distances between the two PNA-peptides bound to the DNA 
nanocage and build a model of the designed complex. In the future this design principle 
could lead to the assembly of enzyme active centers inside DNA nanocages. 
 
Results and Discussion 
DNA-PNA-peptide complex design 
Our design is based on a DNA tetrahedron assembled out of four 63nt ssDNA se-
quences originally designed by Goodman, Turberfield and coworkers.
65
 The sequences of 
each strand are unique and fully addressable for incorporating guest molecules through 
hybridization based linkers such as PNA (Figure 3-2). The authors were able to identify 
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the location of the major and minor grooves and approximate base orientations through a 
series of DNA linking
65
 and protein encapsulation experiments,
50
 along with electron 
density from cryo-electron microscopy.
64
 We inferred from their study that base positions 
around the 8
th
 and 18
th
 bases point inward and around the 3
rd
 and 14
th
 base point outward 
when counting from the vertex in the 3’ direction. We introduced an 8nt single stranded 
gap in the center of opposite 20 base pair (bp) edges of the DNA nanocage to bind two 
PNA strands each containing a short prototype peptide (Gly-Pro-Gly) protruding from the 
N terminus (5’) of the PNA sequence into the DNA nanocage at the 7th base position 
(Figure 3-1). Because of the structural symmetry of the DNA nanocage, the same strategy 
can be applied to any edge in the DNA nanocage, thereby allowing a number of different 
peptides to be assembled at sequence specific locations. The 8nt length of each PNA 
binding domain was chosen to provide sufficient thermal stability of PNA binding to the 
DNA nanocage with minimal disruption of the DNA nanocage structure in absence of the 
PNA-peptide. Standard dsDNA of B-DNA form has a helical pitch of 10.5bp/turn
120,121
 
whereas PNA-DNA duplexes have been observed to adopt a helical pitch from 
13.0bp/turn
122
 to 15.6bp/turn
78
. For the 8bp PNA-DNA domain in our design this leads to 
an underwinding of the helix by 53 to 90 degrees, respectively, along the edges that bind 
PNA. However, the original DNA nanocage design
65
 included unhybridized adenosine 
nucleotides connecting each edge of the DNA nanocage, which should be able to counter 
rotate and neutralize this effect. Throughout this report we use the nomenclature defined 
in Figure 3-2 and Figure 3-3 when we describe the various strands and constructs used in 
each experiment. Briefly, PNA1 (TGCGTGTC) and PNA2 (GCTCACTG) are both PNA 
sequences written from C to N (3’ to 5’), abbreviated as PNA1 and PNA2, respectively,  
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Figure 3-2. DNA and PNA sequences and schematic showing their arrangement in 
the complex. [Top Figure] Schematic of the PNA and DNA sequence layout, where the 
PNA1-peptide is attached to Edge C and the PNA2-peptide is attached across the DNA 
nanocage to Edge F. The strand nicks are indicated and the arrow is pointing in the 3’ di-
rection. Strand S4g is redrawn above for clarity. This schematic was redrawn from 
65
 with 
changes to incorporate the PNA-peptides. [Bottom Figure] DNA, PNA and peptide se-
quences with the color code matching the schematic in the top figure. The DNA and PNA 
sequences are written in the 5’ to 3’ direction. The peptides sequences are written using 
three letter amino acid codes from N to C. Dye labeled DNA strands are defined using 
the nomenclature for ordering from IDT, where the dye names are enclosed by “/” marks 
and are attached to a modified thymine base at the vertex. 
S1 - AGGCAGTTGAGACGAACATTCCTAAGTCTGAAATTTATCACCCGCCATAGTAGACGTATCACC 
S1P AGGCAGTTGAGACGAACATTCCTAAGTCTGAAATTTATCCGAGTGACTAGTAGACGTATCACC 
S1P-FAM AGGCAGTTGAGACGAACATTCCTAAGTCTGAAATTTATCCGAGTGACTAGTAG/iFluorT/CGTATCACC 
S2 - CTTGCTACACGATTCAGACTTAGGAATGTTCGACATGCGAGGGTCCAATACCGACGATTACAG 
S2P CTTGCTACACGATTCAGACTTAGGAATGTTCGACATGCGACGCACAGATACCGACGATTACAG 
S2P-FAM CTTGCTACACGATTCAGACTTAGGAATGTTCGACATGCGACGCACAGATACCG/iFluorT/CGATTACAG 
S2P-TMR CTTGCTACACGATTCAGACTTAGGAATGTTCGACATGCGACGCACAGATACCG/i6-TAMN/CGATTACAG 
S3g GATAAAACGTGTAGCAAGCTGTAATCGACGGGAAGAGCATGCCCATCCACTACTA 
PNA2-peptide 5-TMR-Gly-Pro-Gly-GTCACTCG 
S4g CGCATGACTCAACTGCCTGGTGATACGAGGATGGGCATGCTCTTCCCGACGGTAT 
PNA1-peptide 5-FAM-Gly-Pro-Gly-CTGTGCGT 
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Figure 3-3. Complex nomenclature with list of constituent DNA and PNA-peptide 
strand names. 
 
GPG (Gly-Pro-Gly) is the peptide sequence and FAM (Fluorescein) and TMR (Tetra-
methylrhodamine) are the dye labels. 
The PNA1 sequence was slightly changed from the original DNA nanocage de-
sign
65
 and the complementary S2 sequence was modified accordingly on the yellow edge 
to S2P (changes shaded in grey). The PNA2 sequence was also updated from the original 
DNA nanocage design in order to eliminate a stretch of 5 of 6 guanine bases (three con-
secutive) which proved to be more difficult to synthesize. To accommodate binding of 
the modified PNA2 sequence, the complementary S1 sequence was modified on the yel-
low edge to S1P (changes shaded in grey). S4 and S3 were also modified to S4g and S3g, 
respectively, by trimming back 8nt from the ends to create an 8nt gap, exposing an 8nt 
DNA + PNA1-FAM = S1, S2P, S3, S4g, PNA1-GPG-FAM 
DNA + PNA1-TMR = S1, S2P, S3, S4g, PNA1-GPG-TMR 
DNA-TMR + PNA1-FAM = S1, S2P-TMR, S3, S4g, PNA1-GPG-FAM 
DNA-FAM = S1, S2P-FAM, S3, S4g 
DNA-FAM + PNA1-TMR = S1, S2P-FAM, S3, S4g, PNA1-GPG-TMR 
DNA + PNA1-FAM + PNA2-TMR = S1P, S2P, S3g, S4g, PNA1-GPG-FAM, PNA2-GPG-TMR 
DNA + PNA1-FAM + PNA2-Ac = S1P, S2P, S3g, S4g, PNA1-GPG-FAM, PNA2-GPG-Acetylated 
DNA + PNA1-Ac + PNA2-TMR = S1P, S2P, S3g, S4g, PNA1-GPG-Ac, PNA2-GPG-TMR 
DNA + PNA1-Ac + PNA2-Ac = S1P, S2P, S3g, S4g, PNA1-GPG-Ac, PNA2-GPG-Acetylated 
DNA-FAM-TMR = S1P-FAM, S2P-TMR, S3g, S4g (No PNA) 
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ssDNA domain on the complementary strands, S2P and S1P, respectively, for binding 
PNA1 and PNA2, respectively. 
 
PNA-peptide synthesis 
We synthesized two dye labeled PNA-peptides, PNA1-GPG-FAM and PNA2-
GPG-TMR, using microwave assisted solid phase synthesis following established proto-
cols
67,83,84
 with some modifications detailed in the Materials and Methods section called 
PNA-peptide synthesis, purification and functionalization. Unlabeled versions of each 
PNA-peptide were also prepared to serve as controls for fluorescence experiments by 
acetylating the N terminus. The PNA-peptide constructs were purified using Reverse-
Phase High Pressure Liquid Chromatography (RP-HPLC) and identified using Matrix 
Assisted Laser Desorption Ionization (MALDI) mass spectrometry. MALDI and RP-
HPLC chromatograms are shown for all products in Figure 2-3 and Figure 2-4, respec-
tively. 
Peptide Nucleic Acid (PNA) was originally designed by Nielsen and coworkers to 
link nucleobases together via amide bonds with the proper spacing in its aminoethygly-
cine backbone to hybridize with DNA.
119
 The unique PNA backbone provides it with 
many an ability to invade double stranded DNA sequences,
66
 resistance to enzymatic 
degradation
73
 as well as compatibility with peptide synthesis. PNA monomers are now 
commercially available with Fmoc protection so they can be sequentially assembled fol-
lowing protocols compatible with milder solid phase peptide synthesis (SPPS) condi-
tions.
67,83
  
Although substantial similarity exists between the coupling mechanisms of con-
secutive PNAs and amino acids, PNA requires considerably more care during synthesis. 
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PNA coupling is less efficient than amino acid coupling and thus requires additional time 
or heat for efficient coupling. PNA also contains a carbonyl linkage to the nucleobase 
‘side chain’ that is subject to nucleophilic attack by its free N terminus after deprotection, 
which can lead to nucleobase migration and isomerization.
123
 We followed a recently 
published protocol for microwave assisted PNA synthesis, which emphasized the im-
portance of turning off microwave heating during deprotection and capping steps to min-
imize side reactions.
83
 Our initial synthesis of PNA1 showed an impurity associated with 
the recommended PyBOP activator, which we found was reported elsewhere,
84
 so we 
opted to use HATU and anhydrous DMF as reported in many earlier PNA synthesis pro-
tocols.
67,84
  
Microwave assisted solid phase synthesis was used to first synthesize the PNA 
domains with an N terminal glycine residue, using conditions optimized for PNA. During 
PNA2-Gly synthesis, the cytosine solution partially precipitated which led to an impurity 
with a deleted cytosine and another with an inserted cytosine as identified by MALDI in 
Figure 2-3. RP-HPLC showed these impurities were minor, as shown in Figure 2-4. The 
same synthesizer was used to add the remaining amino acids for the peptide using condi-
tions optimized for peptides. Initially a capping step was performed after each PNA cou-
pling to facilitate purification, but we found that without capping the yield was much im-
proved and the removal of impurities for these short sequences was straightforward. Fi-
nally, the PNA-peptide conjugates were fluorescently labeled on resin with either 
5(6)carboxyfluorescein (FAM) or 5(6)tetramethylrhodamine (TMR), or the free amino 
terminus was acetylated as a control for fluorescence studies. The 5(6) dye isomer mix-
tures were used due to substantially reduced cost with negligible spectral differences. 
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MALDI of the PNA-peptides identified a minor impurity with an extra glycine (+57 Da) 
in the peptide sequence, as shown in Figure 2-3. Each product was purified using a C18 
prep column. The product was identified by MALDI and the purity verified by RP-HPLC 
using a C18 analytical column, as shown in Figure 2-3 and Figure 2-4, respectively. 
 
PNA-peptide assembly with the DNA nanocage 
PNA-DNA duplexes are typically formed from single stranded DNA and PNA by 
heating both strands to around 90 °C to remove any secondary structure or sample aggre-
gation, followed by cooling to room temperature or below.
124
 Alternatively, short PNA 
sequences have been shown to bind to their target DNA sequence after incubating for 5–
10 minutes at room temperature.
75
 This incubation strategy is especially important for 
hybridizing PNA-peptides to 3D DNA nanostructures, because assembling peptides in-
side a preformed DNA nanocage avoids the high temperature annealing step, which could 
denature the polypeptide structure. Furthermore the incubation strategy allows for higher 
PNA-peptide concentrations to drive more rapid assembly and lets the PNA-peptides be 
assembled in a desired order. 
In order to determine the PNA-peptide hybridization efficiency, the DNA 
nanocage was prepared (without any PNA) by annealing and purified by Size Exclusion 
Fast Protein Liquid Chromatography (SE-FPLC), as shown in Figure 2-13 (A). The pre-
formed DNA nanocage was incubated for 5–10 minutes at room temperature with in-
creasing molar excess (0x to 5x) of PNA1-GPG labeled with FAM and separately with 
PNA1-GPG labeled with TMR. The samples were cooled to 4 °C and were directly ana-
lyzed using native polyacrylamide gel electrophoresis (PAGE) at 4 °C. The bands of in-
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terest are shown in Figure 3-4 and the complete gel is shown in Figure 2-15. Both con-
structs exhibit a band shift upon PNA binding which could be due in part to the DNA 
nanocage becoming less spherical and more tetrahedral in shape with a slightly larger di-
ameter after PNA binding. PNA1-GPG-FAM shows the most dramatic shift, which could 
be further enhanced from the FAM
2-
 dianion being repelled away from the negatively 
charged DNA nanocage, forcing the attached peptide to adopt an orientation pointing 
outward and further retarding migration of the complex through the gel. The chemical 
structures of FAM and TMR are shown in Figure 2-2.  
 
 
Figure 3-4. Native PAGE of the DNA nanocage hybridized to increasing molar ex-
cess of the PNA1-peptide labeled with the fluorescent dyes FAM and TMR. The 
DNA nanocage was incubated at room temperature for 5–10 minutes with increasing mo-
lar excess of PNA1-peptide labeled with TMR and with FAM. The upper image shows 
EtBr fluorescence (Ex. 302 nm, Em. 605 nm) after staining while the lower images were 
taken of the native dye fluorescence (FAM Ex. 475 nm, Em. 535 nm; TMR Ex. 560 nm, 
Em. 645 nm) prior to EtBr staining. The normalized integrated fluorescence intensities of 
the gel bands are shown plotted versus the incubated PNA to DNA ratio, where the initial 
hybridization fit a linear model. The slope m represents the fraction of PNA that binds to 
the DNA nanocage. 
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The gel in Figure 3-4 also shows that PNA1-GPG-TMR induces some structural 
heterogeneity upon binding. In addition to a distinct band showing TMR fluorescence, 
some minor band broadening is apparent that extends from the initial position of DNA 
nanocage without any PNA up to the PNA1-GPG-FAM band, suggesting the TMR pep-
tide stabilizes a range of slightly different DNA nanocage conformations. Figure 3-4 also 
shows the ratio of PNA bound to the DNA nanocage calculated from the integrated band 
intensities, which increases linearly with the added molar excess until saturation is 
achieved by two times excess. The PNA1-GPG hybridization was further confirmed us-
ing absorption spectroscopy by comparing the absorption of the dye labeled PNA to that 
of the DNA nanocage after removing the unhybridized PNA. The PNA-peptide hybridi-
zation increases linearly until PNA-peptide saturation occurs just after two times excess 
for PNA1-GPG-TMR (extrapolated to 2.4x) and for PNA1-GPG-FAM (extrapolated to 
2.5x), as shown in Figure 3-5.  
The need for excess PNA-peptide to achieve quantitative binding to the DNA 
nanocage is likely because a fraction of the PNA-peptides irreversibly self-aggregate be-
fore binding to the DNA nanocage. Some PNA sequences show mild aggregation at con-
centrations as low as 1 μM and are often modified to improve solubility.80 However, once 
bound to the DNA nanocage the PNA-peptides are quite stable at low temperatures, even 
once excess PNA-peptides are removed. To ensure quantitative PNA-peptide binding to 
the DNA nanocage, five times molar excess was used to prepare the constructs for all 
subsequent experiments. Samples were stored at -20 °C or 4 °C and experiments were 
carried out between 4 °C and 11 °C to prevent PNA-peptide dissociation. 
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Figure 3-5. Absorbance of the labeled PNA1-peptide hybridized to the DNA 
nanocage. Graph showing the amount of PNA-peptide hybridized to the DNA nanocage 
plotted against the molar excess of PNA-peptide incubated with the DNA nanocage. The 
hybridization efficiency was calculated as (Adye/A258) / (ɛdye / ɛ258), for each dye as de-
scribed in the Materials and Methods section called PNA-peptide hybridization efficien-
cy. The fitting parameters for the linear model are as follows: Fit (TMR): slope = 0.46, 
intercept = -0.01; Fit (FAM): slope = 0.43, intercept = 0.02, where the slope indicates the 
fraction of PNA-peptide that binds to the DNA nanocage. The inset shows the measured 
absorbance spectra of the DNA nanocage with PNA1-GPG-FAM (green) and the DNA 
nanocage with PNA1-GPG-TMR (red). The difference in absolute absorption between 
the samples was due to differences in concentrations (PNA1-GPG-FAM = 3–4 μM, 
PNA1-GPG-TMR = 2 μM). 
 
A time course study was performed in order to determine the kinetics of PNA hy-
bridization to the 3D DNA nanocage. Fluorescently labeled DNA nanocages were pre-
pared using one strand labeled by the manufacturer (Integrated DNA Technologies) with 
a dye complementary to that on the PNA-peptide and located at the vertex adjacent to the 
PNA-peptide’s N terminus. The fluorescence intensity of the FAM labeled DNA 
nanocage (DNA-FAM) was monitored as a function of time after mixing in five times 
molar excess PNA1-GPG-TMR (PNA1-TMR) with the DNA nanocage at 25 °C, as 
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shown in Figure 3-6 (A) The data from Figure 3-6 (A) was converted to the fraction of 
PNA-peptide bound as described in the methods section and plotted in Figure 3-6 (B). 
86% of the PNA bound while mixing the PNA during the first 15 seconds, 94% after 1 
minute and 99% after 6.8 minutes. Such rapid hybridization of short PNA sequences to 
DNA is in agreement with another kinetic study of PNA-DNA duplex formation.
75
 
 
Figure 3-6. Time course PNA1-peptide hybridization with the DNA nanocage. 5x 
excess PNA1-TMR was added to the DNA nanocage labeled with FAM at 25 °C. [A] 
Plot of the peak FAM fluorescence at 521 nm as a function of time after the PNA1-TMR 
was added. [B] The data from [A] was normalized and inverted to show the fraction of 
PNA1-TMR bound as a function of time. The exponential fit was produced as described 
in the methods section and the fitting parameters are shown in Table 3-1. No data was 
collected for the first 15 seconds after PNA1-TMR was added and mixed with a pipet. 
 
DNA nanocages were also prepared with both dye labeled PNA-peptides for fluo-
rescence characterization. Five times molar excess of the each PNA-peptide was incubat-
ed at room temperature for 5–10 minutes and with the preformed DNA nanocage then 
chilled on ice for 1 hour. The unhybridized PNA-peptides were removed by SE-FPLC 
with the column cooled to 4 °C. The chromatogram of the fully assembled DNA 
nanocage with both dye labeled PNA-peptides (DNA + PNA1-FAM + PNA2-TMR) is 
shown in Figure 2-13 (B). The PNA-peptides could also be assembled in stepwise fashion 
by first forming the DNA nanocage with one PNA-peptide, removing excess PNA-
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peptide using 30k MWCO centrifugal filters, adding the second PNA-peptide and remov-
ing excess PNA-peptide in the same fashion. This strategy produced the same end prod-
uct as when both PNA-peptides were assembled simultaneously (data not shown). 
Table 3-1. Fitting parameters and time to reach 99% hybridization for PNA1-GPG-
TMR binding kinetics with DNA nanocage. Table of parameters obtained by fitting the 
hybridization kinetics data shown in Figure 3-6 to an exponential function. The equation 
is described in the methods section, and was used to determine the time for each PNA1-
GPG-TMR to reach 99% hybridization. 
Fitting 
Parameter 
DNA-FAM + 
PNA1-GPG-TMR 
y0 99.02 ± 0.06% 
A (counts) (134.2 ± 0.3) x 10
-3
 
R0 
(counts/sec)
 
(15.7 ± 0.5) x 10
-3
 
R
2
 0.9792 
Time to 99% 
Hybridization 
408 sec (6.8 min) 
 
DNA-PNA-peptide thermal stability 
We quantified the thermal stability of PNA1-GPG when labeled with each dye 
and bound to the DNA nanocage by incubating PNA1-GPG-TMR and PNA1-GPG-FAM 
with DNA nanocages labeled with the complementary dye at the vertex adjacent to the 
PNA-peptide (e.g., DNA-FAM and DNA-TMR, respectively), as shown in Figure 3-7 C 
and D. Figure 3-7 A and B show the fluoresce spectra taken of the complex DNA-FAM + 
PNA1-TMR and DNA-TMR + PNA1-FAM, respectively, as defined in Figure 3-3, while 
gradually heated from 11 °C to 85 °C. Initially for both complexes, the donor (FAM) flu-
orescence is significantly quenched because FRET occurs when the complex is fully as-
sembled with the donor and acceptor in close proximity. As the temperature increases and 
the PNA-peptide dissociates from the DNA nanocage, the FRET signal becomes negligi-
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ble as the separation between the donor and acceptor becomes large causing the donor 
fluorescence to increase significantly. 
 
Figure 3-7. Fluorescence spectra of the TMR and FAM labeled PNA1-peptide 
bound to the FAM and TMR labeled DNA nanocage as a function of temperature. 
[A] PNA1-GPG labeled with TMR bound to the DNA nanocage labeled with FAM 
(DNA-FAM+PNA1-TMR), as shown in schematic “C” of the bottom figure. [B] PNA1-
GPG labeled with FAM bound to the DNA nanocage labeled with TMR (DNA-
TMR+PNA1-FAM), as shown in schematic “D” of the bottom figure. [E] The peak donor 
fluorescence is plotted versus temperature and fitted with a sigmoidal dose response 
curve, where the inflection point corresponds to the TD indicated on the plot. The differ-
ence (Δ) from a theoretical value (36.6 °C) is also shown, which is greater than that pre-
dicted for a similar DNA sequence (34.5 °C). 
 
The change in peak donor fluorescence with temperature in the presence of the 
acceptor was corrected for the change in fluorescence of the donor alone with tempera-
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ture (Figure 2-17) and was fitted with a sigmoidal dose response curve (Figure 3-7 E), 
where the inflection point of the fitted curve indicates the dissociation temperature (TD) 
of the PNA-peptide from the DNA nanocage. We use the term TD instead of melting 
temperature (Tm) to avoid confusion from the melting of the DNA nanocage itself, which 
occurs at temperatures (~60 °C) above the dissociation of the PNA-peptides from the 
DNA nanocage.
125
 We then used a method described by Giesen, Nielson and coworkers
95
 
to predict the TD of a PNA-DNA duplexes based on the TD of a DNA-DNA duplex with 
the same sequence, the length of the sequence and the fraction of pyrimidine bases also 
shown in Figure 3-7 (E). One possible interpretation of the higher TD for PNA1-GPG-
TMR might be that TMR interacts with guanine residues through π stacking104 which 
could significantly stabilize PNA binding to the DNA nanocage.  
While the stability of a DNA-PNA duplex depends on GC content, Sen and Niel-
sen showed that PNA strands have a much stronger increase in binding enthalpy and free 
energy with increasing purine content in the PNA strand than a DNA strand with the 
same sequence, possibly because of structural changes that were too subtle for them to 
detect by circular dichroism.
126
 They demonstrated that a 10mer PNA sequence with 80% 
purine content increased the TD to a complementary DNA sequence over a similar DNA 
sequence by 28.8 °C from 36.2 °C to 65.0 °C, whereas a 10mer PNA sequence with 80% 
pyrimidine content only increased the TD by 2.8 °C to 39.0 °C. For applications that re-
quire higher PNA-peptide binding stability the purine content of our sequences could be 
increased further. 
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Fluorescence characterization: lifetime, anisotropy and energy transfer 
We used Time Correlated Single Photon Counting (TCSPC) to measure the time 
resolved fluorescence decay of the dye labels to investigate the degree of interaction be-
tween both dye labeled PNA-peptides assembled into the DNA nanocage. Unlabeled 
PNA-peptides were prepared with N terminal acetylation (Ac) to serve as controls for our 
fluorescence experiments. Fluorescence decay kinetics of the donor alone (DNA + 
PNA1-FAM + PNA2-Ac) and the acceptor alone (DNA + PNA1-Ac + PNA2-TMR) 
were measured at their corresponding fluorescence maxima, and the fluorescence decay 
kinetics of the donor in the presence of the acceptor (DNA + PNA1-FAM + PNA2-TMR) 
was measured in the donor only emission region as shown in Figure 3-8 (A). The se-
quences and strand names of these complexes are defined in Figure 3-2 and Figure 3-3, 
respectively. Exponential fitting of each fluorescence decay required either two or three 
parameters, which are shown in Table 3-2. The long lived component is from the natural 
decay of each fluorophore. The short lived component is likely from fluorophore interac-
tions with the DNA nanocage, such as quenching by nearby guanine nucleobases.
127
 The 
medium length component identified for the donor in the presence of the acceptor is like-
ly from energy transfer from donor to acceptor. For each decay the fitted components 
were averaged to facilitate comparing with the steady state fluorescence data discussed 
later. The calculated average lifetime of the donor alone is 3.9 ± 0.1 ns, which is in good 
agreement with another study,
128
 as is the calculated average lifetime of the acceptor 
alone of 3.5 ± 0.1 ns.
104
 The average donor lifetime is reduced to 2.5 ± 0.4 ns in the pres-
ence of the acceptor due to energy transfer from donor to acceptor, which corresponds to 
an energy transfer efficiency of 36%. 
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Table 3-2. Lifetime components and calculated average lifetimes of the donor and 
acceptor. Ex/Em (nm) indicates the excitation and emission wavelengths and each “%” 
column shows the relative amount of each lifetime component ( ). The lifetime of the 
donor (FAM) in the presence of the acceptor (TMR) was measured in the donor emission 
region (500 nm). 
Name Ex/Em 
(nm) 
 1 % of 
 1 
 2 % of 
 2 
 3 % of 
 3 
Average 
Lifetime 
Donor 
(FAM) 
alone 
450/520 4.20 ± 
0.04ns 
91.0
% 
1.27 
± 
0.4ns 
9.0% - - 3.9 ± 
0.1ns 
Acceptor 
(TMR) 
alone 
500/600 3.79 ± 
0.06ns 
84.3
% 
1.88 
± 
0.3ns 
15.7
% 
- - 3.5 ± 
0.1ns 
Donor with 
Acceptor 
450/500 4.3 ± 
0.7ns 
21.2
% 
2.5 ± 
0.3ns 
56.4
% 
0.7 ± 
0.25n
s 
22.4
% 
2.5 ± 
0.4ns 
 
 
Figure 3-8. Fluorescence decay of the DNA nanocage with two fluorescently labeled 
PNA-peptides. [A] Plot of the fluorescence decay kinetics measured by TCSPC at 11 °C 
of the DNA nanocage with both PNA-peptides labeled with the donor (FAM) only (blue), 
the acceptor (TMR) only (red) and labeled with both the donor and acceptor and detected 
in the donor only emission region (green). [B] Fluorescence decay spectra were collected 
at several wavelengths and fit simultaneously to three components using global analysis. 
The relative amplitudes of each component from the analysis are plotted as a function of 
wavelength in the Decay Associated Spectra (DAS). 
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To gain insight into the different decay pathways of the donor excited state ener-
gy, we collected fluorescence decay kinetics data at several wavelengths spanning the 
donor and acceptor emission spectra. The kinetics curves at all recorded wavelengths 
were fit simultaneously to three components of the donor-acceptor system using global 
analysis. The relative amplitudes of each component from the analysis are plotted as a 
function of wavelength in the Decay Associated Spectra (DAS) as shown in Figure 3-8 
(B). The most dominant component of donor decay has a lifetime of 2.5 ± 0.3 ns and 
shows a positive peak in the donor emission wavelength region (fluorescence decay) and 
a similarly sized negative peak (increase in fluorescence) in the acceptor region, which is 
characteristic of energy transfer from the donor to the acceptor. The second major com-
ponent has a lifetime of 4.1 ± 0.2 ns, which has a positive peak in both the donor and ac-
ceptor region. This component indicates that there is a subpopulation of the donor that 
does not undergo energy transfer, but instead decays with its natural lifetime, possibly 
from an orthogonal orientation with respect to the acceptor. Global analysis is unable to 
resolve the differences in this component from the natural decay of the acceptor and thus 
provides an average lifetime of both components. The remaining component has a life-
time of 0.7 ± 0.4 ns with a positive peak in the donor region and small negative peak in 
the acceptor region suggesting that a second faster pathway for energy transfer exists. 
The DAS shows energy transfer between both dye labeled PNA peptides, indicative of 
proper complex assembly, and suggests that on average the dye labeled peptides adopt 
two distinct conformational states. 
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Figure 3-9. Fluorescence Decay and Anisotropy of FAM and TMR dyes attached to 
a complex of a PNA-peptide inside the DNA nanocage. [Top of A and B] Plot of the 
fluorescence decay of TMR at 600nm when excited at 500nm (A) and FAM at 520 nm 
when excited at 450 nm (B). The decay was measured by TCSPC at the indicted tempera-
ture both parallel (Ivv) and perpendicular (Ivh) to the excitation polarization, with the dye 
attached to the PNA and hybridized to the DNA nanocage or attached directly to the 
DNA nanocage. [Bottom Figure of A and B] The anisotropy was calculated for each data 
point of the decay, as described in the Materials and Methods section called Fluorescence 
anisotropy, and plotted for each complex. 
 
TCSPC was also used to evaluate how freely the dye labels can rotate within the 
DNA-PNA-Peptide complex by probing the rate of depolarization of their emission when 
excited by polarized light as a function of time. The complex with the acceptor alone 
(DNA + PNA1-Ac + PNA2-TMR) was excited by vertically polarized light at 500 nm 
and the TMR emission was monitored at 600nm with polarization both parallel (VV, ver-
tical excitation and emission) and perpendicular (VH, vertical excitation and horizontal 
emission) relative to the polarization of the excitation, as shown in Figure 3-9 (A). The 
difference in the emission intensity of VV and VH was used to determine the anisotropy 
using the equations described in the Materials and Methods section called Fluorescence 
anisotropy. The calculated anisotropy is plotted as a function of time in Figure 3-9 (A), 
which shows a steady decrease in anisotropy from 0.36 initially to 0.24 after 17 ns. The 
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maximum possible anisotropy value is 0.4 for a perfectly rigid complex with no depolari-
zation, whereas the minimum value of zero indicates a rapidly rotating dye molecule that 
has fully depolarized. This measured value of 0.24 is in excellent agreement with a value 
(0.24) reported for the steady state anisotropy of a TMR labeled oligonucleotide, due to 
restricted dye mobility from π stacking with nearby guanine nucleobases.104 The same 
method was used to determine the anisotropy of the DNA nanocage directly labeled with 
TMR (DNA-TMR). Interestingly, the calculated anisotropy of DNA-TMR decays in a 
nearly identical fashion over time to a value of 0.24 after 17 ns, as shown in Figure 3-9 
(A). Evidently the TMR dye interacts equally with guanine when intercalated in the DNA 
helix along the edge or when stacked to one of the terminal guanines at the end of the 
three helices that converge at the vertex, as identified in the DNA sequences in Figure 
3-2. 
 The complex with the donor alone (DNA + PNA1-FAM + PNA2-Ac) was meas-
ured in the same way as for TMR, however, the sample was excited at 450 nm and the 
FAM emission was monitored at 520 nm. The calculated FAM anisotropy decays much 
faster to a value of 0.12 after 17 ns, as shown in Figure 3-9 (B). This value is slightly 
higher than the steady state values reported in the literature
104
 for FAM labeled oligonu-
cleotides, which may be due to the 3D conformation of the DNA nanocage used in our 
study further restricting the motion of the dye. The calculated anisotropy of DNA-FAM 
at 11 °C and at 22 °C decay to values of 0.11 and 0.12, respectively, after 17 ns. Just as 
with TMR, the calculated anisotropy of FAM was found to decay in nearly identical fash-
ion regardless of whether it was attached to the PNA-peptide or directly attached to the 
DNA nanocage. 
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Figure 3-10. Förster distance measurements between FAM and TMR dyes attached 
to a complex of a DNA nanocage with 0, 1 or 2 PNA-peptides inside. A schematic is 
shown of each of the following complexes: [A] DNA + PNA1-FAM + PNA2-TMR, [B] 
DNA-TMR-FAM (no PNA), [C] DNA-TMR + PNA1-FAM, [D] DNA-FAM + PNA1-
TMR. Next to each schematic is the fluorescence emission spectra (Ex. 450 nm) of the 
donor only (D) and of the donor with the acceptor (DA) measured at 11 °C along with the 
calculated energy transfer efficiency. Below the fluorescence spectra is the determined 
quantum yield (QY), calculated Förster radius (R0) and Förster distance (r). 
 
The steady state fluorescence spectra were measured at 11 °C for the following 
complexes, as shown in Figure 3-10: (A) the designed DNA-PNA-peptide complex 
(DNA + PNA1-FAM + PNA2-TMR), (B) the DNA nanocage labeled at two adjacent 
vertices but without any bound PNA (DNA-FAM-TMR), as well as the constructs pre-
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pared to measure PNA1-GPG thermal stability of (C) DNA-TMR + PNA1-FAM and (D) 
DNA-FAM + PNA1-TMR For each construct, Figure 3-10 shows a cartoon schematic, 
the fluorescence spectra with the change in donor fluorescence (D) in the presence of the 
acceptor (DA), the determined quantum yield (QY), and the calculated Förster radius (R0) 
and Förster Distance (r). The QY of the donor only complexes were determined by com-
paring the fluorescence intensity of each complex (without the acceptor) to that of a sodi-
um fluorescein standard,
101
 when normalized to concentration. The calculated QY for the 
donor (FAM) attached to the PNA1-peptide and hybridized to the DNA nanocage were 
higher (0.62 and 0.51) than when directly attached to the DNA nanocage vertex (0.36). 
This range of QY were in agreement with those reported in the literature for FAM at-
tached to dsDNA.
128,129
 The change in donor (FAM) fluorescence in the presence of the 
acceptor (TMR) was used to determine the FRET efficiency and together with the QY was 
used to calculate the corresponding Förster distances using the Förster equations de-
scribed in the Materials and Methods section called Förster radius, energy transfer effi-
ciency and distance calculations. For the designed construct shown in Figure 3-10 (A), 
the FRET efficiency determined from steady state fluorescence (30%) is similar to the 
value (36%) obtained by the change in average donor lifetime observed using TCSPC.  
When calculating the Förster distances we assumed the dyes were randomly ori-
ented, with an orientation factor (κ2) of ⅔. However, the anisotropy data indicate that 
both dyes interact with the DNA nanocage, which could bias particular orientations and 
introduce uncertainty into the calculated distances. Dale and coworkers developed a 
method to determine the limits of the orientation factor based on the anisotropy data.
130
 
We used a variation of this method developed by Lakowicz and coworkers
131
 and de-
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scribed in the Materials and Methods section called Förster radius, energy transfer effi-
ciency and distance calculations, to determine the upper and lower limits of the orienta-
tion factor (κ2) to be between κ2min = 0.2 and κ
2
max = 1.7, which translates to the distance 
uncertainties shown in Figure 3-10 for each construct. 
The calculated Förster distances of the different complexes in Figure 3-10 were 
used in combination with gel electrophoresis, lifetime and anisotropy data to develop a 
model of the insertion and structural arrangement of the fluorescently labeled PNA-
peptides inside the DNA nanocage. The Förster distances of 6.3 ± 1.1 nm measured be-
tween edges through the center of the DNA nanocage (Figure 3-10 A) and of 6.0 ± 1.0 
nm measured along one of the DNA nanocage edges (Figure 3-10 B) are slightly longer 
and shorter, respectively, than the corresponding distances of 7 nm and 5–6 nm, respec-
tively, of a tetrahedron with straight edges. These measurements suggest a conformation 
of the DNA nanocage where the edges are bowed outward giving the tetrahedron a more 
spherical rather than pyramid shape, similar to a previously reported cryo-electron mi-
croscopy study.
64
 The FAM labeled PNA-peptide causes a pronounced native gel band 
shift of the DNA nanocage upon binding, which suggests the negatively charged FAM
2-
 
is repelled away from the DNA nanocage slowing its migration through the gel. The rela-
tively high TMR anisotropy data suggests that it strongly interacts with the DNA 
nanocage and stabilizes the bound PNA-peptide, resulting in a 9.2 °C increase its dissoci-
ation temperature. Gel electrophoresis data of the TMR labeled PNA-peptide shows a 
dominant conformation that does not significantly affect the complex migration in the 
gel, which suggests the TMR may intercalate with the DNA nucleobases or bind on the 
interior of the DNA nanocage. The gel also shows minor band broadening suggesting that 
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TMR may also non-specifically interact with the surrounding DNA helix in a range of 
conformations. This TMR labeled PNA-peptide conformational heterogeneity is likely 
the source of the two energy transfer pathways identified using TCSPC. The donor-
acceptor distances for the dominant energy pathway (2.5 ns, 36% FRET efficiency) was 
calculated to be 6.0 ± 1.0 nm, while the faster pathway (0.7 ns, 82% FRET efficiency) 
was calculated to be 4.3 ± 0.7 nm. The longer distance suggests a peptide conformation 
with the TMR intercalating with nearby DNA bases, while the shorter distance suggests a 
peptide conformation with the TMR extended into the center of the DNA nanocage to-
ward the FAM labeled PNA-peptide. 
 
Conclusion 
We have demonstrated a rapid and flexible method using PNA linkers to assemble 
peptides inside a small 3D DNA nanocage. The PNA-peptides could be introduced quan-
titatively by incubating for 5–10 minutes at room temperature with the preassembled 
DNA nanocage, either in parallel or stepwise fashion, with as little as two times molar 
excess of PNA-peptide. The TMR dye label was found to significantly stabilize PNA-
peptide binding to the DNA nanocage, increasing the TD by 9.2 °C from a predicted value 
of 36.6 °C to 45.8 °C. Data from biophysical characterization using gel electrophoresis as 
well as steady state and time resolved fluorescence spectroscopy allowed us to develop a 
model for the arrangement of the PNA-peptides inside the DNA nanocage that is in 
agreement with the intended design.  
Our design strategy can be further expanded to introduce four PNA binding gaps 
by shortening the length of the remaining two DNA strands (e.g., S1 and S2). In order to 
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access the remaining two edges of the DNA nanocage two of the existing four DNA 
strands must each be divided into a 13bp strand and a 34bp strand, which may require 
further optimization of the annealing conditions for proper DNA nanocage assembly. The 
gaps can also be translated to other edges contacted by the same strand, or shifted along 
the same edge to control the orientation of the N terminally attached peptide. Additional 
peptides can be introduced at the C terminus of the PNA during the initial synthesis or 
along the PNA backbone using orthogonal protecting groups.
82
 A previous study estimat-
ed the DNA nanocage could accommodate a 60 kDa (~500 amino acid) globular 
protein,
50
 but could just as easily be filled by a series of peptides assembled together us-
ing multiple PNAs. This work illustrates how a 3D DNA scaffold can be used to assem-
ble polypeptides through rapid and controlled hybridization with PNA linkers. The flexi-
bility of our method offers a biomimetic route to rebuild protein active sites and further 
expand the structure and functional landscape of polypeptide engineering. 
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CHAPTER 4 – Low Temperature Assembly of Functional 3D DNA-PNA-Protein 
Complexes 
Adapted with permission from Flory, J. D.; Simmons, C. R.; Lin, S.; Johnson, T.; 
Andreoni, A.; Zook, J.; Ghirlanda, G.; Liu, Y.; Yan, H.; Fromme, P. Manuscript submit-
ted for publication to J. Am. Chem. Soc. 2014.
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Abstract 
Proteins have evolved to carry out nearly all the work required of living organ-
isms within complex inter and intracellular environments. However, systematically inves-
tigating the range of interactions experienced by a protein that influence its function re-
mains challenging. DNA nanostructures are emerging as a convenient method to arrange 
a broad range of guest molecules. However, flexible methods are needed for arranging 
proteins in more biologically relevant 3D geometries under mild conditions that preserve 
protein function. Here we demonstrate how peptide nucleic acid (PNA) can be used to 
control the assembly of cytochrome c (12.5 kDa, pI 10.5) and azurin (13.9 kDa, pI 5.7) 
proteins into separate 3D DNA nanocages, in a process that maintains protein function. 
Toehold-mediated DNA strand displacement is introduced as a method to purify PNA-
protein conjugates. The PNA-proteins were assembled within 2 minutes at room tempera-
ture, within 4 minutes at 11 ⁰C, and hybridize with even greater efficiency than PNA con-
jugated to a short peptide. Gel electrophoresis, steady state and time resolved fluores-
cence spectroscopy were used to investigate the effect of protein surface charge on its 
interaction with the negatively charged DNA nanocage. These data were used to generate 
a model of the DNA-PNA-protein complexes that show the negatively charged azurin 
protein repelled away from the DNA nanocage while the positively charged cytochrome c 
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protein remains within and closely interacts with the DNA nanocage. When conjugated to 
PNA and incorporated into the DNA nanocage, the cytochrome c secondary structure and 
catalytic activity were maintained, and its redox potential was reduced modestly by 20 
mV possibly due to neutralization of some positive surface charges. This work demon-
strates a flexible new approach for using 3D nucleic acid (PNA-DNA) nanostructures to 
control the assembly of functional proteins, and facilitates further investigation of protein 
interactions as well as engineering more elaborate 3D protein complexes. 
 
Introduction 
Proteins evolved an enormous diversity of function that is carried out through 
massively complex pathways of interactions with other biomolecules, which are being 
compiled into streamlined databases of possible protein-protein interactions and net-
works.
55,56
 However, many of these interactions are dependent on the method used to dis-
cover them or are non-functional,
57
 so new methods are needed to validate and further 
characterize the specific properties of each interaction.
58
 DNA nanostructures offer an 
intriguing platform to study the function of proteins through controlled manipulation of 
the protein orientation and proximity to other molecules of interest. The field of DNA 
nanotechnology has been extensively reviewed,
15,133
 including specialized reviews focus-
ing on protein functionalization.
134,135
 Methods for manipulating proteins on 1D and 2D 
DNA nanostructures have been utilized for selectively arranging multiple enzymes,
42
 in-
vestigating DNA binding with aptamers
44
 and zinc finger proteins,
45
 assembling com-
plementary protein subunits
46
 or protein ligands,
40,47
 and for investigating the spatial de-
pendence of enzyme cascades.
48,49
 3D DNA nanostructures have been used to encapsu-
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late
50
 and arrange proteins
51–53
 as well as to organize membrane proteins for NMR struc-
ture determination.
54
 Because natural protein interactions occur in complex 3D arrange-
ments there is a need to develop methods for spatially and temporally controlling protein 
interactions in 3D, which may not be accessible in nanostructures of lower dimension. 
Furthermore, some proteins contain specific DNA binding domains
61
 and many others are 
likely influenced by the presence of a negatively charged DNA scaffold, so a better un-
derstanding of the electrostatic effects of DNA nanostructures on proteins is needed to 
establish guidelines for using DNA scaffolds to study proteins. Previous work conjugat-
ing protein to DNA has largely focused on introducing proteins onto large 2D DNA lat-
tices
8
 or DNA origami nanostructures.
136
 Small DNA nanostructures facilitate confining 
proteins to more biologically relevant interaction distances and frequencies, and can also 
be more easily incorporated into other materials and complexes.
137
 Furthermore, small 
DNA nanostructures (<100 kDa) allow higher molar concentration to be achieved, which 
enables a broader range of protein assays, such as spectroelectrochemistry,
59
 and struc-
tural analytical techniques, such as circular dichroism,
60
 not practical with large DNA 
origami nanostructures (> 4 MDa).
21
 
Previously, a DNA tetrahedron was used to encapsulate the protein cytochrome 
c.
50
 In that work the authors directly conjugated the protein to one of the four ssDNAs 
required for proper assembly of the DNA tetrahedron, then assembled the DNA-protein 
complex in a single high temperature annealing step. It is unclear how the protein func-
tion was affected by the preparative methods and whether this method could be extended 
to a wider range of proteins. While it is possible to assemble DNA nanostructures at low-
er temperature, this generally reduces the assembly yield and complicates purification. 
116 
 
Furthermore, if multiple proteins were assembled on the same scaffold in one step, the 
timing of the interactions could not be controlled. Nucleobase hybridization coupling 
strategies can overcome this limitation, by first assembling the DNA nanostructure with a 
binding site for a guest molecule conjugated to a ssDNA, and then incorporating the 
guest molecule by hybridization under mild conditions.
29,41
 However, even oligonucleo-
tides of moderate length can substantially reduce the efficiency of incorporating proteins 
in close proximity.
41
 Peptide nucleic acid (PNA)
66
 is an artificial nucleic acid with en-
hanced binding affinity for DNA that shows great promise for applications in gene target-
ing,
116
 sensing
118,138
 and as a nanomaterial.
78,139,140
 We previously showed that 8 nucleo-
tide (nt) strands of PNA can be used to rapidly and efficiently assemble short, fluores-
cently labeled peptides at room temperature into an existing DNA tetrahedron design
65
 
modified to include a single-stranded PNA binding domain for each peptide.
79
 It was un-
clear if the effectiveness of this strategy could be extended to much longer polypeptides 
and if it would preserve function. 
In this report we conjugate a PNA linker to two small proteins, cytochrome c 
(12.5 kDa, pI 10.5) and azurin (14 kDa, pI 5.7), and assemble each conjugate into sepa-
rate 3D DNA nanocages via nucleobase hybridization with the attached PNA linker, as 
shown in Figure 4-1. These proteins allowed us to investigate the feasibility of using 
PNA to assemble longer, functional polypeptides, as well as compare the effect of each 
protein’s net surface charge on its interaction with the negatively charged 3D DNA 
nanocage. First we synthesized an 8nt PNA sequence and conjugated it to a surface thiol 
on either protein. Toehold-mediated DNA strand displacement was developed to purify 
the PNA-protein conjugates from unreacted protein. Gel electrophoresis was used to de-
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termine the PNA-protein binding efficiency. Förster resonance energy transfer between 
the tetramethylrhodamine (TMR) labeled PNA-protein and the fluorescein (FAM) la-
beled DNA nanocage (DNA-FAM) was used to monitor the PNA-protein hybridization 
kinetics, thermal dissociation, and separation distances. Time resolved spectroscopy was 
used to analyze the interaction of the TMR labeled PNA-proteins with the DNA-FAM 
nanocage. Gel electrophoresis along with steady-state and time-resolved fluorescence da-
ta were used to construct a model of each DNA-PNA-protein complex. Finally, the func-
tion of cytochrome c, when conjugated to PNA and hybridized inside the DNA nanocage, 
was characterized by measuring the activity of luminol oxidation and by determining its 
redox potential using spectroelectrochemistry. 
 
Results and Discussion 
DNA-PNA-protein complex design 
 
Figure 4-1. Proposed design to separately assemble two proteins into a DNA 
nanocage using a PNA linker. 
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Strand Name Sequence 
S1 
 
AGGCAGTTGAGACGAACATTCCTAAGTCTGAAATTTATCACCCGCCA-
TAGTAGACGTATCACC 
S2P CTTGCTACACGATTCAGACTTAGGAATGTTCGACATGCGACGCACAGA-
TACCGACGATTACAG 
S2P-FAM CTTGCTACACGATTCAGACTTAGGAATGTTCGACATGCGACGCACAGA-
TACCG/iFluorT/CGATTACAG 
S2Pg ATACCGACGATTACAGCTTGCTACACGATTCAGACTTAG-
GAATGTTCGACATGCG 
S3 GGTGATAAAACGTGTAGCAAGCTGTAATCGACGGGAAGAG-
CATGCCCATCCACTACTATGGCG 
S4g CGCATGACTCAACTGCCTGGTGATACGAGGATGGG-
CATGCTCTTCCCGACGGTAT 
S4P CTCTTCCCGACGGTATACGCACAGCGCATGACTCAACTGCCTGGTGA-
TACGAGGATGGGCATG 
PNA-FAM FAM-Gly-CTGTGCGT 
PNA-TMR TMR-Gly-CTGTGCGT 
PNA-Az Azurin-SMCC-Gly-CTGTGCGT 
PNA-Az-TMR TMR-Azurin-SMCC-Gly-CTGTGCGT 
PNA-CytC Cytochrome c-SPDP-SMCC-Gly-CTGTGCGT 
PNA-CytC-TMR TMR-Cytochrome c-SPDP-SMCC-Gly-CTGTGCGT 
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Figure 4-2. DNA and PNA sequences and schematic showing their arrangement in 
the complex. [Top] Schematic of the PNA and DNA sequence layout, where the PNA-
protein is attached to Edge C. The strand nicks are indicated with the arrow pointing in 
the 3’ direction. Strand S4g is redrawn above for clarity. This schematic was redrawn 
from Flory et al.
79
 with changes to incorporate the PNA-proteins. [Bottom] DNA and 
PNA sequences with the color code matching the schematic in the top figure. Variations 
of strand S2 are included with a FAM label (S2-FAM) and with a PNA binding sequence 
(S2P) for an ‘inverted’ DNA nanocage design where the PNA binding domain is moved 
across the helix, rotating the orientation of protein attachment by about 180 degrees on 
edge C. The DNA and PNA sequences are written in the 5’ to 3’ direction. The PNA se-
quence has an N-terminal (5’) glycine followed by the SMCC cross-linker for attaching 
to the surface thiol on azurin (N42C mutant) or cytochrome c (introduced with SPDP). 
Dye labeled DNA strands are defined using the nomenclature for ordering from IDT, 
where the dye names are enclosed by “/” marks and are attached to a modified thymine 
base at the vertex. 
 
Previously we demonstrated the PNA-driven assembly of two fluorescently la-
beled peptides within a DNA nanocage.
79
 Briefly, we introduced modifications to an ex-
isting DNA tetrahedron design by introducing two 8nt single stranded domains on oppo-
site edges of the DNA nanocage for binding complementary PNA strands with short pep-
tides on the N terminus oriented toward each other through the center of the DNA 
nanocage. The design allowed the DNA nanocage to be preassembled, purified and then 
subsequently populated with one or two PNA-peptides under mild conditions. Here, we 
extend this strategy to introduce two different metalloproteins into separate DNA 
nanocages, as shown in Figure 4-1, at the PNA binding site on one of the edges, as shown 
in the sequence schematic in Figure 4-2. Throughout this report we use the nomenclature 
defined in Figure 4-2, Figure 4-3 and Figure 4-6 when we describe the various strands 
and constructs used in each experiment.  
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Complex Name Strands Required to Assemble Construct 
DNA (nanocage) S1, S2P, S3, S4g 
DNA-FAM S1, S2P-FAM, S3, S4g 
DNAi (inverted nanocage) S1, S2Pg, S3, S4P 
DNA + PNA-Az S1, S2P, S3, S4g, PNA-Az 
DNA + PNA-Az-TMR S1, S2P, S3, S4g, PNA-Az-TMR 
DNA-FAM + PNA-Az-TMR S1, S2P-FAM, S3, S4g, PNA-Az-TMR 
DNA + PNA-CytC S1, S2P, S3, S4g, PNA-CytC 
DNA + PNA-CytC-TMR S1, S2P, S3, S4g, PNA-CytC-TMR 
DNA-FAM + PNA-CytC-TMR S1, S2P-FAM, S3, S4g, PNA-CytC-TMR 
 
Figure 4-3. Complex nomenclature with list of required DNA and PNA-protein 
strands for assembly. List of names of complexes referred to in this chapter with the 
corresponding strands and conjugate names required to assemble the complex. 
 
PNA-protein conjugation, purification and fluorescent labeling 
The schemes used to construct conjugates of PNA with either dye labeled or un-
labeled azurin or cytochrome c are shown in Figure 4-4. Detailed methods for the conju-
gation, purification and fluorescent labeling and further discussion can be found in the 
Materials and Methods section called Fluorescent labeling of cytochrome c with TMR 
and section called TMR labeling of PNA-azurin. Briefly, the PNA sequence 
TGCGTGTC-Gly, written from C to N terminus (3′ to 5′) was prepared by microwave-
assisted solid phase synthesis as described previously,
79,83
 and the free N terminus was 
labeled with an SMCC cross-linker. RP-HPLC and MALDI of PNA-SMCC is shown in 
Figure 2-5. PNA-SMCC was conjugated to a single surface cysteine (N42C) containing 
azurin mutant (~40% yield).
107
 The chemical structure of the linker connecting the PNA 
to azurin is shown in Figure 4-10B. The SPDP cross-linker was used to introduce 1.1–2.6 
thiols per cytochrome c, conjugated to PNA-SMCC (yield 5–10%) and quenched using 
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aminoethylmalemide (AEM) to restore positive surface charges lost during the thiolation 
of surface amines with SPDP. The chemical structure of the linker connecting the PNA to 
cytochrome c is shown in Figure 4-10A. Some of the conjugates were dye labeled with 
TMR for subsequent fluorescent studies. 
Further purification of the conjugates was not essential since the remaining free 
protein could be removed by size exclusion fast protein liquid chromatography (SE-
FPLC) after the PNA-protein (15-16 kDa) hybridizes with the much larger DNA 
nanocage (80 kDa). However, characterization of the PNA-CytC conjugates within a 
mixture of free protein was challenging due to the low amount of conjugate (5–10%) and 
the significant absorbance of cytochrome c at 260 nm (ε260 = 20,140 M
-1
cm
-1
) compared 
to PNA (ε260 = 69,932 M
-1
cm
-1
), as shown in Figure 2-7. Due to the neutral charge and 
small size of the PNA linker (2.4 kDa) as compared to the protein (12.5 kDa), charge and 
molecular weight based separation techniques were not effective to separate the PNA-
CytC conjugates from unreacted cytochrome c. This motivated our pursuit to develop a 
new method of purifying PNA-protein conjugates using toehold-mediated DNA strand 
displacement, as described in the next section. 
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Figure 4-4. Scheme used to produce the following dye labeled and unlabeled PNA-
protein conjugates: PNA-CytC, PNA-CytC-TMR, PNA-Az, PNA-Az-TMR. 1A) Sol-
id Phase Synthesis of 8nt PNA sequence with N terminal glycine, 1B) Functionalization 
of PNA with maleimide on N terminus using SMCC cross-linker. 2A) Labeling of cyto-
chrome c surface lysines with TMR dye, 2B) Functionalization of cytochrome c surface 
lysines with thiols using SPDP cross-linker, 3) Conjugation of PNA-SMCC to surface 
thiol(s) on cytochrome c and azurin, 4B) Quenching of unreacted surface thiols on cyto-
chrome c with AEM to restore positive charge, 4B) Labeling azurin surface lysines with 
TMR dye. 
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Figure 4-5. Scheme for purifying PNA-protein using toehold-mediated DNA strand 
displacement. Details about the procedure are described in the text. 
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PNA-protein purification by toehold-mediated DNA strand displacement 
In order to further isolate and characterize the PNA-CytC conjugate from the free 
cytochrome c, we sought to leverage PNAs ability to hybridize to DNA. Toehold-
mediated DNA strand displacement is an established technique that uses a partially com-
plementary DNA strand to initially bind a target, but leaves a ssDNA ‘toehold’ domain 
available for a fully complementary strand to bind and release the target, due to the more 
favorable binding energies, as reviewed by Zhang and Seelig.
141
 Here we adapted this 
technique to purify PNA-protein conjugates, as shown in Figure 4-5. To our knowledge 
this is the first application of this technique for purification purposes. In step 1, the crude 
mixture of PNA-CytC and free cytochrome c was incubated with either a 16nt or 66nt 
toehold ssDNA. Each toehold strand contains an 8nt domain (shown in yellow) fully 
complementary to the 8nt PNA sequence conjugated to the protein, and an 8nt toehold 
domain (shown in purple) that remains unhybridized. In step 2, the additional mass pro-
vided by either the 16nt (4.8 kDa) or 66nt (20.3 kDa) toehold in the DNA-PNA-protein 
complex allows SE-FPLC to be used to separate it from the free protein. In step 3, a 
ssDNA fully complementary to the toehold (cDNA) is incubated with the DNA-PNA-
protein complex. The cDNA initially binds to the free part of the toehold DNA domain 
and then it completely displaces the PNA-protein. In step 4, the cDNA and toehold DNA 
are removed from the PNA-protein using ion exchange FPLC (IEX-FPLC). The sequenc-
es of the strands used in this method are described in Figure 4-6. 
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Figure 4-6. DNA sequences for toehold mediated PNA purification. DNA sequences 
used for purifying the PNA or PNA-protein conjugates by toehold mediated strand dis-
placement. The sequences are written in the 5’ to 3’ direction. The 16nt toehold strand is 
comprised of an 8nt domain (yellow), which is fully complementary to PNA, an 8nt do-
main (purple) that provides a site for the complementary toehold strand (cDNA) to bind 
and displace the PNA or PNA-protein. A larger molecular weight 66nt toehold was also 
used, which was designed with self-complementary 10nt stem s (green and black) and 5nt 
loops (grey) flanking each binding domain. 
 
Initially we suspected that the additional charge from the toehold DNA strand 
would make charge based separation techniques straightforward to isolate the DNA-
PNA-protein complexes. Both IEX-FPLC and native PAGE were successful for separat-
ing fluorescently labeled PNA strands, as shown in Figure 2-10 and Figure 2-11, respec-
tively, which is discussed further in the Materials and Methods section called ssDNA 
toehold mediated PNA and PNA-protein purification. Subsequent mixing of the DNA-
PNA complex with the fully complementary (cDNA) strand liberated the PNA. When the 
same method was applied to PNA-CytC, however, the DNA-PNA-CytC hybridization 
was disrupted during purification. Two major factors may contribute to the dissociation 
of the toehold DNA from the PNA-CytC: 1) structural changes to the DNA as it binds to 
the anion exchange column may weaken its binding to PNA-CytC, and 2) the dipole 
Strand Name Sequence 
16nt Toehold AGCTCCAAACGCACAG 
 
FAM Labled 16nt 
Toehold 
/56-
FAM/AGCTCCAAACGCACAG 
 
66nt Toehold CGAACATTCCAAAAAGGAAT
GTTCGAGCTCCAAAC-
GCACAGCGATTACAG-
CAAAAAGCTGTAATCG 
 
16nt Complementary 
Toehold (cDNA) 
CTGTGCGTTTGGAGCT 
126 
 
moment between the positively charged PNA-CytC and negatively charged DNA may 
increase the rate of dissociation in the presence of a large electric field during PAGE. To 
circumvent this issue, we performed SE-FPLC on the DNA-PNA-CytC mixture. Figure 
4-7A shows the SE-FPLC chromatogram with the nucleobase absorbance at 260 nm and 
the heme absorbance of cytochrome c at 414 nm. Peaks 1 and 2 show significant A260 and 
A414, which we assign to cytochrome c labeled with one (19.7 kDa) and two (26.9 kDa) 
PNA strands, respectively (masses include complementary toehold DNA strands). We 
assign the third peak to the free cytochrome c (12.5 kDa), because of the large A414 and 
modest A260. The fourth peak, showing A260 but negligible A414, is attributed to unhybrid-
ized 16nt toehold DNA strand (4.8 kDa). 
In order to improve the separation of the PNA-CytC conjugates, a 66nt (20.3 kDa) 
toehold strand was designed to induce an even larger mass shift. Figure 4-7B shows the 
SE-FPLC chromatogram of PNA-CytC incubated with the 66nt toehold DNA. Peaks 1 
and 2 show cytochrome c with one and two PNAs attached, respectively. These peaks 
show superior separation from the free cytochrome c peak to what was achieved with the 
16nt toehold strand. Because of its larger size, the 66nt toehold DNA strand partially 
overlaps with the PNA-conjugate peaks, but which is removed during the subsequent pu-
rification step (vide infra). An additional peak is observed just prior to the free cyto-
chrome c peak (peak 0), which could be PNA-CytC conjugate that dissociated from its 
complementary toehold DNA during the run. 
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Figure 4-7. Results for PNA-protein conjugate purification by toehold-mediated 
strand displacement. Size Exclusion (SE) FPLC chromatogram of PNA-CytC (15.1 
kDa, ε260 = 90k M
-1
cm
-1, ε414 = 106k M
-1
cm
-1
) incubated with a complementary ssDNA 
of 16nt (4.8 kDa, ε260 = 157k M
-1
cm
-1
) [A] and 66nt (20.3 kDa, ε260 = 661k M
-1
cm
-1
) [B]. 
The nucleobase absorption at 260 nm and heme absorption at 414 nm were monitored to 
detect the elution of the product. [C] Ion Exchange (IEX) FPLC chromatogram showing 
the toehold and fully complementary ssDNA and corresponding dsDNA retained on the 
anion exchange column while the cationic PNA-CytC conjugate flows through. [D] Sil-
ver stain of a 4% stacking and 15% resolving SDS-PAGE of the SE-FPLC peaks of the 
PNA-CytC conjugates after purification using different complementary ssDNAs (16nt or 
66nt). Lanes 2 and 3 are free cytochrome c and SPDP-AEM modified cytochrome c, re-
spectively (refer to Figure 4-4 for SPDP-AEM complex); lanes 5 and 7 are the crude 
PNA-CytC and PNA-CytC-TMR mixtures with free cytochrome c; lane 4, 8 and 9 show 
conjugate purified using the 66nt toehold DNA; Lanes 4 and 8 show the overlapping 
peaks 1 and 2 combined for PNA-CytC and PNA-CytC-TMR, respectively, and lane 9 
contains peak 0 from PNA-CytC-TMR. 
 
All PNA-CytC conjugate peaks were collected and then incubated with fully 
complementary DNA (cDNA) strands to liberate the PNA-CytC conjugate. An IEX-
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FPLC step was performed to separate the PNA-CytC from the DNA toehold. Figure 4-7C 
shows a typical IEX-FPLC chromatogram for the separation: the positively charged 
PNA-CytC conjugate does not bind to the resin and elutes in the void volume fraction, 
while the negatively charged ssDNA and dsDNA are retained on the column and are elut-
ed when an increasing salt gradient is applied. The unknown peak eluting before the free 
DNA may be a small amount of conjugate still bound to the toehold DNA strand that was 
not completely displaced by the cDNA. Figure 4-7D shows an SDS-PAGE gel comparing 
unlabeled and TMR labeled PNA-CytC conjugates after toehold-mediated purification. 
On the gel, lanes 2 and 3 were loaded with free cytochrome c and SPDP-AEM modified 
cytochrome c, respectively (refer to Figure 4-4 for SPDP-AEM constructs). Both lanes 
show a single band at the expected molecular weight (~13 kDa). Lanes 5 and 7 were 
loaded with PNA-CytC and PNA-CytC-TMR, respectively. Both samples were purified 
by SE-FPLC to remove unreacted PNA, but still contain free cytochrome c. The low frac-
tion of conjugate (~6%) estimated from the UV-Vis spectrum was not observed on the 
gel using silver stain. After toehold-mediated purification of the crude mixtures, the 
PNA-CytC peak from IEX-FPLC was concentrated and loaded in lane 6. A clear enrich-
ment of the PNA-CytC conjugate is observed when using the 16nt toehold strand. The 
product obtained using a 66nt toehold DNA to purify PNA-CytC(-TMR) was loaded on 
lane 4, 8 and 9. A larger enrichment than what was obtained with the 16nt strand is ob-
served both in the case of PNA-CytC (lane 4) and PNA-CytC-TMR (lane 8 and 9) conju-
gates.  
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PNA-protein assembly with the DNA nanocages 
DNA nanocages with an 8nt single stranded domain for binding the PNA-protein 
conjugates were prepared by thermal annealing as described previously.
79
 The DNA 
nanocage was purified using IEX-FPLC (Figure 2-14A), as described and discussed fur-
ther in the Materials and Methods section called DNA nanocage assembly. In separate 
experiments, the preformed DNA nanocage was incubated at room temperature with in-
creasing molar excess of PNA-CytC, PNA-azurin or with 5x molar excess of a fluores-
cently labeled PNA (PNA-FAM).
79
 The sample was cooled to 4 °C and then directly ana-
lyzed using native PAGE at 4 °C. The results are shown in Figure 4-8: all the constructs 
exhibit a band shift upon PNA hybridization to the DNA nanocage. Both PNA-proteins 
achieve near quantitative binding after stoichiometric amounts are added. This is a no-
ticeable improvement from our previous study of PNA- peptides,
79
 which , due to self-
aggregation,
80
 required two-fold PNA excess for quantitative binding. This improvement 
in the hybridization efficiency may be explained by an enhanced solubility of the PNA 
after conjugation to the protein. 
The smallest gel shift, with respect to the empty DNA nanocage, was observed for 
the binding of PNA-FAM, followed by a slightly larger shift induced from the binding of 
PNA-CytC, and then a more substantial shift caused from the binding of PNA-azurin. 
The binding of PNA itself induces a shift as observed previously,
79
 likely because the 
DNA nanocage becomes more rigid as the single stranded binding domain for PNA be-
comes double stranded. The slight additional shift observed for PNA-CytC is likely due 
to a lower overall negative charge of the DNA-PNA-CytC nanocage assembly after bind-
ing the positively charged cytochrome c (pI ~10.5). The substantial shift induced by 
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Figure 4-8. Gel showing the binding of PNA-cytochrome c, PNA-azurin or PNA-
FAM to the DNA nanocage. [Left] Native PAGE (7%), run at 4 ⁰C, of the DNA 
nanocage incubated with increasing molar excess (0x to 5x) of PNA-CytC or 5x PNA-
FAM. From left to right: ethidium bromide staining of all lanes, FAM fluorescence (Ex. 
475 nm, Em 535 nm) for the lane loaded with PNA-FAM, and silver staining of all lanes. 
[Right] Native PAGE (7%) of the DNA nanocage incubated with increasing molar excess 
(0x to 8x) of PNA-azurin, 4x PNA-azurin with a DNA nanocage with a non-
complementary binding sequence, 2.9x free azurin with the DNA nanocage and 2.9x free 
azurin alone. From left to right: ethidium bromide and silver staining for all lanes. 
 
PNA-azurin, suggests that the negatively charged protein is repelled away from the DNA 
nanocage; this increases the hydrodynamic radius of the assembly, therefore causing a 
slower migration in the gel, as compared with the empty DNA nanocage. A substantial 
gel shift was also observed for the same DNA nanocage attached to a slightly larger but 
also negatively charged green fluorescent protein (28 kDa, pI 5.7)
52
 as well as streptavi-
din.
53
 An alternative ‘inverted’ DNA nanocage design was assembled that moved the 
PNA binding domain across the helix, rotating the orientation of the point of protein at-
tachment by about 180 degrees (sequences described in Figure 4-2). After incubating 
PNA-Az-TMR with the original DNA nanocage design as well as the inverted DNA 
nanocage design (DNAi), native PAGE showed no difference in the mobility of the com-
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plexes, as shown in Figure 2-14C lanes 2–5. A possible explanation for this is that, re-
gardless of the orientation provided by the PNA attached to the DNA nanocage, the gly-
cine-SMCC linker provides sufficient flexibility for the protein to adopt its most thermo-
dynamically favored orientation, based on the surrounding environment. 
The kinetics of PNA-protein hybridization into the DNA nanocage was investi-
gated at room temperature by monitoring quenching of the FAM labeled DNA nanocage 
fluorescence emission as TMR labeled PNA-proteins were added, as discussed in the Ma-
terials and Methods section called PNA-polypeptide hybridization kinetics. PNA-Az-
TMR and PNA-CytC-TMR were found to reach 99% hybridization within 2 minutes, as 
shown in Figure 2-16. These rates are faster than the 5–10 minutes previously observed 
for TMR labeled PNA-peptides.
79
 PNA-CytC-TMR was also found to hybridize to the 
DNA nanocage within 4 minutes at 11 ⁰C. Since proteins are normally kept frozen or 
chilled to extend their useful lifetime, hybridization at low temperature may be ideal to 
study temperature sensitive proteins or protein complexes. The cytochrome c heme ab-
sorbance was also found to quench FAM fluorescence upon binding to the DNA 
nanocage. Unlabeled PNA-CytC hybridized within at 13 minutes at 25 ⁰C and within 25 
minutes at 11 ⁰C, suggesting that the TMR dye label may facilitate binding of PNA-
CytC. TMR is known to interact with DNA nucleobases, which may help to keep the pro-
tein close to the DNA nanocage to facilitate PNA hybridization.
104
 The dissociation tem-
perature (TD) of the TMR labeled PNA-proteins bound to the FAM labeled DNA 
nanocage was determined by monitoring FRET of the complex while the temperature was 
slowly increased from 11 ⁰C to 85 ⁰C, as shown in Figure 2-18. The measured TD of both 
PNA-proteins were 3–4 ⁰C lower than the theoretical value for the PNA sequence alone. 
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This indicates that the presence of either protein destabilizes the PNA-DNA duplex to the 
same degree. 
 
Figure 4-9. Fluorescence decay and anisotropy of two TMR dye labeled proteins hy-
bridized to a DNA nanocage with PNA. (A, B, C) Plot of the parallel (Ivv) and perpen-
dicular (Ivh) TMR fluorescence decay of PNA-Az-TMR hybridized to the DNA 
nanocage (A), and of PNA-CytC-TMR when hybridized to the DNA nanocage (B) and 
when free in solution (C). Panel (D): The anisotropy for each data point of the decays, 
shown in panels A, B, and C, was calculated as described in the Materials and Methods 
section called Fluorescence anisotropy, and the results are plotted here. The central mov-
ing average for each dataset is reported in the same plot for clarity. 
 
Fluorescence characterization: anisotropy, lifetime and energy transfer 
The arrangement of both proteins in the DNA nanocage environment was further 
investigated using fluorescence spectroscopy. We used time-correlated single photon 
counting (TCSPC) to evaluate how freely the dye labels can rotate when attached to the 
PNA-protein and when hybridized into the DNA nanocage by probing the rate of depo-
larization of their emission when excited by polarized light. Each complex was excited by 
vertically polarized light at 500 nm and the emission of TMR was monitored at 600 nm 
with polarization both parallel (VV, vertical excitation and emission) and perpendicular 
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(VH, vertical excitation and horizontal emission) relative to the polarization of the excita-
tion, as shown in Figure 4-9 (A, B and C). The difference in the emission intensity of VV 
and VH was used to calculate the anisotropy decay kinetics using the equations described 
in the Materials and Methods section called Fluorescence anisotropy. The anisotropy de-
cay and corresponding central moving average are plotted for each complex as a function 
of time in Figure 4-9 (D). The maximum possible anisotropy value is 0.4 for a perfectly 
rigid complex with no depolarization, whereas the minimum value of zero indicates a 
rapidly rotating dye molecule that has fully depolarized. The anisotropy for TMR decays 
with three distinct components, a <0.2 ns fast component due to energy transfer between 
proteins with multiple TMR labels, a 0.2–2 ns intermediate component due to the rotation 
of the protein and a >2 ns slow component due to the rotation of the DNA nanocage. In-
terpretation of the anisotropy decay of the fast components and absolute anisotropy val-
ues of the slow components are complex due to the differences in TMR labeling of both 
proteins and is discussed in the next paragraph. The intermediate decay component (0.2–
2 ns) due to protein rotation is observed for PNA-Az-TMR in the DNA nanocage and for 
PNA-CytC-TMR in solution but not for PNA-CytC-TMR in the DNA nanocage. This 
suggests that cytochrome c remains within and closely interacts with the DNA nanocage, 
which significantly restricts its rotation, while azurin is repelled away from the DNA 
nanocage and rotates quite freely. 
Interpretation of the anisotropy decay of TMR attached to both protein shown in 
Figure 4-9 at short (<0.2 ns) and long (>2 ns) times is complex because of the differences 
in labeling between both proteins. The fast initial decay for PNA-CytC-TMR from 0.4 to 
~0.25 during the first 0.1 ns is not resolved during the measurement, but is observed both 
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when PNA-CytC-TMR is in solution and when bound to the DNA nanocage using PNA. 
Such rapid decay is likely because of multiple TMR dyes conjugated to each protein 
which rapidly transfer energy between each other and thus accelerate the rate of depolari-
zation.
142
 The initial decay for PNA-Az-TMR is slightly slower (~0.2 ns) than for PNA-
CytC-TMR (~0.1 ns), which is likely because of a lower degree of TMR labeling on az-
urin. This is consistent with the observed changes in the TMR absorbance spectra for 
PNA-CytC-TMR and PNA-Az-TMR. After 2 ns the anisotropy levels out for each com-
plex, where the PNA-CytC-TMR in solution depolarizes completely (0.04) but both 
PNA-CytC-TMR and PNA-Az-TMR hybridized to the DNA nanocage maintain substan-
tial anisotropy due to the slow rotation of the DNA nanocage. The observed differences 
in the residual anisotropy of PNA-Az-TMR (0.14) and PNA-CytC-TMR (0.20) cannot be 
directly compared due to the differences in TMR labeling of both proteins.
142
 However, 
the intermediate anisotropy decay component shows meaningful differences between the 
both proteins based on the DNA nanocage environment as previously discussed. 
Additional TCSPC measurements were performed to obtain information on the 
position of each of the proteins inside the DNA nanocage after hybridization. The fluo-
rescence emission decay of FAM on an empty DNA-FAM nanocage was compared to the 
decay of the same label after either PNA-CytC-TMR or PNA-Az-TMR was hybridized to 
the DNA-FAM nanocage. The results of these experiments are shown in Figure 2-20. 
From the time dependent intensity decay it is clear that the lifetime of FAM is reduced 
upon binding of either of the two TMR-labeled PNA-protein conjugates. The average 
lifetimes determined from the fitting the data in Figure 2-20 with exponential functions 
are presented in Table 2-2. The change in FAM lifetime in the presence of each TMR-
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labeled PNA-protein was used to determine the energy transfer efficiency of 17 ± 5% for 
PNA-Az-TMR and 37 ± 3% for PNA-CytC-TMR as described in the Materials and 
Methods section called Fluorescence lifetime. The fluorescence decay kinetics of a DNA  
 
Figure 4-10. Steady State Fluorescence Spectra, Molecular Model of the DNA-PNA-
protein complexes and linker chemical structure. [Top] Fluorescence emission spectra 
(Ex. 450 nm) of the donor only (D) and of the donor with the acceptor (DA) measured at 
11 °C of the DNA-FAM nanocage with PNA-CytC-TMR (A) or PNA-Az-TMR (B). 
Each spectra also shows the calculated energy transfer efficiency (ET), the determined 
quantum yield (QY), calculated F rster radius (R0), and F rster distance (r). [Middle] Mo-
lecular models of the dye labeled DNA nanocage hybridized to either a dye labeled PNA-
cytochrome c conjugate (A) or PNA-azurin conjugate (B), with an arrow indicating the 
direction of energy transfer. The chemical structure of the linkers used to conjugate PNA 
to each protein is shown below each model. 
 
nanocage labeled with FAM at the vertex adjacent to the TMR labeled PNA-protein was 
also measured at various wavelengths between 500-640 nm that span the FAM emission 
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spectrum. The data were fit using a global analysis algorithm and plotted as a function of 
wavelength in the Decay Associated Spectra (DAS) shown in Figure 2-21. Both the DAS 
and fluorescence decay indicate that energy transfer occurs from FAM to TMR in the 
DNA-PNA-protein nanostructures. These data are furthered discussed in the Materials 
and Methods section called Fluorescence lifetime. 
Together with TCSPC, steady-state fluorescence spectroscopy was used to meas-
ure the distance between the TMR labeled PNA-proteins and the DNA nanocage vertex 
labeled with FAM. The steady state fluorescence spectra of DNA-FAM + PNA-CytC-
TMR and DNA-FAM + PNA-Az-TMR were recorded at 11 °C, and are shown in Figure 
4-10 panel (A), and (B), respectively. Figure 4-10 reports the following for each con-
struct: the fluorescence spectra of the donor (D), the fluorescence spectra of the donor in 
the presence of the acceptor (DA), the energy transfer efficiency (ET), the quantum yield 
of FAM bound to DNA (QY), the F rster radius of the FAM-TMR FRET pair (R0), and 
the F rster distance in the construct (r). The values of ET, QY, R0, and r were calculated as 
described by Flory et al.
79
 The energy transfer efficiency values calculated from the in-
tensity change of the DNA-FAM fluorescence in the presence of either PNA-CytC-TMR 
or PNA-Az-TMR were 37% and 18%, respectively. These values agree well with the 37 
  3% and 17   5% calculated using the change in DNA-FAM lifetime as measured by 
TCSPC. The F rster radii for the FRET pairs DNA-FAM with PNA-CytC-TMR-FAM or 
PNA-Az-TMR were calculated to be 5.2 nm and 4.3 nm, respectively. The larger F rster 
radius for PNA-CytC-TMR was due to the greater overlap of its absorption spectrum 
with the DNA-FAM emission spectrum. The details of the calculations, as well as discus-
sion about the spectral data used to obtain these values are presented in the Materials and 
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Methods section called Förster radius, energy transfer efficiency and distance calcula-
tions and section called Calculating the absorption spectra and extinction coefficients for 
the overlap integral of TMR labeled PNA-proteins, respectively. The F rster distances 
separating the FAM label on the DNA nanocage from the PNA-CytC-TMR or PNA-Az-
TMR were found to be 5.7 ±1.0 nm and 5.6 ± 0.9 nm, respectively. 
With the constraint that both proteins have approximately the same separation dis-
tance from the adjacent DNA nanocage vertex, we developed a model of the DNA-PNA-
protein complexes that account for differences observed during PAGE and time resolved 
anisotropy, as shown in Figure 4-10. The significantly larger PAGE gel shift and faster 
anisotropy decay kinetics observed for TMR labeled PNA-azurin attached to the DNA 
nanocage suggest it is repelled away from the DNA nanocage creating a larger hydrody-
namic radius for the complex and allows the protein to rotate freely. PNA-CytC induces a 
gel shift similar to that observed for the PNA alone, suggesting that the protein is con-
fined within the DNA nanocage. The TMR anisotropy decay due to PNA-CytC rotation 
in solution is absent when hybridized into the DNA nanocage suggesting that PNA-CytC 
is tightly interacting with the DNA nanocage, and thus restricts its rotation. The chemical 
linkers used to connect PNA to each protein are shown in Figure 4-10 along with the pro-
jected length. Our model suggests that despite the same PNA binding site in the DNA 
nanocage, these chemical linkers are not rigid enough to hold two similarly sized proteins 
at the same location. Instead, the flexibility of the linker allows each protein to find a fa-
vorable orientation based on its surface electrostatic interactions with the negatively 
charged DNA nanocage. To improve control over the protein in the future, it may be ad-
vantageous to operate near the isoelectric point of the protein, increase the salt concentra-
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tion, add a second specific conjugation site to further constrain the orientation of the pro-
tein, or include a complementary protein in an adjacent part of the DNA nanocage that 
can form a stable protein-protein complex. 
 
Cytochrome c activity 
One of the most challenging aspects of working with proteins is to identify rele-
vant in situ methods to assess the integrity of their structural and functional properties. 
Cytochrome c is a redox active heme containing protein that functions as an electron car-
rier in the mitochondrion. Like other heme containing proteins, such as horseradish pe-
roxidase, it has the ability to oxidize luminol in the presence of hydrogen peroxide to 
produce chemiluminescence. Furthermore, the heme absorbance at 550 nm changes sig-
nificantly upon oxidation and reduction, thereby facilitating the spectroscopic assessment 
of its oxidation state. Wild type azurin is a copper containing redox active protein, how-
ever, the mutant used in this study contained redox inactive zinc in the metal center. 
 The activity of cytochrome c in the DNA-PNA-CytC complex was analyzed di-
rectly in a native polyacrylamide gel using the luminol assay, where the gel was imaged 
for 2 hours to monitor the progression of the reaction, as described in the Materials and 
Methods section called Luminol oxidation activity. Figure 4-11A and Figure 4-11B show 
the ethidium bromide stain and luminol chemiluminescence, respectively, of the DNA 
nanocage alone (lane 1), the DNA nanonocage with PNA-CytC (lane 2), the DNA 
nanocage incubated with 5x free cytochrome c (lane 3) and separately incubated with 5x 
PNA-FAM (lane 4). All DNA constructs migrate uniformly, with a noticeable shift for 
the DNA-PNA-CytC containing band from the empty DNA nanocages. Only the DNA-
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PNA-CytC complex shows chemiluminescence. The intensity of the DNA-PNA-CytC 
(lane 2) and DNA + free cytochrome c (lane 3) bands in each image was integrated and 
plotted as a function of integration time, as shown in Figure 4-11C. Cytochrome c 
demonstrates substrate diffusion limited kinetic behavior as it catalyzes the oxidation of 
luminol in the DNA nanocage, which is in agreement with what was observed in solu-
tion.
143
 
 
Figure 4-11. In-gel activity of PNA-cytochrome c bound to the DNA nanocage. [A] 
Ethidium bromide stain of a 4% stacking and 15% resolving native PAGE of 100 pmols 
of DNA nanocage alone (lane 1), DNA + PNA-CytC (lane 2), the DNA nanocage incu-
bated with 5x free cytochrome c (lane 3) and separately incubated with 5x PNA-FAM 
(lane 4). [B] Chemiluminescence image of the gel from [A] due to luminol oxidation by 
PNA-CytC in the DNA nanocage. [C] Integrated chemiluminescence band intensities of 
DNA-PNA-CytC and DNA + Free CytC taken every 20 minutes. 
 
Cytochrome c redox potential 
The redox potential of cytochrome c was also investigated inside the DNA 
nanocage by monitoring the ratio of oxidized and reduced cytochrome c based on the ab-
sorbance change at 550 nm. The potential of the solution was adjusted using the ferricya-
nide-ferrocyanide redox couple, as described in the Materials and Methods section called 
Redox potential titration with ferri/ferrocyanide. A schematic of the reaction is shown in 
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Figure 4-12A. The fraction of ferricytochrome c (oxidized) is plotted as a function of the 
heme absorption spectra in Figure 4-12B. The log of the ratio of ferrocytochrome c to 
ferricytochrome c is plotted against the log of the ratio of ferrocyanide to ferricyanide 
(which set the solution potential) as shown in Figure 4-12C. The x intercept of a linear fit  
 
Figure 4-12. Spectroelectrochemical results of PNA-cytochrome when bound to the 
DNA nanocage. [A] Schematic of the oxidation of ferrocytochrome to ferricytochrome c 
inside the DNA nanocage by ferricyanide. [B] Absorption spectra of the DNA-PNA-
CytC complex as a function of the fraction of ferricytochrome c (oxidized). [C] Log of 
the ratio of ferrocytochrome c to ferricytochrome c plotted against the log of the ratio of 
ferrocyanide to ferricyanide for free cytochrome c (red) and DNA-PNA-CytC (green). 
Also shown is a linear fit of each dataset and the calculated redox potential values. 
 
of this plot determines the potential at equilibrium between ferri and ferrocytochrome c, 
which can be used to determine the redox potential using the Nernst equation. The calcu-
lated potential for free horse heart cytochrome c was 278 ± 0.6 mV at 23 ⁰C, which is 
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about 10 mV higher than reported elsewhere,
144
 and may be due to a systematic offset in 
our experimental setup. The calculated redox potential for PNA-CytC in solution was 
found to be 267 ± 1.6 mV at 23 ⁰C. The experiment for the DNA-PNA-CytC complex 
was carried out at 6 ⁰C to ensure the PNA-CytC stayed hybridized to the DNA nanocage. 
The redox potential of cytochrome c is known to be inversely dependent on temperature 
(–0.45 mV / ⁰C), which has been explained due to the higher ordering of water at low 
temperature stabilizing the cytochrome c conformation in the reduced state.
145,146
 The 
calculated redox potential for PNA-CytC when incorporated into the DNA nanocage was 
found to be 266 ± 1.7 mV at 6 ⁰C with an equivalent potential of 258 ± 1.7 mV at 23 ⁰C.  
The 10 mV negative shift in the cytochrome c redox potential observed after con-
jugation to PNA and additional 10 mV shift observed once PNA-CytC is incorporated 
into the DNA nanocage may both be due to a less positive net charge of the protein, 
which helps to stabilize the net positive charge of the heme in the oxidized state. The pos-
itive charges from some surface lysine residues are displaced during PNA conjugation. 
Furthermore, close interaction of cytochrome c with the negatively charged DNA 
nanocage may neutralize some positive surface charges on the protein. This shows a simi-
lar trend to that reported for ferrocene conjugated to ssDNA upon hybridization with a 
complementary ssDNA.
147,148
 The DNA microenvironment was also shown to effect the 
activity of a β-lactamase enzyme attached to a giant λ DNA (48.5 kbp) strand when the 
DNA was toggled between an unfolded and compact state.
149
 This suggests that DNA 
nanostructures may be able to modulate the activity of proteins through a variety of 
mechanisms. Together, the activity and redox potential data indicate that the preparation 
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of the PNA-CytC conjugates as well as the incorporation of the conjugates in a DNA 
nanocage the maintain functionality of the protein. 
 
Cytochrome c secondary structure 
Circular dichroism (CD) of cytochrome c was used to determine the effect of conjugating 
PNA and hybridizating into the DNA nanocage on the secondary structure of the protein, 
as described in the Materials and Methods section called Circular dichroism of cyto-
chrome c. The UV CD spectrum of cytochrome c and PNA-CytC (Figure 2-23A) both 
show similar negative-in-sign peaks at 222 nm and 208 nm and a positive-in-sign peak at 
195 nm in agreement with the literature,
150
 suggesting that the overall secondary structure 
of cytochrome c is unaffected by PNA conjugation. CD of the Soret band has also been 
used as a structural probe of the bond strength of the axial Met(80) ligand to the heme 
iron in the oxidized state of cytochrome c.
151
 A pronounced negative-in-sign peak at 417 
nm occurs in the oxidized state when Met(80) is in close proximity to the heme iron, but 
which disappears upon denaturation. The Soret CD spectrum of cytochrome c, PNA-
CytC and DNA-PNA-CytC (Figure 2-23B) all show a negative-in-sign peak at 417 nm 
suggesting cytochrome c retains its native conformation around the heme active site after 
conjugation with PNA and incorporation into the DNA nanocage. This is further support-
ed by nearly identical heme absorption spectra in both the oxidized and reduced states, as 
shown in Figure 2-22.  
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Conclusion 
We have demonstrated gentle methods to conjugate, purify and assemble protein 
into a 3D DNA nanocage using a PNA linker. The results obtained with cytochrome c 
suggest that the methodology preserves protein functional activity. Toehold-mediated 
DNA strand displacement is introduced as an effective method for purifying PNA and 
enriching PNA-protein conjugates. Each of the PNA-protein conjugates was assembled 
into separate DNA nanocages within 2 minutes at room temperature, and within 4 
minutes at 11 ⁰C. The presence of protein increased the PNA solubility, allowing the 
PNA-protein conjugate to bind to the DNA nanocage in near stoichiometric quantities, 
with faster binding kinetics and with increased hybridization efficiency than the same 
PNA sequence conjugated to a short, neutral peptide.
79
 The effect of the surface charge of 
two different proteins on their interactions with a DNA nanocage was also investigated. 
Gel electrophoresis, steady state and time-resolved fluorescence spectroscopy data were 
used to propose a model of the DNA-PNA-protein complexes. Our model suggests that 
the negatively charged azurin is repelled away from the DNA nanocage, whereas the pos-
itively charged cytochrome c remains within and closely interacts with the DNA 
nanocage. When incorporated into the DNA nanocage, cytochrome c maintained catalytic 
activity and its redox potential was reduced by 20 mV possibly due to neutralization of 
positive surface charges during PNA conjugation and from close interaction with the 
DNA nanocage. 
This report describes a flexible approach to studying protein function and interac-
tions within a 3D nucleic acid framework. The design could be further expanded to con-
nect up to 4-6 polypeptides (up to 60 kDa)
50
 on adjacent edges of the DNA nanocage by 
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introducing the appropriate PNA binding sequences. The ability to systematically intro-
duce different proteins into defined locations within such a three dimensional structure 
may facilitate investigations of protein-protein interactions. The maturation of the DNA 
nanotechnology field has greatly simplified the process of designing a wide variety of 
DNA nanostructures. Our method of incorporating proteins into 3D DNA nanostructures 
by means of a PNA linker facilitates exploiting the enormous diversity of DNA 
nanostructures for investigating and engineering functional 3D protein-nucleic acid com-
plexes. 
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CHAPTER 5 – Purification and assembly of Cy5 labeled γ-PNAs into a 3D DNA 
nanocage 
Adapted with permission from Flory, J. D.; Johnson, T.; Simmons, C. R.; Ghir-
landa, G.; Fromme, P. Manuscript submitted for publication to Artificial DNA 2014.
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Abstract 
PNA is hybrid molecule ideally suited for bridging the functional landscape of 
polypeptides with the structural diversity that can be engineered with DNA nanostruc-
tures. However, PNA can be more challenging to work with in aqueous solvents due to 
its hydrophobic nature. A 3D DNA nanocage was designed with binding sites for two 
fluorescently labeled PNA strands in close proximity. Denaturing polyacrylamide gel 
electrophoresis (PAGE) is introduced as an efficient method for purifying charged, dye-
labeled PNA conjugates from large excesses of unreacted dye and unreacted, neutral 
PNA. Elution from the gel in water was monitored by fluorescence and found to be more 
efficient for the more soluble PNA strand. Native PAGE shows that both PNA strands 
hybridize to their intended binding sites within the DNA nanocage. The dye label in-
creased the solubility of the PNA and the efficiency at which it hybridizes to the DNA 
nanocage.  
 
Introduction 
DNA nanostructures are an intriguing platform for manipulating molecules and 
materials on the nanometer scale,
15,133,153
 including proteins and peptides.
134,135
 DNA 
nanostructure assembly is governed mostly by Watson-Crick base pairing
11
 and therefore 
is more straightforward to engineer than proteins or peptides.
17,18
 Chemical strategies are 
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routinely used for conjugating nucleic acids to peptides or proteins in order to enhance 
the functionality of unmodified DNA. However, the number of efficient bioorthogonal 
coupling strategies can become limiting for creating more highly interconnected peptide 
complexes that could be used to mimic protein catalytic sites. Alternatively, nucleobase 
hybridization can be used to leverage a few robust chemical coupling methods for conju-
gating a number of polypeptides, each to a unique nucleic acid strand, which hybridize to 
specific binding sites within the DNA scaffold. 
PNA
66
 (peptide nucleic acid) is an intriguing synthetic polymer for bridging the 
diverse functional landscape of polypeptides with the straight-forward construction of 
nucleic acid nanostructures. Like peptides, PNAs are linked by amide bonds and can be 
synthesized using similar solid phase protocols,
67
 thus allowing for seamless synthesis of 
PNA-peptide conjugates.
68
 Applications have been recently reviewed
71
 including a re-
view focused on chemical modifications to PNA.
72
 Its synthetic backbone makes it highly 
resistant to nucleases and proteases
73
 and useful for targeting DNA
70
 and RNA,
74
 as well 
as using it as a molecular probe
75
 and biosensor.
76,77
 PNA has also been assembled within 
DNA scaffolds to investigate applications in bionanotechnology.
47,78,79
 Previously we 
showed the versatility of using PNA linkers for assembling peptides
79
 and proteins
132
 into 
a 3D DNA nanocage. The assembly process was rapid and could be performed at or be-
low room temperature, providing mild conditions that preserved the function of the at-
tached polypeptides. The previous PNA sequence design provided modest thermal stabil-
ity and could be functionalized at the N terminus. Substitutions to the gamma position on 
the PNA backbone, as shown in Figure 1-6, have been shown to increase the solubility 
and thermal stability of the PNA strand,
80
 as well as provide a handle to introduce func-
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tional groups without affecting its binding to a complementary strand.
81
 Functionalizing 
PNA at the gamma position would also allow a peptide to be connected anywhere along 
the backbone or even at multiple locations.
47,82
 
Here we report a 3D DNA nanocage design for binding two PNAs fluorescently 
labeled with Cy5. The PNAs were labeled using strain-promoted, copper-free click chem-
istry and purified using denaturing PAGE. Native PAGE was used to characterize the 
DNA nanocage when populated with either of two Cy5 labeled PNAs. 
 
Results and Discussion 
DNA-PNA complex design 
Previously we incorporated two fluorescently labeled peptides
79
 or proteins
132
 
within a 3D DNA nanocage using PNA linkers. Briefly, we modified an existing DNA 
tetrahedron design by introducing 8nt single stranded domains complementary to a PNA 
strand functionalized on the N terminus with a short peptide or small protein oriented to-
ward the center of the DNA nanocage. This design allowed the DNA nanocage to be pre-
assembled, purified and then subsequently populated with one or two PNA-polypeptides 
under mild conditions. Here we introduce a third 8nt PNA binding site (PNA3), to be 
used in conjunction with the PNA1 binding site for introducing guest molecules, as 
shown in Figure 5-1. The PNA3 binding site is in closer proximity to the PNA1 binding 
site (3 nm) than a similar PNA binding site on edge F used in the previous design (5–6 
nm),
79
 which is better suited for assembling protein active sites. Although the PNA se-
quences in our previous design were stable at room temperature
79
, we sought to increase 
the thermal stability to make a more robust artificial OEC complex without significantly 
148 
 
changing the DNA nanocage design (i.e., the length of PNA binding sites). PNA se-
quences generally bind with higher thermal stability to a complementary DNA strand 
than a similar DNA sequence. The neutral charge of the PNA backbone provides some 
added stability, but sequences rich in purines can provided significantly higher thermal 
stabilities over the same sequence of DNA.
126
 We updated the PNA1 and PNA3 binding 
sequences in order to double the purine content of PNA sequences from 37.5% (3 of 8) to 
 
Figure 5-1. Schematics showing the DNA and PNA sequence arrangement in the 
complexes. γ-PNA1 and γ-PNA3 are labeled with Cy5, thiol functionalized at the gamma 
position of 4
th
 PNA base, and attached to edge C and D respectively. This schematic was 
redrawn from
65
 with changes to incorporate the gamma modified PNAs. The ssDNA 
strand nicks are indicated with the arrow pointing in the 3’ direction. Strand S4g is re-
drawn above for clarity. [Left] DNA and γ-PNA strands used for the experiments de-
scribed in the text. [Right] Sequences corrected to orient the peptide attached to γ-PNA3 
toward the peptide attached to γ-PNA1 to more closely mimic the PSII active site, as 
shown in Figure 6-4. 
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Table 5-1. DNA, PNA and peptide strand names and sequences. DNA, PNA and pep-
tide sequences with the color code matching the schematics in Figure 5-1. The DNA and 
PNA sequences are written in the 5’ to 3’ direction. The γ-PNA1 binding sequence is 
highlighted in blue and the γ-PNA3 binding sequence is highlighted in grey. N3 indicates 
the PNA N terminal azide functionalization, and Lys(C3SH) is a thiol introduced to a ly-
sine residue at the gamma position of the 4
th
 PNA base. The peptides sequences are writ-
ten using one letter amino acid codes from N to C termini. For each peptide, the N termi-
nus is either free (NH2) or maleimide functionalized, and the C terminus is either free 
(OH) or amidated (CONH2). Ligands for the Mn4O5Ca cluster from the first coordination 
sphere of the OEC are enclosed in curly brackets {}. Dye labeled and thiolated DNA 
strands are defined using the nomenclature for ordering from IDT, where the dye names 
and thiol functionalization are enclosed by “/” marks and are attached to a modified thy-
mine base at the BCD vertex for the dyes or to the 7
th
 base from the DEF vertex for the 
thiol. 
Strand Name Sequence 
S1 
 
AGGCAGTTGAGAC-
GAACATTCCTAAGTCTGAAATTTATCACCCGCCATAGTAGAC-
GTATCACC 
S1P AGGCAGTTGAGACGAACATTCCTAAGTCTGAAATTTATCCGAG-
TGACTAGTAGACGTATCACC 
S2M GAATGTTCGACATGCGCCATCGCTATACCGA 
CGATTATCGCCGTTTACACGATTCAGACTTAG 
S2M-FAM GAATGTTCGACATGCGCCATCGCTATACCG/iFluorT/ 
CGATTATCGCCGTTTACACGATTCAGACTTAG 
S2M-TMR GAATGTTCGACATGCGCCATCGCTATACCG/i6-TAMN/ 
CGATTATCGCCGTTTACACGATTCAGACTTAG 
S2M-Cy3 GAATGTTCGACATGCGCCATCGCTATACCG/iCy3/ 
CGATTATCGCCGTTTACACGATTCAGACTTAG 
S2gMc TACACGATTCAGACTTAGGAATGTTCGACATGCGCCATCGCTATAC-
CGACGATTA 
S3 GGTGATAAAACGTGTAGCAAGCTGTAATCGACGGGAAGAG-
CATGCCCATCCACTACTATGGCG 
S3MP GGCGATAATCGACGGGAAGAGCATGCCCATCCACTACTAGTCAC-
TCGGATAAAACGTGTAAAC 
S3gMP TAATCGACGGGAAGAGCATGCCCATCCACTACTAGTCACTCGGA-
TAAAACGTGTA 
S3Mc CGGGTGATAAAACGTGTATCGCCGTTTAATCGA 
CGGGAAGAGCATGCCCATCCACTACTATGG 
S3Mc-SH CGGGTGATAAAACGTGTA/iThioMC6-D/CGCCGTTTAATCGA 
CGGGAAGAGCATGCCCATCCACTACTATGG 
S4M TGGCGCATGACTCAACTGCCTGGTGATACGAGGATGGG-
CATGCTCTTCCCGACGGTATAGCGA 
S4g CGCATGACTCAACTGCCTGGTGATACGAGGATGGG-
CATGCTCTTCCCGACGGTAT 
γ-PNA1 N3-AGCG(Lys-C3SH)ATGG-CONH2 
Red Peptide Maleimide-GEIIFGG{E}TMRFWDK-CONH2 
γ-PNA3 N3-AACG(Lys-C3SH)GCGA-CONH2 
Yellow Peptide NH2-AVFLI{Y}PIGQGSFS{D}GMPLGISGTFNFMIVFQA{E}HNILMC-
CONH2 
Green Peptide Maleimide-ADIINRANLGMEVM{HE}RNAHNFPL{D}L{A}-OH 
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Table 5-2. Complex nomenclature with list of constituent DNA and γ-PNA(-peptide) 
strand names. In the DNA-pep and DNA-PNA-aOEC complexes, strand S3Mc-SH is 
conjugated to the green peptide. 
Complex Name Strands Required to Assemble Construct 
DNA1γ S1, S2M, S3, S4g 
DNA1γ-FAM S1, S2M-FAM, S3, S4g 
DNA1γ-TMR S1, S2M-TMR, S3, S4g 
DNA3γ S1P, S2M, S3gMP, S4M 
DNA3γ-FAM S1P, S2M-FAM, S3gMP, S4M 
DNA3γ-TMR S1P, S2M-TMR, S3gMP, S4M 
DNA3γ-Cy3 S1P, S2M-Cy3, S3gMP, S4M 
DNA1γ + γ-PNA1 S1, S2M, S3, S4g, γ-PNA1 
DNA1γ + γ-PNA1-Cy5 S1, S2M, S3, S4g, γ-PNA1-Cy5 
DNA3γ + γ-PNA3 S1P, S2M, S3gMP, S4M, γ-PNA3 
DNA3γ + γ-PNA3-Cy5 S1P, S2M, S3gMP, S4M, γ-PNA3-Cy5 
DNA-pep S1, S2gMc, S3Mc-SH(-pep), S4g 
DNA-PNA-aOEC S1, S2gMc, S3Mc-SH(-pep), S4g, γ-PNA1-pep, γ-PNA3-pep 
 
75% (6 of 8), which is predicted to increase the dissociation temperature from about 37 
⁰C to 49 ⁰C and 53 ⁰C, respectively.95 Throughout this report we use the nomenclature 
defined in Figure 5-1, Table 5-1 and Table 5-2 when we describe the various strands and 
constructs used in each experiment. 
 
Fluorescently labeled and unlabeled DNA nanocage assembly  
Unlabeled DNA nanocages, for binding either γ-PNA1 (DNA1γ) or γ-PNA3 
(DNA3γ), were assembled and purified by SE-FPLC, as previously described.79 DNA 
nanocages were also assembled that were fluorescently labeled on the vertex shared be-
tween γ-PNA1 and γ-PNA3 with fluorescein (DNA1γ-FAM, DNA3γ-FAM) or tetra-
methylrhodamine (DNA1γ-TMR, DNA3γ-TMR) to characterize the γ-PNA binding ki-
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netics and thermal stability and using Fӧrster resonance energy transfer (FRET) with a γ-
PNA labeled with tetramethylrhodamine (TMR) or fluorescein (FAM), respectively, as 
previously described.
79
 The left panel of Figure 5-2 shows the native PAGE of the each 
of the fluorescently labeled and unlabeled DNA nanocages.  
 
Figure 5-2. Native PAGE (7%) of labeled and unlabeled DNA nanocages for binding 
two γ-PNAs. [Lane 2] DNA1 is the unlabeled DNA nanocage with a binding site for a 
standard PNA1 sequence reported previously
79, as a control. DNA1γ is the same DNA 
nanocage with the binding sequence updated for γ-PNA1, shown unlabeled [Lane 3], la-
beled with TMR [Lane 4] or with FAM [Lane 5]. DNA3γ has the binding site moved to 
an adjacent edge with a sequence for binding γ-PNA3, shown unlabeled [Lane 6], labeled 
with FAM [Lane 7] or with TMR [Lane 8]. The ethidium bromide fluorescence (left pan-
el), FAM fluorescence (middle panel) and TMR fluorescence (right panel) are shown. 
[Right] The DNA3γ nanocage unlabeled [Lane 4] and labeled with Cy3 [Lane 6]. The 
ethidium bromide (EtBr) fluorescence (left panel) and Cy3 fluorescence of lane 6 (right 
panel) are shown. 
 
With exception of DNA3γ-FAM, all constructs assembled correctly and show a 
pronounced band that migrates at the same rate as a positive control (DNA1) described 
previously.
79
 DNA3γ-FAM showed significant aggregation during assembly without any 
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dominant product. DNA3γ-TMR also showed more aggregation than was observed in the 
unlabeled DNA3γ construct or than in any of the DNA1γ constructs. This suggests that 
the assembly of DNA3γ may be more sensitive to dye functionalization at the vertex. To 
circumvent this issue, we tried assembling DNA3γ labeled with Cy3, which can be used 
for FRET studies by labeling the PNA with the complementary dye Cy5. The right panel 
of Figure 5-2, shows native PAGE of the DNA3γ labeled with Cy3, which assembled 
correctly and shows a defined band with the expected migration. Both gels in Figure 5-2 
also show the native fluorescence of FAM, TMR or Cy3 for the assembled complexes. 
 
Figure 5-3. Scheme for labeling γ-PNAs with Cy5-DBCO using copper-free click 
chemistry. Cy5 functionalized with DBCO was conjugated to γ-PNA functionalized with 
an N terminal azide, as described in the methods section. 
 
Fluorescent labeling and purification of γ-PNA  
Cy5 functionalized with the strained alkyne dibenzocyclooctyl (DBCO) was used 
to label each γ-PNA at the N terminal azide position, as shown in Figure 5-3 and de-
scribed in the methods section. Strained alkynes can be efficiently conjugated to azides 
without adding any copper catalyst,
154,155
 which could interfere with assembling metallo-
peptide complexes and can be difficult to completely remove.
155,156
 We were unable to 
separate the unreacted Cy5 from the γ-PNA-Cy5 conjugate using reverse-phase high 
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pressure liquid chromatography (RP-HPLC). We had similar problems when trying re-
move unreacted fluorescein (FAM) from γ-PNA-FAM, which suggests the dye labeled γ-
PNA sequences may strongly interact with the unreacted dyes
157,158
 or they have similar 
levels of hydrophobicity. Denaturing PAGE has been shown as an alternative to RP-
HPLC for purifying unmodified PNA under acidic conditions (pH 3) with single-base 
resolution.
159
 We adapted this technique to work under slightly alkaline conditions (pH 
8.5) to take advantage of the difference in mobility in an electric field of unlabeled (neu-
tral) PNA and negatively charged γ-PNA-Cy5 conjugates, as well as the significant dif-
ference in size between the unreacted Cy5 (1 kDa) and the γ-PNA-Cy5 conjugates (~3.5 
kDa). Figure 5-4 shows the denaturing PAGE gel after the reaction of Cy5 with γ-PNA3. 
The unreacted Cy5 migrates significantly faster than the γ-PNA-Cy5 conjugate. matrix 
assisted laser desorption ionization mass spectrometry (MALDI-MS) of the other weakly 
fluorescent bands were found to contain impurities. 
 The bands for the γ-PNA-Cy5 conjugates were cut from the gel and eluted with 
nanopure water up to four times to extract the product, as detailed in Table 5-3. The fluo-
rescent signal remaining in the gel blocks after each elution step, for both γ-PNA3-Cy5 
and γ-PNA1-Cy5, was integrated and fit with an exponential function, as shown in Figure 
5-4, and described in the methods section. Both samples are efficiently eluted after 3–4 
elution steps. Despite a lower percent gel with larger pores, γ-PNA1-Cy5 elutes with 
slightly lower efficiency, which may be due to its reduced solubility compared to γ-
PNA3-Cy5. Although the times allowed for elution during each step were significant dif-
ferent (1.25–115 hours), it appears that equilibrium was still achieved after each elution 
step, which suggests that the elution could be performed in much less time (i.e., 4 elu-
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tions over 6 hours). The eluted product was desalted using RP-HPLC. The expected mo-
lecular weight of each collected product was detected by MALDI-MS, as shown in Fig-
ure 5-5 for γ-PNA1-Cy5 and Figure 5-6 for γ-PNA3-Cy5. Both samples show an impuri-
ty +70 Da from the expected molecular weights. However, native PAGE of the γ-PNA1-
Cy5 shows a single species, which suggests the impurity is minor. Native PAGE analysis 
of γ-PNA3-Cy5 shows the expected band as well as a slower moving band, which may be 
dimerization of γ-PNA3-Cy5 via an intramolecular disulfide between thiols at the gamma 
position. The dimer may be the result of insufficient disulfide cleavage by tris(2-
carboxyethyl)phosphine (TCEP) prior to PAGE analysis. 
 
Figure 5-4. Purification of Cy5 labeled γ-PNAs using denaturing PAGE and time 
course elution from gel blocks. [A] Cy5 fluorescence image of a 10% denaturing PAGE 
gel containing a control with Cy5 only (Lane 1) and the γ-PNA3 and Cy5 reaction cock-
tail (Lanes 3-11). [B] Cy5 fluorescence image of the of γ-PNA1-Cy5 bands cut from a 
7.5% gel, similar to that shown in [A], when eluted with water and centrifuged in Spin-
X™ tubes up to 4 times to remove the product eluted from the gel blocks. [C] The fluo-
rescence intensity of the gel blocks after each elution in [B] was used to determine the 
fraction of PNA remaining in the gel blocks for γ-PNA1-Cy5 and γ-PNA3-Cy5. Each 
curve was fit with an exponential decay function as described in the methods section. The 
parameters for the fitting functions are shown in Table 5-4. 
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Figure 5-5. Characterization of purified Cy5 labeled γ-PNA1 by MALDI-MS and 
native PAGE. MALDI-MS spectrum of the purified γ-PNA1-Cy5 product. The meas-
urement was performed in reflector mode using sinapinic acid as the matrix. The meas-
ured mass of 3,500.2 Dalton (Da) agrees with the expected mass for γ-PNA1-Cy5 (M+H) 
within –0.1 Da. The spectrum also shows two impurities 3,570 Da (M+H+70) and 3,469 
Da (M+H–31). The inset shows a 10% native PAGE of the purified γ-PNA1-Cy5. 
 
The expected molecular weight of each collected product was detected by MAL-
DI-MS, as shown in Figure 5-5 for γ-PNA1-Cy5 and Figure 5-6 for γ-PNA3-Cy5. Both 
samples show an impurity +70 Da from the expected molecular weights. However, native 
PAGE of the γ-PNA1-Cy5 shows a single species, which suggests the impurity is minor. 
Native PAGE analysis of γ-PNA3-Cy5 shows the expected band as well as a slower mov-
ing band, which may be dimerization of γ-PNA3-Cy5 via an intramolecular disulfide be-
tween thiols at the gamma position. The dimer may be the result of insufficient disulfide 
cleavage by TCEP prior to PAGE analysis. 
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Figure 5-6. Characterization of purified Cy5 labeled γ-PNA3 by MALDI-MS and 
Native PAGE. MALDI-MS spectrum of the purified γ-PNA3-Cy5. The measurement 
was performed in reflector mode using sinapinic acid as the matrix. The measured mass 
of 3,470.5 Dalton (Da) agrees with the expected mass for γ-PNA3-Cy5 (M+H) within 
+1.3 Da. The spectrum also shows an impurity with 3,539 Da (M+H+70). The inset 
shows a 10% native PAGE of the purified γ-PNA3-Cy5. 
 
Table 5-3. Progress of γ-PNA-Cy5 elution from gel blocks. For each elution, the table 
shows the number of hours allowed for each product to elute out of the gel blocks (Elu-
tion Time) prior to centrifugation and analysis, the fraction of product remaining in the 
gel blocks determined from the Cy5 fluorescence of the gel blocks, as well as the corre-
sponding fraction of product eluted.  
Strand Elution Num-
ber 
Elution Time 
(hrs) 
Fraction in 
Gel Blocks 
Fraction 
Eluted 
γ-PNA1-Cy5 
(7.5% gel) 
1 44 46% 54% 
2 26 22% 78% 
3 68 8% 92% 
4 1.25 5% 95% 
γ-PNA3-Cy5 
(10% gel) 
1 115 43% 57% 
2 6 18% 82% 
3 18 8% 92% 
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Table 5-4. Fitting parameters for of γ-PNA1-Cy5 and γ-PNA3-Cy5 elution. The frac-
tion of product remaining in the gel blocks after each elution was fit to an exponential 
function with the parameters listed here, as described in the methods section. Because 
only three data points were collected for γ-PNA3-Cy5, error bars for each parameter and 
a goodness-of-fit value (R
2
) could not be determined (ND). 
Strand y0 A R0 R
2
 
γ-PNA1-Cy5 892 ± 898 22,074 ± 2,725 0.7798 ± 0.177 0.989 
γ-PNA3-Cy5 4,382 ± ND 30,868 ± ND 0.8498 ± ND ND 
 
 
Assembly of the DNA nanocages with fluorescently labeled γ-PNAs  
DNA nanocages, for binding either γ-PNA1 (DNA1γ) or γ-PNA3 (DNA3γ), were 
assembled and purified by ion-exchange fast protein liquid chromatography (IEX-FPLC), 
and incubated with increasing molar excess (0–3x or 10x) of the corresponding γ-PNA 
sequence at room temperature, as described previously.
79
 The assembled complexes were 
analyzed directly by native PAGE at 4 ⁰C, as shown in Figure 5-7. A small gel shift is 
observed for the DNA nanocage upon binding each γ-PNA, with respect to the empty 
DNA nanocage, and is attributed to the single stranded γ-PNA binding domain becoming 
double stranded and more rigid, as observed previously.
79
 A 2-5x excess of unlabeled γ-
PNA is required to achieve quantitative binding to the DNA nanocage. This is similar to 
the 2x excess of PNA-peptide required for quantitative binding to the same DNA 
nanocage.
79
 Some PNA sequences show mild aggregation at concentrations as low as 1 
μM,80 which could prevent binding of some PNA to the DNA nanocage. The larger ex-
cess required for γ-PNA1 may be due to its reduced solubility compared to γ-PNA3. 
However, when γ-PNA1 is labeled with the negatively charged Cy5, only 2x excess is 
required for quantitative binding to the DNA nanocage, as shown in the right panel of 
Figure 5-7, suggesting the Cy5 label may improve the solubility of γ-PNA1. Figure 5-7 
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also shows the Cy5 fluorescence of the DNA nanocages containing the Cy5 labeled γ-
PNAs, as well as a more diffuse band containing some unhybridized γ-PNA-Cy5. These 
results indicate the proper assembly of the γ-PNAs into the DNA nanocage before and 
after Cy5 labeling. 
 
Figure 5-7. Gel showing the binding of the unlabeled and labeled γ-PNAs to the 
DNA nanocage. [Left] Ethidium bromide image of the unlabeled DNA1γ and DNA3γ 
nanocages with increasing amount of unlabeled γ-PNA1 and γ-PNA3, respectively. 
[Right] The unlabeled DNA1γ and DNA3γ nanocages with increasing amount of Cy5 
labeled γ-PNA1 and γ-PNA3, respectively. The ethidium bromide (EtBr) fluorescence 
(left panel) and Cy5 fluorescence (right panel) are shown, with the corresponding excita-
tion and emission wavelengths (Ex/Em). 
 
Conclusion 
We introduced denaturing PAGE as a method to efficiently purify PNA fluores-
cently labeled with Cy5. The fluorescence of the product was used to monitor its elution 
from the gel blocks, which allows the method to be extended to other charged molecules 
that may not be so easily detected. The Cy5 labeled γ-PNAs were assembled into DNA 
nanocages under benign conditions that were previously shown to preserve polypeptide 
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function.
132
 A perspective application of using the DNA nanocage design for assembling 
cyclic PNA-peptides is described, which offer a promising approach for constructing arti-
ficial catalytic centers. 
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CHAPTER 6 – Prospective: Building a peptide-based artificial Oxygen-Evolving Com-
plex within a 3D DNA nanocage using γ-PNA linkers 
Abstract 
While photosynthetic organisms offer a promising route to generate sustainable 
transportation fuels using solar energy, their low efficiency in converting sunlight to fuel 
presents a significant challenge for economic viability. A major limitation for high effi-
ciency is photosystem II (PSII). The PSII reaction center-pigment-protein complexes cat-
alyze the oxidation of water to produce all the oxygen in the Earth's atmosphere and ena-
ble conversion of solar energy to bioenergy for the entire biosphere. Under full sunlight 
the native PSII complexes are damaged every 30 minutes due to the accompanying chlo-
rophyll-based photochemistry, resulting in the loss of 60% of the captured photons per 
day to heat.
160
 The site of water oxidation is called the oxygen-evolving complex (OEC) 
and one could hypothesize that it may function independently of the PSII complex when 
reconstructed in a more stable environment. Three polypeptide domains from PSII are 
responsible for coordinating the metal cluster that catalyzes the water oxidation reaction. 
This chapter discusses a potential design concept for assembling these three OEC poly-
peptides from PSII into a DNA nanocage using γ-PNA linkers to form an artificial OEC. 
This artificial OEC has the potential to leverage the high catalytic activity of PSII for ox-
idizing water, but, by integrating it within an artificial system, may avoid the damage that 
limits the natural OEC within PSII. 
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Discussion 
Natural Photosynthesis 
The evolution of photosystem II (PSII) 2.5 billion years ago dramatically changed 
the makeup of life on earth by enabling photoautotrophic growth from abundant sources 
of water and sunlight. The overall chemical reaction catalyzed by PSII is: 2H2O + light 
→ O2 + 4H
+
 + 4e
–
. PSII provides the electrons to the photosynthetic electron transport 
chain shown in Figure 6-1. The light-driven electron transfer reactions in photosystem I 
(PSI) and PSII lead to the formation of an electrochemical gradient that drives synthesis 
of the high energy products ATP and NADPH, which are finally used to reduce atmos-
pheric CO2 into carbohydrates to produce all of biomass on earth. The synthesis of all 
complex organic compounds used for energy storage and other critical life processes de-
pend on photosynthesis. As molecular oxygen, which is the byproduct from water split-
ting by PSII, began to significantly accumulate in the atmosphere about 500 million years 
ago,
161
 it caused a large extinction of organisms that could not adapt to the presence of 
this powerful oxidant, but at the same time provided a large driving force to evolve com-
plex cellular metabolisms and higher orders of life, such as ourselves.
161
  
The light-driven photosynthetic electron transport chain, shown in Figure 6-1, is 
localized within the thylakoid membranes of the chloroplast, which separate the lumen 
from the stroma, and has been reviewed by Renger.
162
 PSII uses light energy to catalyze 
the oxidation of water, in four sequential light-driven charge separation steps, where one 
proton and one electron are extracted in each step from two substrate water molecules. 
The protons are released into the thylakoid lumen and contribute to the electrochemical 
gradient used by ATP synthase to create ATP, which is the energy currency of the cell.  
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Figure 6-1. Photosynthetic electron transport chain. [A] Structure of the major protein 
complexes involved in the light reactions of the photosynthetic electron transport chain. 
[B] Flow of electrons and protons within the photosynthetic electron transport chain. Fig-
ure adapted with permission from Fromme et al.,
163
 © Wiley 2008.  
 
Light energy form the sun is captured by external and PSII internal antenna complexes 
and channeled to the center of the PSII complex to what is called the primary donor 
P680. When P680 is excited to P680
*
, charge separation takes place and an electron is 
transported across the membrane to the terminal electron acceptor a plastoquinone (PQ) 
molecule in the QB binding pocket, which is located at the stromal acceptor side of the 
membrane. After two charge separation events, PQ
--
 takes up two protons from the stro-
mal side and leaves the binding pocket as PQH2 (i.e., plastoquinol). At the lumenal donor 
site, P680
+
 is reduced to P680 by electrons extracted from water molecules bound to the 
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Mn4O5Ca cluster of the oxygen evolving complex (OEC) in PSII via a redox active tyro-
sine TyrZ.  
Plastoquinol migrates within the thylakoid membrane to the cytochrome b6f com-
plex. The b6f complex releases the two protons into the lumen, and pumps one additional 
proton per two electrons across the thylakoid membrane in the so-called Q-cycle, thereby 
further enhancing the electrochemical gradient for ATP production. The cytochrome b6f 
complex transfers one electron to the soluble electron carrier protein plastocyanin, which 
is located in the lumen. Once the reduced plastocyanin diffuses into the lumen, an oxi-
dized plastocyanin docks to the cytochrome b6f complex to receive the second electron 
that originated from the bound plastoquinol. Reduced plastocyanin transfers its electron 
to photosystem I (PSI), which uses light energy to further increase the reducing potential 
of the electron in order to reduce ferredoxin on the stromal side. The net result of the PSI 
electron transport chain is to induce transmembrane charge separation from plastocyanin 
on the lumenal side to ferredoxin (fd) on the stromal side of the membrane. Ferredoxin-
NADP reductase (FNR), then accepts two highly reducing electrons from two reduced 
ferredoxin molecules (fd
red
) to catalyze the following redox reaction: 2fd
red
 + NADP
+
 + 
H
+
 → NADPH + 2fdox. The net result of the “light reactions” of photosynthesis is to pro-
vide highly reducing electrons to make NADPH and to produce an electrochemical gradi-
ent across the membrane, which is used by the ATP-synthase to synthesize ATP from 
ADP and inorganic phosphate (Pi). ATP and NADPH are then used in the "dark reac-
tions" via the Calvin cycle to reduce CO2 in to carbohydrates, which has been reviewed 
by Shively et al
164
 and Raines.
165
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Figure 6-2. Photosystem II structure and electron transport chain. [A] Crystal struc-
ture of PSII solved by Umena et al
3
 (PDB accession code 3ARC). Figure made from 
3ARC by Ingo Grotjohann. [B] Electron transport chain in PSII (PDB accession code 
2AXT).
108
 Figure [B] reproduced with permission from Loll et al.,
108
 © NPG 2005. 
 
Photosystem II: Nature’s solar-driven water oxidation catalyst 
Light-induced water oxidation by PSII is a remarkable function that is highly de-
sirable for designing artificial catalysts to economically produce fuels from solar energy. 
The structure of PSII is shown in Figure 6-2A, and its function has been recently re-
viewed by Vinyard, Ananyev and Dismukes.
166
 The protein complex is a dimer, where 
each monomer consists of 19 protein subunits to which more than 50 cofactors (e.g., 
chlorophylls, carotenoids, lipids, quinones and the metal complex of the OEC) are bound. 
The antenna system consists of chlorophyll pigments (shown in green) that funnel the 
excitation energy to the reaction center, where the PSII cofactors of the electron transport 
chain are located. When the excitation energy reaches P680 (special chlorophyll mole-
cules) the excited state P680
*
 is formed, which catalyzes the charge separation event. 
P680
*
 serves as the primary electron donor by sending its excited electron up the electron 
transport chain and then becoming the primary oxidant P680
+
, which has the most oxidiz-
ing potential in any biological system of 1.1 V [E
0’ vs normal hydrogen electrode 
(NHE)]
167
 The PSII electron transport chain is shown in Figure 6-2B, where P680
+
 is de-
165 
 
noted as PD1. The electron is quickly funneled away up the left branch through a thermo-
dynamically favorable potential gradient, first to a pheophytin (PheoD1) molecule, then to 
a tightly bound plastoquinone (QA), and finally to a transiently bound plastoquinone (QB). 
After accepting two electrons and picking up two protons from the stroma, plastoquinol 
(PQH2) diffuses into the membrane and is replaced by an oxidized plastoquinone to ac-
cept another two electrons and protons. The plastoquinols transport their electrons to cy-
tochrome b6f and on down the photosynthetic electron transport chain. The highly oxidiz-
ing P680
+
 is reduced again by extraction of electrons from two water molecules bound to 
the Mn4O5Ca cluster contained within a domain of PSII called the oxygen-evolving com-
plex (OEC). The electron transfer between P680
+
 and the OEC is mediated through a 
special tyrosine amino acid (TyrZ). In each charge separation step one electron and one 
proton are extracted from the two water molecules by the OEC. After four photons are 
absorbed, and four oxidizing equivalents are stored by the Mn4O5Ca cluster in the OEC, 
molecular oxygen is released. While many models exist for this process
168–171
 the exact 
mechanism of the water oxidation is still unknown. 
Soon after dawn, PSII is able to capture and convert enough light energy to com-
pletely reduce the PQ pool to PQH2, such that an average of 60% of the captured light 
energy each day is wasted as heat.
160
 With the PQH2 pool reduced, electrons from the in-
termediate states on the reducing side (QA
–
 or QB
–
) recombine back to P680
+
 form a tri-
plet state (
3
P680). 
3
P680 is highly energetic and can significantly damage the protein near 
the reaction center. 
3
P680 can also react with molecular oxygen (
3
O2) via triplet-triplet 
annihilation to form singlet oxygen (
1
O2), which can significantly damage the surround-
ing protein matrix.
172
 After an average of 30 minutes in full sunlight, the damage to the 
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PSII reaction center accumulates to the point where PSII is inhibited (i.e., photoinhibi-
tion) and must be repaired, which involves a complex process including disassembly of 
large parts of the PSII complex. The repair process involves proteolytic degradation and 
re-synthesis of the D1 protein that binds most of the cofactors of the PSII electron 
transport chain, followed by a complex reassembly process that includes light-driven re-
assembly of the OEC.
173,174
 While charge recombination also occurs in artificial systems, 
such as semiconductor photovoltaics (PV), which results in energy lost as heat, it does 
not damage the materials as it does in PSII. 
 
Artificial Photosynthesis 
Artificial systems can also be used to create simple fuels from sunlight and wa-
ter.
175
 Figure 6-3 shows a PV device, which uses a semiconductor to absorb light and cre-
ate a potential that can be used to drive a platinum catalyst to electrolyze water and re-
duce protons to H2. Artificial systems have some advantages over biological systems. Sil-
icon based PV absorbs photons further into the infrared (700–1100 nm) than photosyn-
thetic pigments, allowing for capture of about twice the number of photons.
176
 PV is also 
about 4-fold more efficient converting solar energy into current than photosynthesis is to 
produce glucose.
176
 Other rare earth metals, such as iridium
177
 and ruthenium
178
 are also 
capable of catalyzing water oxidation and with impressive longevity (>10k and >8k turn-
overs, respectively) and turnover frequencies (0.09 and 300 s
-1
, respectively), but are not 
an economical or sustainable solution to create fuels from solar energy.
179
 A number of 
other homogenous
180
 and heterogenous
181,182
 water oxidation catalysts have also been 
constructed, but which have not been able to match both the fast turnover frequency (60–
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400 s
-1
) and longevity (100–700k turnovers) of PSII.183,184 Our current understanding of 
PSII has helped to determine design principles for constructing solar-driven artificial wa-
ter splitting systems,
180
 however, these efforts could be significantly enhanced by eluci-
dating the catalytic mechanism of PSII. 
 
Figure 6-3. Artificial system to create fuel from sunlight and water. A photovoltaic 
device is used to drive water electrolysis to generate H2 as a fuel from water.
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Potential design of an artificial oxygen-evolving complex 
Solar-driven water oxidation by PSII is accomplished through three distinct functions:  
1. Light absorption and energy transfer from the large antenna complex to a reaction 
center (P680). 
2. Conversion of light energy into electrical potential through charge separation in the 
reaction center. 
3. Storage of four oxidizing equivalents in a Mn4O5Ca cluster, which ultimately catalyz-
es the oxidation water: 2H2O + light → O2 + 4H
+
 + 4e
–
. 
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PSII is highly conserved among diverse species of photosynthetic organisms and 
this suggests that further optimization, either through natural evolution or mutagenesis, to 
improve the efficiency of this complex protein is unlikely.
161
 From an engineering per-
spective, photosynthesis might be improved by decoupling each of its three functions, 
such that they could be controlled independently, and then recombined in an optimal 
manner so as to achieve a superior outcome. For example, photodamage of PSII occurs 
because of a lack of electron acceptors, which leads to charge recombination, the for-
mation of 
3
P680, 
1
O2 and damage to the PSII protein around the reaction center, as previ-
ously described. Photodamage could be prevented if the pool of electron acceptors could 
be significantly expanded by directly coupling an artificial light-driven water splitting 
complex to a transparent electrode. While light absorption and most of the electron trans-
fer reaction take place in the membrane intrinsic part of PSII, the catalytic site for water 
oxidation is located in the membrane extrinsic part of PSII suggesting that a water soluble 
version of the oxygen-evolving complex (OEC) could be produced. To this end, we pro-
pose a design strategy to decouple the water oxidation function from the light reactions in 
PSII by assembling three peptide domains from the OEC, which provide the ligand 
framework for its Mn4O5Ca active site, within an artificial scaffold. This design approach 
could enable further investigation into the PSII catalytic mechanism, as well as provide 
insights into how to optimize the catalyst for engineering into more practical and eco-
nomical solar to fuel devices. 
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Figure 6-4. Peptides identified from PSII for assembling an artificial OEC. Crystal 
structure of photosystem II (PDB accession code 2AXT)
108
 and close up view showing 
the peptides coordinating the Mn4O5Ca cluster for the artificial OEC. These peptides in-
clude the CD loop of PsbA (Ala156–His195) depicted in yellow, the C-terminus of PsbA 
(Ala318–Ala344) in green, and the short loop of PsbC (Gly347–Asp360) in red. Figure 
made from 2AXT by Ingo Grotjohann. 
 
From the PSII crystal structure,
108
 the essential ligands to coordinate the Mn4O5Ca 
cluster in the active site are found in two adjacent proteins of PSII (PsbA and PsbC). Alt-
hough the ligands are not in close sequence proximity, they could be provided using three 
peptide segments (referred to as the OEC peptides), as shown in Figure 6-4. The se-
quences of each peptide are described in Table 5-1, which also denotes the amino acids 
directly coordinating the Mn4O5Ca cluster. A more recent, higher resolution crystal struc-
ture
3
 confirmed the importance of the ligands provided by these three peptides and sug-
gests Asp61 from PsbA may provide an additional ligand via a water molecule. Because 
it is not clear which residues in the secondary and tertiary coordination sphere are critical 
to perform the catalytic cycle, a logical first step is to assemble the basic peptide frame-
work of the OEC before considering more complex and potentially superfluous peptide 
domains. The modular DNA-PNA scaffold design described in Chapters 3–5, provides 
flexibility for investigating various combinations of different peptide sequences, as well 
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as introducing additional peptide domains from PSII to further investigate their roles in 
the catalytic cycle.  
By encapsulating the OEC peptides inside a 3D DNA nanostructure, it may be 
possible to perform high resolution structural analysis of the OEC during the catalytic 
cycle, to provide new insights into the mechanism. Previous x-ray analysis of 3D DNA 
nanocage crystals did not provide sufficient resolution to solve the structure.
186
 However, 
incorporating the artificial OEC into the same DNA nanocage in the future could aid 
structure determination by stabilizing the DNA nanocage and providing asymmetry dur-
ing crystal formation, as well as reducing the solvent content and increasing the electron 
density of the crystals during x-ray analysis. 3D DNA nanostructures are also conducive 
to electron transport
187
 and have been incorporated within conductive metal oxide 
films.
137
 Although DNA is a stable molecule,
188,189
 the purine nucleobases can become 
oxidized at potentials as low as 1.0–1.3 V vs NHE at pH 7,190,191 which is close to the 
thermodynamic redox potential for water oxidation of 0.82 V vs NHE at pH 7. Fortunate-
ly, PSII operates efficiently with a low overpotential
192
 suggesting that an artificial OEC, 
which would be able to closely mimic the catalytic center of PSII, could be driven with 
potentials low enough to prevent damage to the DNA nanocage. 
To further constrain the OEC peptides in an orientation that mimics the scaffold 
provided by PSII, the termini of each OEC peptide can be anchored to the DNA 
nanocage, with exception of the C terminal end of the green peptide, which provides a 
direct ligand to the Mn4O5Ca cluster, as shown in Figure 6-5. The OEC peptides could be 
oriented in the DNA nanocage in such a way that would allow for a single PNA strand to 
be used to connect both ends of either the red or yellow peptide at the N terminus and at 
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the gamma position of the 4
th
 PNA base, to form cyclic PNA-peptides. The DNA 
nanocage would, in an ideal arrangement, place each peptide within 0.6 nm of its relative 
position in the PSII crystal structure. The strands used to form this model of the complex 
(DNA-PNA-aOEC) are shown in Table 5-1.  
 
Figure 6-5. Model and schematic of assembling the PSII active site within a DNA 
nanocage using γ-PNA linkers. [Left] A molecular model of the photosystem II (PSII) 
oxygen-evolving complex (OEC) inside the DNA nanocage. [Right] Schematic of the 
DNA nanocage arranging three peptides from the OEC using γ-PNA linkers. The red and 
yellow peptides are cyclized with γ-PNA1 and γ-PNA3, respectively. The green peptide 
is attached directly to the DNA nanocage. The distances between the peptide points of 
attachment in the DNA nanocage model are labeled. The small differences in distances 
compared to the PSII crystal structure are shown in parenthesis, where positive values 
indicate the peptides are further apart in the DNA nanocage than in the protein. 
 
Furthermore, by forming cyclic PNA-peptides, the same two orthogonal linking 
chemistries could be used to form any number of cyclic PNA-peptides, which can each 
be assembled at specific locations within the DNA nanocage based on the unique PNA 
sequence. While it would be ideal to also attach the green peptide to a third PNA se-
quence in order to maintain the most flexibility when assembling the OEC peptides and 
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constructing the artificial OEC, the described DNA nanocage design is best suited for no 
more than one 8nt PNA binding site per edge of the DNA nanocage. Because other near-
by edges in the nanocage would anchor the peptide too far (>2 nm) from the red and yel-
low peptides, the design presented here directly attaches the green peptide to the DNA 
nanocage by chemical crosslinking. 
 
Potential strategy to form cyclic γ-PNA-peptide conjugates 
A potential bioorthogonal conjugation strategy is now discussed, using thiol-
maleimide and alkyne-azide chemistry, as a conceivable strategy to introduce the OEC 
peptides into the DNA nanocage, as shown in Figure 6-6. The γ-PNA1 and γ-PNA3 se-
quences were designed to form cyclic PNA-peptides with the red and yellow peptides 
from the PSII active site, respectively. The following γ-PNA sequences were purchased 
(PNA Bio, Thousand Oaks, CA, USA) with the desired functionalization (written from N 
to C terminus): γ-PNA1 {N3-AGCG(Lys-C3SH)ATGG}, γ-PNA3 {N3-AACG(Lys-
C3SH)GCGA}, where N3 is an N terminal azide functionalization, and Lys-C3SH is a 
thiol with a 3 carbon linker conjugated to a lysine residue at the gamma position of the 4
th
 
PNA base from the N terminus. The chemical structure of PNA showing the gamma sub-
stitution position on the backbone is presented in Figure 1-6.  
The peptide sequences are provided in Table 5-1. Because no cysteine or lysine 
residues are present in any of the peptide sequences identified from PSII, they can be 
added to the termini of each sequence as low cost, orthogonal handles, which can be 
functionalized in solution after peptide synthesis. The 15 amino acid (AA) red peptide 
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was designed with N terminal maleimide functionalization for conjugating to the thiol at 
the gamma position of γ-PNA1. A C terminal lysine residue was added to the red peptide 
 
Figure 6-6. Proposed conjugation scheme to form cyclic γ-PNA-peptides and DNA-
peptides for assembling the artificial OEC. Description provided in the text. 
 
sequence as a handle to introduce alkyne functionalization for conjugating to the N ter-
minal azide of γ-PNA1. The 40AA yellow peptide was designed with a free amino termi-
nus for introducing alkyne functionalization for conjugating to the N terminal azide of γ-
PNA3. A C terminal cysteine residue was added to the yellow peptide sequence as a han-
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dle to introduce maleimide functionalization for conjugating to the thiol at the gamma 
position of γ-PNA3. The maleimide may be introduced with bis(maleimido)ethane, by 
using a large excess of to prevent cross-linking . The 27AA green peptide was designed 
with N terminal maleimide functionalization for conjugating to thiolated ssDNA. In order 
to complete the peptide functionalization, the strained alkyne dibenzocyclooctyl (DBCO) 
functionalized with N-hydroxysuccinimide (ClickChemistryTools, Scottsdale, AZ, USA) 
may be used to introduce the necessary alkyne to the C terminal lysine on the red peptide 
and the N terminus of the yellow peptide. Strained alkynes, such as DBCO, can be effi-
ciently conjugated to azides without adding any copper catalyst,
154,155
 which can be diffi-
cult to completely remove
155,156
 and could compete with manganese binding during as-
sembly of the artificial OEC.  
 The proposed conjugation scheme to form the cyclic γ-PNA-peptides is shown in 
Figure 6-6. In step 1, using the same approach for labeling the PNAs with Cy5, copper-
free click chemistry is used to conjugate the C and N terminus of the red and yellow pep-
tides functionalized with DBCO to the N terminal azide on γ-PNA1 or γ-PNA3, respec-
tively. Because strained alkynes can sometimes have mild cross-reactivity with other nu-
cleophiles,
193
 the click reaction is carried out under mildly acidic conditions of pH 4 to 
ensure the thiol remains protonated and cannot react with DBCO. In step 2, the PNA-
peptides are resuspended in phosphate buffer at pH 7.2 in the presence of TCEP to per-
form the cyclization reaction between the N and C terminal maleimide on the red and yel-
low peptide to γ-PNA1 and γ-PNA3, respectively. The reaction is performed at high dilu-
tion (nanomolar) to favor the formation of intramolecular cyclization over the competing 
intermolecular reaction leading to polymerization.
194
 The N terminal maleimide of the 
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green peptide is directly conjugated to the thiol of ssDNA in the same fashion, but at high 
concentration (micro to millimolar), since there is no possibility of forming polymers. It 
is worth noting that by performing the click reaction first, TCEP can be used to reduce 
any oxidized thiols prior to maleimide conjugation, which would otherwise rapidly re-
duce the γ-PNA N terminal azides to primary amines.195 
Synthesis of the OEC peptides used in the conjugation scheme proposed above 
might be challenging. I requested several companies (Pierce and Genscript) to synthesize 
the OEC peptides, but they were unable to successfully synthesize and purify all three 
peptides due to their hydrophobicity. Genscript was able to synthesize the more water 
soluble green peptide (27AA) with >95% purity and the shorter red peptide (15AA) with 
~80% purity, but was unable to synthesize and purify the longer yellow peptide (40AA). 
RP-HPLC purification of the more hydrophobic peptides might be improved in the future 
using small amounts of methanol or ethanol mixed with water in the stationary phase to 
prevent peptide aggregation on the column, followed by eluting the peptide with isopro-
panol instead of acetonitrile.
196
 In order to improve synthesis yields, the yellow peptide 
solubility could be improved by shortening the sequence or inserting charged residues.
197
 
Alternatively, the yellow peptide could be expressed in a biological system with a soluble 
fusion protein.
198
  
  
Potential strategy to assemble and operate the artificial OEC 
The DNA nanocage design used throughout this dissertation provides flexibility 
to control the timing and sequence of OEC peptide assembly using PNA linkers, allowing 
many assembly conditions to be investigated. The green peptide could be conjugated to 
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one of the ssDNA sequences (S3Mc-SH) and then assembled along with the DNA 
nanocage or conjugated to the preassembled DNA nanocage. The red and yellow peptides 
are each conjugated to separate PNAs and can be assembled concurrently or in a particu-
lar sequence by incubation each with the preformed DNA nanocage, with or without the 
green peptide. A stepwise process to assemble the OEC may also help to reduce the com-
plexity of its formation, by first assembling mono or dimanganese complexes, such as 
those found in some bacterial reaction centers
199
 and superoxide dismutase (mono-Mn) or 
in manganese catalase (di-Mn). Manganese catalase is hypothesized to be a precursor in 
the evolution of the OEC, which may provide a clue as to how to assemble more complex 
manganese containing catalytic centers.
200
 Manganese superoxide dismutase also has a 
mild redox potential of 0.3–0.4 V vs NHE, which is easily tolerated by the DNA 
nanocage.
201
 Formation of the Mn4O5Ca cluster can be performed after, or concurrent 
with, the OEC peptide assembly, and may be accomplished through the addition of calci-
um chloride and manganese acetate followed by, or concurrent with, the (elec-
tro)chemical oxidation of the manganese to the catalytically active manganese oxidation 
states (i.e., III, IV or V).
202
  
The thermodynamic potential of water oxidation (0.82 V vs NHE) provides a 0.2–
0.5 V window to drive the reaction without potential damage to the DNA nanocage 
through oxidation of the guanine nucleobases. Although this is a relatively small over-
head, native PSII operates with low overpotential. De novo designed water oxidation cat-
alysts also suffer from many limitations, such as low turnover rates, low stability and 
high cost.
203
 The approach described here has the advantage that the OEC from PSII is 
known to function as a highly active and robust catalyst. If the activity of the assembled 
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artificial OEC is found to be low, the flexibility of the described methodology to assem-
ble the DNA-PNA-polypeptide complexes may allow the assembled catalyst to be opti-
mized further, perhaps through molecular evolution. By integrating the artificial OEC 
into nanopourous electrodes,
137
 the artificial OEC could be driven directly, without a re-
action center, and thus would not suffer the same damage that occurs in the native PSII 
reaction center, thus extending the longevity of the artificial OEC and improving its eco-
nomic viability. 
 
Conclusion 
PSII is a remarkable water oxidation catalyst that currently exceeds the perfor-
mance and stability of most synthetic catalysts, even those using cost-prohibitive rare 
earth metals (e.g., Pt, Ir, Ru). However, when integrated in the photosynthetic electron 
transport chain, PSII can quickly saturate the pool of electron acceptors, such that toxic 
radicals are generated during charge recombination, which cause irreversible damage to 
the catalyst. In this chapter we presented and discussed a novel approach to reassemble 
the oxygen-evolving complex, which encompasses the PSII catalytic site of water oxida-
tion, inside a stable DNA nanocage. By integrating the OEC into synthetic systems it may 
prevent charge recombination and extend its longevity. In this way, it may be possible to 
leverage the performance of this highly active catalyst without being constrained by the 
constant damage that occurs within photosynthetic organisms.  
Building an artificial OEC from PSII presents many challenges, such as synthesiz-
ing and purifying several hydrophobic peptides, assembling an active site containing five 
metal sites of two different metals (Mn4O5Ca) and must be driven using fairly high redox 
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potentials (>0.82 V vs NHE). The prospective design strategy proposed here provides 
flexibility to control the timing and sequence of OEC peptide assembly, allowing many 
assembly conditions to be investigated, and may provide further insight into the catalytic 
mechanism of one of nature’s most remarkable proteins. Furthermore, by mimicking one 
of the best known water oxidation catalyst, which is made of earth abundant materials, 
the artificial OEC could provide a recipe to design economically viable solar to fuel cata-
lysts. 
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CHAPTER 7 – Summary and Outlook 
Summary 
This dissertation describes a gentle and flexible methodology for using short (8nt) 
PNA linkers to rapidly assemble polypeptides within a 3D DNA nanocage, as a proof of 
concept for constructing artificial catalytic centers. This is the first time that PNA has 
been used to assemble polypeptides into 3D DNA nanostructures. Toehold-mediated 
DNA strand displacement is introduced as an effective method for purifying PNA and 
PNA-protein conjugates. Denaturing PAGE was introduced as an efficient method to pu-
rify PNA fluorescently labeled with Cy5. The PNA-polypeptides could be introduced 
quantitatively by incubating at room temperature with the preassembled DNA nanocage 
for 2 minutes or 5–10 minutes for the PNA-proteins or PNA-peptides, respectively. The 
PNA-proteins could also be assembled within 4 minutes at 11 ⁰C. The presence of protein 
increased the PNA solubility, allowing the PNA-protein conjugate to bind to the DNA 
nanocage in near stoichiometric quantities, with faster binding kinetics and with in-
creased hybridization efficiency than the same PNA sequence conjugated to a short, neu-
tral peptide.
79
 A TMR dye label was found to significantly stabilize PNA-peptide binding 
to the DNA nanocage, increasing the dissociation temperature by 9.2 °C from a predicted 
value of 36.6 °C to 45.8 °C.  
The effect of the surface charge of two different proteins on their interactions with 
a DNA nanocage was also investigated. Data from biophysical characterization using gel 
electrophoresis as well as steady state and time resolved fluorescence spectroscopy al-
lowed us to develop a model for the arrangement of the PNA-polypeptides inside the 
DNA nanocage that is in agreement with the intended design. Our model suggests that 
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the negatively charged azurin is repelled away from the DNA nanocage, whereas the pos-
itively charged cytochrome c remains within and closely interacts with the DNA 
nanocage. The negatively charged DNA nanocage environment also reduces the redox 
potential of cytochrome c by 10 mV, but still remains catalytically active when incorpo-
rated into the DNA nanocage. A methodology for using cyclic PNA-peptides to construct 
an artificial oxygen-evolving complex is also described. This approach could also be ex-
tended to assemble artificial catalytic centers from one of the many other diverse en-
zymes found in nature, in order to investigate their function, and to improve their perfor-
mance and economic viability. 
 
Outlook 
Proteins use a number of metals and cofactors to carry out a wide range of inter-
esting chemistry, many of which have far fewer constraints than the OEC described in 
Chapter 6, and may be useful targets for assembling peptide based catalytic centers with-
in DNA nanocages. Heme containing proteins, such as cytochrome c and horseradish pe-
roxidase, have much simpler active sites, made up of iron coordinated within a porphyrin 
macrocycle, which might be more easily incorporated into a DNA nanocage. Iron is also 
commonly complexed by inorganic and cysteine sulfurs to form iron-sulfur clusters, such 
as those found in ferredoxins and hydrogenases, and, due to their spontaneous assembly 
in vitro, might be more easily incorporated into peptide assemblies stabilized by a DNA 
nanocage.
204
 Giovanna Ghirlanda’s group has de novo designed and synthesized several 
remarkable water soluble, peptide-based analogs of heme
205
 and iron-sulfur cluster con-
taining proteins,
206,207
 which could be used as building blocks for assembling higher order 
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redox active complexes within DNA nanostructures to promote catalytic cascades, to en-
gineer more elaborate artificial electron transfer pathways,
206
 or to enhance solar-driven 
fuel production.
207
 Together, the redox potentials of both heme and iron-sulfur cluster 
proteins span a remarkable range of over 1000 mV, which could be tuned for operating 
within the DNA nanocage.
208
 Cupredoxins are a class of copper containing redox proteins 
that are water soluble and have relatively simple active sites and modest redox potentials, 
which are also good candidates to be assembled within DNA-PNA-peptide complexes.
209
  
The 3D DNA nanocage design could also be modified to accommodate the re-
markable diversity of enzymes and active sites found in nature. The DNA nanocage could 
be further expanded to connect up to 4-6 polypeptides (up to 60 kDa)
50
 on adjacent edges 
of the DNA nanocage, by introducing the appropriate PNA binding sequences. The abil-
ity to systematically introduce different proteins or peptides into defined locations within 
such a three dimensional structure may also facilitate investigating protein-protein inter-
actions. The maturation of the DNA nanotechnology field has greatly simplified the pro-
cess of designing a wide variety of DNA nanostructures. Incorporating proteins and pol-
ypeptides into 3D DNA nanostructures by means of a PNA linker facilitates exploiting 
the enormous diversity of DNA nanostructures for investigating and engineering func-
tional 3D protein-nucleic acid complexes. The flexibility of the methods described here 
offer a biomimetic route to rebuild protein active sites and further expand the structure 
and functional landscape of polypeptide engineering. This has the potential to revolution-
ize the process of designing and building robust catalysts by leveraging the recipes con-
tained within nature’s remarkable molecular machines, and also providing a flexible and 
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controlled artificial environment that might even improve them further towards commer-
cial viability. 
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